ML20072L241
| ML20072L241 | |
| Person / Time | |
|---|---|
| Site: | Midland |
| Issue date: | 06/30/1983 |
| From: | Jackie Cook CONSUMERS ENERGY CO. (FORMERLY CONSUMERS POWER CO.) |
| To: | Harold Denton Office of Nuclear Reactor Regulation |
| References | |
| 22018, PROC-830630, NUDOCS 8307130222 | |
| Download: ML20072L241 (126) | |
Text
7w Of OFFSITE DOSE CALCULATION MANUAL FOR CONSUMERS POWER COMPAhT MIDLAND PLANT JUhT. 1983 i
A O hg9 E PDR ODCM, Midland, Consumers Power Company miO283-1828a131-25 L
t
- TABLE OF CONTENTS LIST OF TABLES . . . . . . . . . . .. . .. . . . . . . . . . . . . . iii LIST OF FIGURES . . . . . . . . . . . . . . . . . . . . . . . . . . . iv REFERENCES . . . . . . . . . . . . . . . . . . .. . . . . . . .. . . v INTRODUCTION . . . . . . . . . . . . . . . . . .. . . .. . . . . . . vi 1.0 LIQUID EFFLUENTS . . . . . . . . . . . . . . . . . . . .. . . . 1.0-1 1.1 LIQUID EFFLUENT MONITOR SETPOINTS . . . . . . . . . . . . . 1.0-1 1.1.1 LIQUID RADWASTE AND LAUNDRY EFFLUENT LINE MONITORS . . . . . . . . . . . . . . . . . . . . . . 1.0-1 1.1.2 TURBINE BUILDING NEUTRALIZER SUMPS (UNIT 1 AhT UNIT 2) EFFLUENT LINES . . . . . . . . . . . . . . . 1.0-9 1.1.3 OILY WASTE SYSTEM EFFLUENT LINE . . . . . . . . . . . 1.0-10 1.1.4 CONSIDERATION OF BACKGROUND AND MONITOR RESPONSE ADJUSTMENTS IN ESTABLISHING LIQUID MONITOR SETPOINTS . . . . . . . . . . . . . . . . . . 1.0-11 1.2 DOSE CALCULATION FOR LIQUID EFFLUENTS . . . . . . . . . . . 1.0-12 1.3 DEFINITIONS OF LIQUID EFFLUENT PARAMETERS . . . . . . . . . 1.0-21 1.4 LIQUID RADWASTE TREATMENT SYSTEM . . . . . . . . . . . . . . 1.0-25 2.0 GASEOUS EFFLUENTS . . . . . . . . . . . . .. . . . . . . . . . . 2.0-1 2.1 GASEOUS EFFLUENT MONITOR SETPOINTS . . . . . . . . . . . . . 2.0-1 2.1.1 REACTOR CONTAINMENT BUILDING VENT STACK (UNIT 1 AND UNIT 2), AUXILIARY BUILDING VENT STACK NO. 1, AND CONDENSER AIR EJECTOR (UNIT 1 AhT UNIT 2) . . . . . . . . . . . . . . . . . . . . . . . 2.0-2 2.1.2 AUXILIARY BUILDING VENT STACK NO. 2 (EMERGENCY) . . . 2.0-5 2.1.3 GASEOUS RADWASTE SYSTEM, REACTOR CONTAINMENT BUILDING PURGE, AND AIR ROOM PURGE . . . . . . . .. 2.0-6 ODCM, Midland, Consumers Power Company miO283-1828a131-25 i
.I
e o l
TABLE OF CONTENTS (Continued) 2 1.4 CONSIDERATION OF BACKGROUND AND MONITOR RESPONSE ADJUSTMENTS IN ESTABLISHING GASEOUS MONITOR-SETPOINTS . ..................... 2.0-11 2.2 GASEOUS EFFLUENT DOSE RATE AND DOSE CALCULATIONS . . . . . . 2.0-14 2.2.1 SITE BOUNDARY DOSE RATES . . . . . . . . . . . . . . 2.0-14 2.2.2 AIR DOSE AND DOSE TO INDIVIDUAL . . . . . . . . . . . 2.0-17 2.3 DEFINITIONS OF GASEOUS EFFLUENTS PARAMETERS . . . . . . . . 2.0-64 2.4 GASEOUS RADWASTE TREATMENT SYSTEM . . . . . . . . . . . . . 2.0-76 3.0 RADIOLOGICAL ENVIRONMENTAL MONITORING . . . . . . . . . . . . . . 3.0-1 l
I i
I i
l I
l ODCM, Midland, Consumers Power Company miO283-1828a131-25 ii i
y- - - - - , _-,+,y ., . , . - - - , , - . - a . - - , - , . ---. ,-. .. - ~ , ,, , , , , ,,, -. _--
..e
o d LIST OF TABLES Table Title Page 1.2-1 Bioaccumulation Factors . . . . . . . . . . . . . . . . . . 1.0-14 1.2-2 Adult Ingestion Dose Factors . . . . . . . . . . . . . . . . 1.0-15 1.2-3 Site Related Ingestion Dose Commitment Factor, A. . . . . . 1.0-18 1T 2.1-1 Dose Factors for Exposure to a Semi-Infinite Cloud of Noble Gases . . . . . . . . . . . . . . . . . . . . . . . . . 2.0-13 2.2-1 Inhalation Dose Factors for Infants . . . . . . . . . . . . . 2.0-33 2.2-2 Inhalation Dose Factors for Children . . . . . . . . . . . . 2.0-36 2.2-3 Inhalation Dose Factors for Teenagers . . . . . . . . . . . . 2.0-39 2.2-4 Inhalation Dose Factors for Adults . . . . . . . . . . . . . 2.0-42 2.2-5 Ingestion Dose Factors for Infants . . . . . . . . . . . . . 2.0-45 2.2-6 Ingestion Dose Factors for Children . . . . . . . . . . . . . 2.0-48 2.2-7 Ingestion Dose Factors for Teenagers . . . . . . . . . . . . 2.0-51 2.2-8 Ingestion Dose Factors for Adults . . . . . . . . . . . . . . 2.0-54 2.2-9 External Dose Factors for Standing on Contaminated Ground . . 2.0-57 2.2-10 Individual Usage Factors . . . . . . . . . . . . . . . . . . 2.0-60 2.2-11 Stable Element Transfer Data . . . . . . . . . . . . . . . . 2.0-61 2.2-12 Controlling Receptors, Locations, and Pathways . . . . . . . 2.0-62 2.2-13 Relative Concentrations and Relative Depositions . . . . . 2.0-63 3.0-1 Radiological Environmental Monitoring Program . . . . . . . 3.0-2 ODCM, Midland, Consumers Power Company miO283-1828a131-25 iii
e a t
LIST OF FIGURES Figure Title Page 1.4-1 Minimum Operable Liquid Radwaste Treatment System . . . . .. 1.0-26 1.4-2 Minimum Operable Liquid Radwaste Treatment System (Treatment Systems Discharge Pathways) . . .. . . .. . . . 1.0-27 2.4-1 Gaseous Radwaste Treatment and Ventilation Systems . .. . . 2.0-77 2.4-2 Gaseous Radwaste Treatment and Ventilation Systems .. . . . 2.0-78 2.4-3 Gaseous Radwaste Treatment and Ventilation Systems . . . . . 2.0-79 3.0-1 Environmental Sampling Location Map on the Site Periphery . . .. . . . . . . . . . . . . . . . . . . . 3.0-3 3.0-2 Environmental Sampling Location Map Beyond the Site Vicinity . . . . .. . .. . . . . . . . . . . . . . 3.0-4 ODCM, Midland, Consumers Power Company miO283-1828a131-25 iv
.a o REFERENCES
- 1. J. S. Boegli, R. R. Bellamy, W. L. Britz, and R. L. Waterfield,
" Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants," NUREG-0133 (October 1978).
- 2. Calculation of Annual Doses to Man From Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR 50, Appendix I, U.S. NRC Regulatory Guide 1.109 (March 1976).
- 3. Calculation of Annual Doses to Man From Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR 50, Appendix I, U.S. NRC Regulatory Guide 1.109, Rev. 1 (October 1977).
- 4. " Environmental Report, Operating License Stage," Consumers Power Company, Midland Plant.
- 5. " Final Safety Analysis Report," Consumers Power Company, Midland Plant.
- 6. Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases From Light-Water-Cooled Reactors, U.S. NRC Regulatory Guide 1.111 (March 1976).
- 7. Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases From Light-Water-Cooled Reactors, U.S. NRC Regulatory Guide 1.111, Rev. 1 (July 1977).
ODCM, Midland, Consumers Power Company miO283-1828a131-25 v
a 0 INTRODUCTION The-OFFSITE DOSE CALCULATION MANUAL (ODCM) is a supporting document of the-TECHNICAL SPECIFICATIONS (TS). As such the ODCM describes the methodology and parameters to be used in the calculation of offsite doses due to radioactive liquid and gaseous effluents and in the calculation of liquid and gaseous effluent monitoring instrumentation alarm / trip setpoints. The ODCM contains a list and graphical description of the specific sample locations for the Radiological Environmental Monitoring Program. Minimum LDERABLE configura-tions of the liquid and gaseous radwaste treatment systems are also included.
The ODCM will be maintained at the plant for use as a reference guide and training document of accepted methodologies and calculations. Changes in the calculaticnal methods or parameters will be incorporated into the ODCM in order to assure that the ODCM represents the present methodology in all applicable areas. Computer software to perform the described calculations will be maintained current with this ODCM.
i ODCM, Midland, Consumers Power Company miO283-1828a131-25 vi
. o SECTION 1.0 LIQUID EFFLUENTS The Midland Plant is located on the Tittabawassee River whic4 supplies make-up water to the Cooling Pond and receives blowdown from the Cooling Pond.
Radioactive liquid effluents are released via the Cooling Pond Blowdown to the Tittabawassee River.
1.1 LIQUID EFFLUENT MONITOR SETPOINTS The liquid monitor setpoint values determined in the following sections will be regarded as upper bounds for the actual setpoint adjustments. Setpoint adjustments are not required to be performed if the existing monitor setpoint is lower than the calculated value. Setpoints may be established at values lower than the calculated values if desired.
For the Midland Plant, liquid monitor setpoints are calculated for concentra-tions, in pCi/ml. The actual monitor setpoint, which corresponds to the calculated concentration plus background for the particular monitor, is determined from calibration data or from operational data associated with liquid sample analysis data. (See Section 1.1.4.)
t i
1.1.1 LIQUID RADWASTE AND LAUNDRY EFFLUENT LINE MONITORS
( Liquid Radwaste Effluent Line Monitors provide alarm and automatic termination of release functions prior to exceeding the concentration limits specified in 10 CFR 20, Appendix B, Table II, Column 2 at the release point to t.he unre-stricted area. To meet this specification, the alarm / trip setpoir.ts for ODCM, Midland, Consumers Power Company miO283-1828b131-20 1.0-1
I l
l liquid effluent monitors and flow measurement devices are set to assure that
]
1 the following equation is satisfied:
yff<CMPC (I) where
, CMPC = the effluent concentration limit (TS 3.11.1.1) implementing'10 CFR 20 for the site, corresponding to the specific mix of radionuclides in the effluent stream being considered for discharge, in pCi/ml.
e = the setpoint, in pCi/m1, of the radioactivity monitor measuring the concentration of radioactivity in the effluent line prior to dilution and subsequent release; the setpoint, which is inversely proportional to the volumetric flow of the effluent line and proportional to the volumetric flow of the dilution stream plus the effluent stream, represents a value which, if exceeded, would result in concentrations exceeding the limits of 10 CFR 20 in the unrestricted area.
f = the flow setpoint as determined at the radiactivity monitor location, in volume per unit time, but in the same units as F, below.
F = the dilution water flow setpoint as determined prior to the release point, in volume per unit time.
At the Midland Plant, the Liquid Radwaste System Monitor Tanks and the Laundry Drain Tanks discharge via the Cooling Pond Blowdown Line to the Tittabawassee River. The dilution flow (F) may come from Cooling Pond Blowdown or the Cooling Pond Makeup Pumps. The waste process flow (f) and the monitor ODCM, Midland, Consumers Power Company miO283-1828b131-20 1.0-2
E setpoint (c) for the particular pathway are determined and set to meet the conditions of Equation (1) for a given effluent concentration, C he MPC.
method by which this is accomplished is as follows:
Step 1 The radionuclide concentration for a waste tank to be released is obtained from the sum of measured concentrations as determined by the analyses required in TS Table 4.11-1:
I C.i = Ig Cg + (C a +C s +C) t (2) i where Cg = the concentration of each measured gamma emitter observed by gamma-ray spectroscopy of each waste sample.
C, = the concentration of alpha emitters in liquid waste as measured in the' MONTHLY composite sample. (NOTE: Sample is analyzed for gross l a.)
C, = the measured concentrations of Sr-89 and Sr-90 in liquid waste as l observed in the QUARTERLY composite sample.
l i l C = the measured concentration of H-3 in liquid waste as determined from
- analysis of the MONTHLY composite sample.
ODCM, Midland, Consumers Power Company miO283-1828b131-20 1.0-3 L
I The C 8 term will be included in the analysis of each batch; terms for I alpha, strontiums, and tritium will be included in the evaluation in accordance with TS Table 4.11-1.
Step 2 The measured radionuclide concentrations are used to calculate a Dilution Factor, F , which is the ratio of total dilution flow rate to tank flow D
rate required to assure that the limiting concentrations of 10 CFR 20, Appendix E, Table II, Column 2 are met at the point of discharge. The dilution factor is calculated as follows:
F D = I (C g/MPCg ) + FS
= [Ig(C /MPC g g) + C a
/MPCa + C s/MPCs + C t/MPCt ] + F S (3) where Cg = measured concentrations of Cg , C,, Cs , and Ct as defined in Step 1. Terms C,, C3 , and C will be included in the calculation as appropriate.
MPC = MPC , MPC , MPC,, and MPC are limiting concentrations of the f s appropriate radionuclide from 10 CFR 20, nppendix B, Table II, Column 2. For dissolved or entrained nob e gases, the concentra-tion shall be limited to 2 x 10 ' pCi/ml tbtal activity.
F 3
= the safety factor; a conservative factor used to compensate for statistical fluctuations and errors of measurements. (For exam-l ple, Fg = 0.5 corresponds to a 100 percent variation.)
L l
ODCM, Midland, Consumers Power Company miO283-1828b131-20 1.0-4
Step '4 For the case FD ;< 1, the waste tank effluent concentration meets the limits of 10 CFR 20 without dilution and the liquid waste effluent may be released at any desired flow rate. Therefore, the remainder of Step 3 and Step 4 should be omitted and the radioactivity monitor setpoint calculated in accordance with Step 5.
For each liquid release pathway for which FD > I' " difi*d dii"ti "
factor, FDN, must be determined so that available dilution may be appor-tioned among simultaneous discharge pathways as follows:
FDN = FD+ A (')
Fg is an administrative allocation factor which may be assigned any value
'4 tween 0 and 1 under the condition that:
I (FA)n 51 n (5) where n = the number of liquid discharge pathways for which Fp > 1 and which are
- planned for simultaneous release. (For convenience FA m y be assigned the value 1/n, if desired.)
The maximum permissible undiluted waste tank effluent flow rate,pf , is calculated based on a selected fraction of the dilution flow rate, f d, and the modified dilution factor, F DN t
ODCM, Midland, Consumers Power Company miO283-1828b131-20 1.0-5
-'-i- - - - -y- - - --
,,mg- m-y -y *m
? , wiv--ww e :t - 4%-
e <
f 5 fd+fp, f d
P F F for fd >> fp (see Note 1) (6)-
DN DN where fd=F xp expected dilution flow rate (see Note 2).
Fp = a selected percent of actual dilution flow rate.
NOTE 1: Normally, the calculated maximum permissible flow rate, f , will be p
greater than the pump capacity (actual maximum flow) for a particular discharge pathway. However, if fp is less than pump capacity, steps must be taken to assure that Equation (1) is satisfied prior to mak-ing the release. These steps may include decreasing I Cg ,-increasing f d, reducing f for p other simultaneous release pathways, or by decreasing the number of simultaneous discharge pathways.
NOTE 2: In the event Cooling Pond Diowdown is being used for dilution and radioactivity in the Cooling Pond exceeds LLD values, the expected dilution flow rate must be multiplied by the term:
1 - 1g (C./MPC.)
i i cooling pond This factor is applied to account for reduced dilution capacity due to radioactivity already present in the dilution stream.
Thus, flow rate monitor setpoints are set at or below f determined for P
those discharge pathways for which simultaneous discharges are permis-sible. For those discharge pathways for which FD < 1, the flow rate setpoint may be assigned any desired value.
i ODCM, Midland, Consumers Power Company miO283-1828b131-20 1.0-6
A
. s Step 4 The dilution flow rate setpoint for minimum dilution flow rate, SD, is established at a selected percent, Fp , of the expected dilution flow rate:
SD* d (7)
Step 5 The liquid radioactivity monitor setpoint may now be determined based on the values of I C f, f , dand f which p
were specified to provide compliance with the limits of 10 CFR 20, Appendix B, Table II, Column 2. The monitor response is primarily to gamma r.idiation; therefore, the actual setpoint is based on I C . The monitor setpcint, in pCi/ml, which corresponds to E 8 the particular setpoint concentratior, c, is determined based on monitor calibration data or on operational data which correlates monitor response to sample analyses associated with actual effluent releases.
The setpoint concentration, c, is deternined as follows:
c=F IC pCi/ml (see Note 3 below) (3)
AA g g where FAA = adjustment factor which will allow the setpoint to be established in
, a practical manner for convenience and to prevent spurious alarms.
(see Note 4 below) (9)
= fp/f(actual)
ODCM,' Midland, Consumers Power Company miO283-1828b131-20 1.0-7
If Fg 2.1, calculate e and determine the maximum value for the actual monitor setpoint (pCi/ml).
If Fg .< 1, no release may be made. Re-evaluate the alternatives presented in Steps 3 and 4.
NOTE 3: The calculated setpoint concentration, c, establishes the base value for the monitor setpoint. However, in establishing the actual raonitor setpoint for a particular monitor, background radiation levels and monitor response adjustments must be considered. These considerations are discussed in Section 1.1.4.
NOTE 4: If Ig < 1, Fg = 1/FD f r the particular pathway based on associated concentrations.
Within the limi s of the conditions stated above, the specific monitor setpoints for the Liquid Radwaste Monitor and the Laundry Waste Monitor are determined as follows:
Liguid Radwaste Discharge Line Monitor (ORE-0764)
Perform Step 2, solving Equation (3) for FD using the appropriate values in the concentration term from the sample analyses for the Liquid Radwaste Monitor Tank bat:h to be discharged. If FD < 1, then perform Step 5 to determine the ralioactivity monitor setpoint.
If FD > 1, then perform Steps 3, 4, and 5 to determine fl w monitor setpoints and the radioactivity monitor setpoint.
ODCM, Midland, Consumers Power Company miO283-1828b131-20 1.0-8
. i Laundry Discharge Line Monitor (ORE-0769)
Perform Step 2, solving Equation (3) for F3 using the appropriate values in the concentration term from the sample analyses for the Laundry Drain Tank batch to be discharged. If F D
1, then perform Step 5 to determine the radioactivity monitor setpoint.
If FD > 1, then perform Steps 3, 4, and 5 to determine flow monitor setpoints and the radioactivity monitor setpoint.
1.1.2 TURBINE BUILDING NEUTRALIZER SUMPS (UNITS 1 AND 2) EFFLUENT LIhTS Concentrations of radionuclides in the liquid effluent discharges from the Turbine Building Neutralizer Sumps are expected to be very low. These path-ways release to the Cooling Pond Blowdown Line prior to entering the Tittabawassee River. These releases will be regarded as batch releases. In the absence of primary-to-secondary leakage, as determined by TS 4.4.6.3, no effluent sampling is required for this pathway and the monitor setpoint should be established at three (3) times background.
In the event of primary-to-secondary leakage, sampling will be performed in accordance with TS Table 4.11-1, and setpoints will be determined following the same methodology presented in Section 1.1.1 as follows:
Turbine Building Neutralizer Sump Monitors (Unit 1: 1RE-7007; and Unit 2: 2RE-7007)
For the affected monitor (s), perform Step 2, solving Equation (3) for FD using the appropriate values in the concentration term from the sample analyses specified in TS Table 4.11-1 for the Turbine Building Neutralizer Sump (s) to ODCM, Midland, Consumers Power Company miO283-1828b131-20 1.0-9 ,
l
. i be discharged. If FD < 1, then perform Step 5 to determine the radioactivity monitor setpoint.
If F D 1, then perform Steps 3, 4, and 5 to determine flow monitor setpoints and the radioactivity monitor setpoint.
1.1.3 OILY WASTE SYSTEM EFFLUENT LINE Concentrations of radionuclides in the liquid effluent discharge from the Oily Waste System are expected to be very low. This pathway releases to the Cooling Pond Blowdown Line prior to entering the Tittabawassee River. This release will be regarded as a continuous release. In the absence of primary-to-secondary leakage, as determined by TS 4.4.6.3, no effluent sampling is required for this pathway and the monitor setpoint should be established at three (3) times background.
In the event of primary-to-secondary leakage, sampling will be performed in accordance with TS Table 4.11-1, and setpoints will be determined following the same methodology presented in Section 1.1.1 as follows:
Oily Waste System Discharge Monitor (0RE-7054)
Perform Step 2, solving Equation (3) for FD using the appropriate values in the concentration term from the sample analyses specified in TS Table 4.11-1 for the Oily Waste System. If FD < 1, then perform Step 5 to determine the radioactivity monitor setpoint.
If FD > 1, then perform Steps 3, 4, and 5 to determine flow monitor setpoints and the radioactivity monitor setpoint.
ODCM, Midland, Consumers Power Company miO283-1828b131-20 1.0-10
~ - - . _ . .
1.1.4 CONSIDI.1ATION OF BACKGROUND AND MONITOR RESPONSE ADJUSTMENTS-IN ESTABLISHING LIQUID MONITOR SETPOINTS The calculated setpoint concentration, c, establishes the base value for the
-monitor setpoint. However, in establishing the actual monitor setpoint for a particular monitor, background radiation levels and monitor response adjust-ments must be considered.
Contributions to background radiation levels may include ambient background, plant environmental background at monitor locations when plant is in shutdown status, plant environmental background at monitor location when plant is at power, and internal background of monitor due to contamination of sample cham-ber. Normally, the actual monitor setpoint includes the calculated setpoint value plus background. Background levels must be controlled such that radio-activity levels in the effluent stream being monitored can be accurately assessed at or below the calculated setpoint value.
Monitor response adjustments may be necessary to assure that monitor readout accurately reflects radioactivity levels in the monitored effluent stream.
Monitor adjustments (monitor setting) may be based on monitor calibrations, monitor calibration data supplied by the monitor vendor, or by operational data which correlates monitor response to sample analyses associated with actual effluent releases. At the Midland Plant the monitor response adjust-ment which correlates actual monitor response to monitor response expected, based on associated sample analyses, is Teferred to as the gain factor.
ODCM, Midland, Consumers Power Company miO283-1828b131-20 1.0-11
.g O' 1.2 DOSE CALCULATION FOR LIQUID EFFLUENTS The dose contribution to the maximum exposed individual from all radionuclides identified in liquid effluents released to unrestricted areas is calculated using the following expression:
m D7 = I [Ag g[3 At Cg ggFg] (10)
I where D
7
= the cumulative dose commitment to the total body or any organ T from m
the liquid effluents for the total time period g[1 Atg, in mrem
-(Reference 1).
At g = the length of the fth time period over which C g and Ff are averaged for all liquid releases, in hours.
Cg = the average concentration of radionuclide i in the undiluted liquid effluent during~ time period At gfrom any liquid release, in pCi/ml.
Ag = the site related ingestion dose commitment factor to the total body or any organ I for each identified principal gamma and beta emitter listed in Table 1.2-3 in mrem-m1 per hr-pCi.
A g = Kg(UF BF g )DF g (11)
ODCM, Hidland, Consumers Power Company miO283-1828b131-20 1.0-12
1 i
i Fg = the near field average dilution factor for C ig during any liquid j effluent release. Defined as the ratio of the undiluted liquid waste flow during release to the product of the average flow from the discharge structure to unrestricted receiving water times 2.
(average undiluted liquid waste flow)
(average flow from the discharge structure during 02) periods of radioactive materials relea:e) x (Z) where Z = 3; applicable dilution factor for the receiving water body (Refer-ence-1, Section 4.3; Reference 5, Section 11.2.3).
K, = units conversion factor, 1.14 x 10 5.
= 106 pCi/pCi x 103 ml/l + 8760 hr/yr (13)
U F
= adult fish consumption (21 kg/yr; taken from Reference 3, Table E-5).
BF i
= bioaccumulation factor for radionuclide i, in fish, in pCi/kg per pCi/1 from Table 1.2-1 (taken from Reference 3, Table A-1).
f7 = dose conversion factor for radionuclide i, for adults in preselected DF organ T, in mrem /pCi, from Table 1.2-2 (taken from Reference 3, Table E-11).
ODCM, Midland, Consumers Power Company miO283-1828b131-20 1.0-13
1 TABLE 1.2-1 Bioaccumulation Factors (pCi/kg per pCi/ liter)*
Element Freshwater Fish H 9.0E-01 C 4.6E+03 Na 1.0E+02 P 1.0E+05 Cr 2.0E+02 Mn 4.0E+02 Fe 1.0E+02 Co 5.0E+01 Ni 1.0E+02 Cu 5.0E+01 Zn 2.0E+03 Br 4.2E+02 Rb 2.0E+03 Sr 3.0E+01 Y 2.5E+01 Zr 3.3E+00 Nb 3.0E+04 Mo 1.0E+01
.Tc 1.5E+01 Ru 1.0E+01 Rh 1.0E+01 Te 4.0E+02 I 1.5E+01 Cs 2.0E+03 Ba -4.0E+00 La 2.5E+01 Ce 1.0E+00 Pr 2.5E+01 Nd 2.5E+01 W 1.2E+03 Np 1.0E+01
- Values in Table 1.2-1 are taken from Reference 3, Table A-1.
ODCM, Midland, Consumers Power Company miO283-1828b131-20 1.0-14
l
. .- 1 I
TABLE 1.2-2 Adult Ingestion Dose Factors *
(mrem /pCi Ingested)
Page 1 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 No Data 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 C-14 2.84E-06 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 Na-24 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 P-32 1.93E-04 1.20E-05 7.46E-06 No Data No Data No Data 2.17E-05 Cr-51 No Data No Data 2.66E-09 1.59E-09 5.86E-10 3.53E-09 6.69E-07 Mn-54 No Data 4.57E-06 8.72E-07 No Data 1.36E-06 No Data 1.40E-05 Mn-56 No Data 1.15E-07 2.04E-08 No Data 1.46E-07 No Data 3.67E-06 Fe-55 2.75E-06 1.90E-06 4.43E-07 No Data No Data 1.06E-06 1.09E-06 Fe-59 4.34E-06 1.02E-05 3.91E-06 No Data No Data 2.85E-06 3.40E-05 Co-58 No Data 7.45E-07 1.67E-06 No Data No Data No Data 1.51E-05 Co-60 No Data 2.14E-06 4.72E-06 No Data No Data No Data 4.02E-05 Ni-63 1.30E-04 9.01E-06 4.36E-06 No Data No Data No Data 1.88E-06 Ni-65 5.28E-07 6.86E-08 3.13E-08 No Data No Data No Data 1.74E-06 Cu-64 No Data 8.33E-08 3.91E-08 No Data 2.10E-07 No Data 7.10E-06 Zn-65 4.84E-06 1.54E-05 6.96E-06 No Data 1.03E-05 No Data 9.70E-06 Zn-69 1.03E-08 1.97E-08 1.37E-09 No Data 1.28E-08 No Data 2.96E-09 Br-83 No Data No- Data 4.02E-08 No Data No Data No Data 5.79E-08 Br-84 No Data No Data 5.21E-08 No Data No Data No Data 4.09E-13 Br-85 No Data No Data 2.14E-09 No Data No Data No Data LT E-24 Rb-86 No Data 2.11E-05 9.83E-06 No Data No Data No Data 4.16E-06 Rb-88 No Data 6.05E-08 3.21E-08 No Data No Data No Data 8.36E-19 Rb-89 No Data 4.01E-08 2.82E-08 No Data No Data No Data 2.33E-21 Sr-89 3.08E-04 No Data 8.84E-06 No Data No Data No Data 4.94E-05 Sr-90 7.58E-03 No Data 1.86E-03 No Data No Data No Data 2.19E-04 Sr-91 5.67E-06 No Data 2.29E-07 No Data No Data No Data 2.70E-05 Sr-92 2.15E-06 No Data 9.30E-08 No Data No Data No Data 4.26E-05 Y-90 9.62E-09 No Data 2.58E-10 No Data No Data No Data 1.02E-04 Y-91m 9.09E-11 No Data 3.52E-12 No Data No Data No Data 2.67E-10 Y-91 1.41E-07 No Data 3.77E-09 No Data No Data No Data 7.76E-05
,- Y-92 8.45E-10 No Data 2.47E-11 No Data No Data No Data 1.48E-05
- Values in Table 1.2-2 are taken from Reference 3, Table E-11.
ODCM, Midland, Consumers Power Company miO283-1828b131-25 1.0-15
TABLE 1.2-2 (Continued)
Adult Ingestion Dose Factors (mrem /pCi ingested)
Page 2 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Y-93 2.68E-09 No Data 7.40E-11 No Data No Data No Data 8.50E-05 Zr-95 3.04E-08 9.75E-09 6.60E-09 No Data 1.53E-08 No Data 3.09E-05 Zr-97' 1.68E-09 3.39E-10 1.55E-10 No Data 5.12E-10 No Data 1.05E-04 Nb-95 6.22E-09 3.46E-09 1.36E-09 No Data 3.42E-09 No Data 2.10E-05 Mo-99 No Data .4.31E-06 8.20E-07 No Data 9.76E-06 No Data 9.99E-06 Tc-99m 2.47E-10 6.98E-10 8.89E-09 No Data 1.06E-08 3.42E-10 4.13E-07 Tc-101 2.54E-10 3.66E-10 3.59E-09 No Data 6.59E-09 1.87E-10 1.10E-21 Ru-103 1.85E-07 No Data 7.97E-08 No Data 7.06E-07 No Data 2.16E-05 Ru-105 1.54E-08 No Data 6.08E-09 No Data 1.99E-07 No Data 9.42E-06 Ru-106 2.75E-06 No Data 3.48E-07 No Data 5.31E-06 No Data 1.78E-04 Ag-110m 1.60E-07 1.48E-07 8.79E-08 No Data 2.91E-07 No Data 6.04E-05 Te-125m 2.68E-06 9.71E-07 3.59E-07 8.06E-07 1.09E-05 No Data 1.07E-05 Te-127m 6.77E-06 2.42E-06 8.25E-07 1.73E-06 .2.75E-05 No Data 2.27E-05 Te-127 1.10E-07 3.95E-08 2.38E-08 8.15E-08 4.48E-07 No Data 8.68E-06 Te-129m 1.15E-05 4.29E-06 1.82E-06 3.95E-06 4.80E-05 No Data 5.79E-05 Te-129 3.14E-08 1.18E-08 7.65E-09 2.41E-08 1.32E-07 No Data 2.37E-08 Te-131m 1.73E-06 8.46E-07 7.05E-07 1.34E-06 8.57E-06 No Data 8.40E-05 Te-131 1.97E-08 8.23E-09 6.22E-09 1.62E-08 8.63E-08 .No Data 2.79E-09 Te-132 2.52E-06 1.63E-06 1.53E-06 1.80E-06 1.57E-05 No Data 7.71E-05 I-130 7.56E-07 2.23E-06 8.80E-07 1.89E-04 3.48E-06 No Data 1.92E-06 I-131 4.16E-06 5.95E-06 3.41E-06 1.95E-03 1.02E-05 No Data 1.57E-06 I-132 2.03E-07 5.43E-07 1.90E-07 1.90E-05 8.65E-07 No Data 1.02E-07 I-133 1.42E-06 2.47E-06 7.53E-07 3.63E-04 4.31E-06 No Data 2.22E-06 I-134 1.06E-07 2.88E-07 1.03E-07 4.99E-06 4.58E-07 No Data 2.51E-10 I-135 4.43E-07 1.16E-06 4.28E-07 7.65E-05 1.86E-06 No Data 1.31E-06 Cs-134 6.22E-05 1.48E-04 1.21E-04 No Data 4.79E-05 1.59E-05 2.59E-06 Cs-136 6.51E-06 2.57E-05 1.85E-05 No Data 1.43E-05 1.96E-06 2.92E-06 Cs-137 7.97E-05 1.09E-04 7.14E-05 No Data 3.70E-05 1.23E-05 2.11E-06 Cs-138 5.52E-08 1.09E-07 5.40E-08 No Data. 8.01E-08 7.91E-09 4.65E-13 Ba-139 9.70E-08 6.91E-11 2.84E-09 No Data 6.46E-11 3.92E-11 1.72E-07 Ba-140 2.03E-05 2.55E-08 1.33E-06 No Data 8.67E-09 1.46E-08 4.18E-05 Ba-141 4.71E-08 3.56E-11 1.59E-09 No Data 3.31E-11 2.02E-11 2.22E-17 Ba-142 2.13E-08 2.19E-11 1.34E-09 No Data 1.85E-11 1.24E-11 3.00E-26 ODCM, Midland, Consumers Power Company miO283-1828b131-25 1.0-16
TABLE 1.2-2 (Continued)
Adult Ingestion Dase Factors (mrem /pCi ingested)
Page 3 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI La-140 2.50E-09 1.26E-09 3.33E-10 No Data No Data No Data 9.25E-05 La-142~ 1.28E-10 5.82E-11 1.45E-11 No Data No Data No Data 4.25E-07 Ce-141 9.36E-09 6.33E-09 7.18E-10 No Data 2.94E-09 No Data 2.42E-05 Ce-143 1.65E-09 1.22E-06 1.35E-10 No Data 5.37E-10 No Data 4.56E-05 Ce-144 4.88E-07 2.04E-07 2.62E-08 No Data 1.21E-07 No Data 1.65E-04 Pr-143 9.20E-09 3.69E-09 4.56E-10 No Data 2.13E-09 No Data 4.03E-05 Pr-144 3.01E-11 1.25E-11 1.53E-12 No Data 7.05E-12 No Data 4.33E-18 Nd-147 6.29E-09 7.27E-09 4.35E-10 No Data 4.25E-09 No Data 3.49E-05 W-187 1.03E-07 8.61E-08 3.01E-08 No Data No Data No Data 2.82E-05 Np-239 1.19E-09 1.17E-10 6.45E-11 No Data 3.65E-10 No Data 2.40E-05 ODCM, Midland, Consumers Power Company miO283-1828b131-25 1.0-17
TABLE 1.2-3 Site Related Ingestion Dose Commitment Factor, A g (mrem /hr per pCi/ml)
Page 1 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 0.00E+00 2.26E-01 2.26E-01 2.26E-01 2.26E-01 2.26E-01 2.26E-01 C-14 3.13E+04 6.26E+03 6.26E+03 6.26E+03 6.26E+03 6.26E+03 6.26E+03 Na-24 4.07E+02 4.07E+02 4.07E+02 4.07E+02 4.07E+02 4.07E+02 4.07E+02 P-32 4.62E+07 2.87E+06 1.79E+06 0.00E+00 0.00E+00 0.00E+00 5.19E+06 Cr-51 0.00E+00 0.00E+00 1.27E+00 7.61E-01 2.81E-01 1.69E+00 3.20E+02 Mn-54 0.00E+00 4.38E+03 8.35E+02 0.00E+00 1.30E+03 0.00E+00 1.34E+04 Mn-56 0.00E+00 1.10E+02 1.95E+01 0.00E+00 1.40E+02 0.00E+00 3.51E+03 Fe-55 6.58E+02 4.55E+02 1.06E+02 0.00E+00 0.00E+00 2.54E+02 2.61E+02 Fe-59 1.04E+03 2.44E+03 9.36E+02 0.00E+00 0.00E+00 6.82E+02 8.14E+03 Co-58 0.00E+00 8.92E+01 2.00E+02 0.00E+00 0.00E+00 0.00E+00 1.81E+03 Co-60 0.00E+00 2.56E+02 5.65E+02 0.00E+00 0.00E+00 0.00E+00 4.81E+03 Ni-63 3.11E+04 2.16E+03 1.04E+03 0.00E+00 0.00E+00 0.00E+00 4.50E+02 Ni-65 1.26E+02 1.64E+01 7.49E+00 0.00E+00 0.00E+00 0.00Et00 4.17E+02 Cu-64 0.00E+00 9.97E+00 4.68E+00 0.00E+00 2.51E+01 0.00E+00 8.50E+02 Zn-65 2.32E+04 7.37E+04 3.33E+04 0.00E+00 4.93E+04 0.00E+00 4.64E+04 Zn-69 4.93E+01 9.43E+01 6.56E+00 0.00E+00 6.13E+01 0.00E+00 1.42E+01 Br-83 0.00E+00 0.00E+00 4.04E+01 0.00E+00 0.00E+00 0.00E+00 5.82E+01 Br-84 0.00E+00 0.00E+00 5.24E+01 0.00E+00 0.00E+00 0.00E+00 4.11E-04 Br-85 0.00E+00 0.00E+00 2.15E+00 0.00E+00 0.00E+00 0.00E+00 1.01E-15 Rb-86 0.00E+00 1.01E+05 4.71E+04 0.00E+00 0.00E+00 0.00E+00 1.99E+04 Rb-88 0.00EiLC 2.90E+02 1.54E+02 0.00E+00 0.00E+00 0.00E+00 4.00E-09 Rb-89 0.00E410 1.92E+02 1.35E+02 0.00E+00 0.00E+00 0.00E+00 1.12E-11 Sr-89 2.21E+04 0.00E+00 6.35E+02 0.00E+00 0.00E+00 0.00E+00 3.55E+03 Sr-90 5.44E+05 0.00E+00 1.34E+05 0.00E+00 0.00E+00 0.00E+00 1.57E+04 Sr-91 4.07E+02 0.00E+SO 1.64E+01 0.00E+00 0.00E+00 0.00E+00 1.94E+03 S r-92 1.54E+02 0.00E+00 6.68E+00 0.00E+00 0.00E+00 0.00E+00 3.06E+03 Y-90 5.76E-01 0.00E+00 1.54E-02 0.00E+00 0.00E+00 0.00E+00 6.10E+03 Y-91m 5.44E-03 0.00E+00 2.11E-04 0.00E+00 0.00E+00 0.00E+00 1.60E-02 Y-91 8.44E+00 0.00E+00 2.26E-01 0.00E+00 0.00E+00 0.00E+00 4.64E+03 Y-92 5.06E-02 0.00E+00 1.48E-03 0.00E+00 0.00E+00 0.00E+00 8.86E+02
- Calculated using Equation (11).
ODCH, Midland, Consumers Power Company miO283-1828b131-25 1.0-18
TABLE 1.2-3 (Continued)
Site Related Ingestion Uose Commitment Factor, A (mrem /hr per pCi/ml) 1I Page 2 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Y-93 1.60E-01 0.00E+00 4.43E-03 0.00E+00 0.00E+00 0.00E+00 5.09E+03 Zr-95 2.40E-01 7.70E-02 5.21E-02 0.00E+00 1.21E-01 0.00E+00 2.44E+02 Zr-97 1.33E-02 2.68E-03 1.22E-03 0.00E+00 4.04E-03 0.00E+00 8.30E+02 Nb-95 4.47E+02 2.48E+02 1.34E+02 0.00E+00 2.46E+02 '0.00E+00 1.51E+06 Mo-99 0.00E+00 1.03E+02 1.96E+01 0.00E+00 2.34E+02 0.00E+00 2.39E+02 Tc-99m 8.87E-03 2.51E-02 3.19E-01 0.00E+00 3.81E-01 1.23E-02 1.48E+01 Tc-101 9.12E-03 1.31E-02 1.29E-01 0.00E+00 2.37E-01 6.72E-03 3.95E-14 Ru-103 4.43E+00 0.00E+00 1.91E+00 0.00E+00 1.69E+01 0.00E+00 5.17E+02 Ru-105 3.69E-01 0.00E+00 1.46E-01 0.00E+00 4.76E+00 0.00E+00 2.26E+02 Ru-106 6.58E+01 0.00E+00 8.33E+00 0.00E+00 1.27E+02 0.00E+00 4.26E+03 ,
Ag-110m 8.81E-01 8.15E-01 4.84E-01 0.00E+00 1.60E+00 0.00E+00 3.33E+02 Te-125m 2.57E+03 9.30E+02 3.44E+02 7.72E+02 1.04E+04 0.00E+00 1.02E+04 Te-127m 6.48E+03 2.32E+03 7.90E+02 1.66E+03 2.63E+04 0.00E+00 2.17E+04 Te-127 1.05E+02 3.78E+01 2.28E+01 7.80E+01 4.29E+02 0.00E+00 8.31E+03 Te-129m 1.10E+04 4.11E+03 1.74E+03 3.78E+03 4.60E+04 0.00E+00 5.54E+04 Te-129 3.01E+01 1.13E+01 7.33E+00 2.31E+01 1.26E+02 0.00E+00 2.27E+01
'Te-131m 1.66E+03 8.10E+02 6.75E+02 1.28Et03 8.21E+03 0.00E+00 8.04E+04 Te-131 1.89E+01 7.88E+00 5.96E+00 1.55E+01 8.26E+01 0.00E+00 2.67E+00 Te-132 2.41E+03 1.56E+03 1.47E+03 1.72E+03 1.50E+04 0.00E+00 7.38E+04 I-130 2.71E+01 8.01E+01 3.16E+01 6.79E+03 1.25E+02 0.00E+00 6.89E+01 I-131 1.49E+02 2.14E+02 1.22E+02 7.00E+04 3.66E+02 0.00E+00 5.64E+01 I-132 7.29E+00 1.95E+01 6.82E+00 6.82E+02 3.11E+01 0.00E+00 3.66E+00 I-133 5.10E+01 8.87E+01 2.70E+01 1.30E+04 1.55E+02 0.00E+00 7.97E+01 1-134 3.81E+00 1.03E+01 3.70E+00 1.79E+02 1.64E+01 0.00E+00 9.01E-03 I
i I-135 1. 5 9E+ 01 - 4.17E+01 1.54E+01 2.75E+03 6.68E+01 0.00E+00 4.70E+01 l
Cs-134 2.98E+05 7.09E+05 5.79E+05 0.00E+00 2.29E+05 7.61E+04 1.24E+04 Cs-136 3.12E+04 1.23E+05 8.86E+04 0.00E+00 6.85E+04 9.38E+03 1.40E+04 Cs-137 3.82E+05 5.22E+05 3.42E+05 0.00E+00 1.77E+05 5.89E+04 1.01E+04 Cs-138 2.64E+02 5.22E+02 2.59E+02 0.00E+00 3.84E+02 3.79E+01 2.23E-03 Ba-139 9.29E-01 6.62E-04 2.72E-02 0.00E+00 6.19E-04 3.75E-04 1.65E+00 l
! Ba-140 1.94E+02 2.44E-01 1.27E+01 0.00E+00 8.30E-02 1.40E-01 4.00E+02 Ba-141 4.51E-01 3.41E-04 1.52E-02 0.00E+00 3.17E-04 1.93E-04 2.13E-10 Ba-142 2.04E-01 2.10E-04 1.28E-02 0.00E+00 1.77E-04 1.19E-04 2.87E-19 ODCM, Midland, Consumers Power Company miO283-1828b131-25 1.0-19
TABLE 1.2-3 (Continued)
Site Related Ingestion Dose Commitment Factor, A 17 (mrem /hr per pCi/ml)
Page 3 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI La-140 1.50E-01 7.54E-02 '1.99E-02 0.00E+00 0.00E+00 0.00E+00 5.54E+03 La-142 7.66E-03 3.48E-03 8.68E-04 0.00E+00 0.00E+00 0.00E+00 2.54E+01 Ce-141 2.24E-02 1.52E-02 1.72E-03 0.00E+00 7.04E-03 0.00E+00 5.79E+01 Ce-143 3.95E-03 2.92E+00 3.23E-04 0.00E+00 1.29E-03 0.00E+00 1.09E+02 Ce-144 1.17E+00 4.88E-01 6.27E-02 0.00E+00 2.90E-01 0.00E+00 3.95E+02 Pr-143 5.51E-01 2.21E-01 2.73E-02 0.00E+00 1.27E-01 0.00E+00 2.41E+03 Pr-144 1.80E-03 7.48E-04 9.16E-05 0.00E+00 4.22E-04 0.00E+00 2.59E-10 Nd-147 3.76E-01 4.35E-01 2.60E-02 0.00E+00 2.54E-01 0.00E+00 2.09E+03 W-187 2.96E+02 2.47E+02 8.65E+01 0.00E+00 0.00E+00 0.00E+00 8.10E+04 Np-239 2.85E-02 2.80E-03 1.54E-03 0.00E+00 8.74E-03 0.00E+00 5.75E+02 ODCM, Midland, Consumers Power Company miO283-1828b131-25 1.0-20
1.3 DEFINITIONS OF LIQUID EFFLUENT PARAMETERS Section of Term Definition Initial Use A g7 = the site related ingestion dose commitment' factor to the 1.2 the total body or any organ I for each identified prin-cipal gamma and beta emitter listed in Table 1.2-3 in mrem-m1 per hr-pCi.
BF g = bioaccumulation factor for radionuclide i, in fish, 1.2 in pCi/kg per pCi/ liter, from Table 1.2-1.
C MPC
=
the effluent concentration limit (TS 3.11.1.1) 1.1.1 implementing 10 CFR 20 for the site, in pCi/ml.
C, = the effluent concentratio.n of alpha-emitting nuclides 1.1.1 observed by gross alpha analysis of the MONTHLY composite sample.
C = the effluent cor.s entration of a gamma-emitting nuclide g 1.1.1 observed by gamr.ia-ray spectroscopy of the waste sample.
C f
= the concentratiot: of nuclide i as determined by the analy- 1.1.1 sis of the waste saaple.
C, = the concentration cf Sr-89 or Sr-90 in liquid wastes as 1.1.1 determined by analysis of the QUARTERLY compo' site sample.
C = the measured concentration of H-3 in liquid waste as 1.1.1 determined by analyr,is of the MONTHLY composite.
ODCM, Midland, Consumers Power Company miO283-1828b131-25 1.0-21
1.3 DEFINITIONS OF LIQUID EFFLUENT PARAMETERS (Continued)
Section of Term Definition Initial Use C gg = the concentration of radionuclide i in the undiluted 1.2 liquid effluent averaged over the duration of the release, At g, in pCi/ml.
c = the setpoint, in pCi/ml, of the radioactivity monitor 1.1.1 measuring the concentration of radioactivity in the effluent line prior to dilution and subsequent release.
D = the cumulative dose commitment to the total body or any 1.2 7
organ T from the liquid effluents for the total time period.
DF g = a dose conversion factor for radionuclide i for adults in 1.2 preselected organ I, in mrem /pCi found in Table 1.2-2.
F = the dilution water flow setpoint as determined 1.1.1 prior to the release point, in volume per unit time.
F = administrative allocation factor applied to apportion 1.1.1 A
liquid releases.
F = the dilution factor, which is the ratio of the total dilu- 1.1.1 D
tion flow rate to the effluent stream flow rate (s), re-quired to assure that the limiting concentrations of 10 CFR, Part 20, Appendix B, Table II, Column 2 are met at the point of discharge.
F = a selected percentage of dilution flow. 1.1.1 p
ODCM, Midland, Consumers Power Company miO283-1828b131-25 1.0-22
1.3 DEFINITIONS OF LIQUID EFFLUENT PARAMETERS (Continued)
Section of
-Term Definition Initial Use F = the safety factor, a conservative factor used to 1.1.1 3
compensate for statistical fluctuations and errors of measurements.
Fg = the near field average dilution factor for C gg during any 1.2 liquid effluent release.
F = a justment factor applied to facilitate setting actual 1.1.1 AA monitor setpoints.
F DN
= m dified dilution factor for simultaneous release pathways. 1.1.1 f = the flow rate setpoint as determined for the radioactivity 1.1.1 i- monitor location (general expression for Equation (1)).
f d
= the flow rate of the dilution stream (cooling pond blow- 1.1.1 down or makeup pump discharge) during the time of release.
= F x expected dilution flow.
p f = maximum permissible undiluted waste tank effluent 1.1.1 p
flow rate.
= 1.14 x 10 5 , units conversion factor. 1.2 K,
1 MPC.
1
= MPC g
, MPC a
, MPC s
, and MPC t
= the limiting concentrations 1.1.1 of the appropriate gamma-emitting radionuclides, alpha-emitting radionuclides, Sr-89 and Sr-90, and tritium, respectively, from 10 CFR, Part 20, Appendix B, Table II, Column 2.
i ODCM, Midland, Consumers Power Company miO283-1828b131-25 1.0-23
o 1.3 DEFINITIONS OF LIQUID EFFLUENT PARAMETERS (Continued)
Section of Term Definition Initial Use n = the number of liquid discharge pathways for which F I'I'I D
and which are planned for simulantaneous release.
S D =.the dilution water flow monitor setpoint as determined 1.1.1 prior to the release point, in volume per unit time.
l U F
= 21 kg/yr, fish consumption (adult). 1.2 Z = applicable factor when additional receiving water body 1.2 dilution is to be considered; Z = 3.
At g = duration of the fth release under consideration. 1.2 i
l ODCM, Midland, Consumers Power Company miO283-1828b131-25 1.0-24 L
. +
1.4 LIQUID RADWASTE TREATMENT SYSTEM Minimum OPERABLE Liquid Radwaste. Treatment System is presented in Figures 1.4-1 and 1.4-2. Figure 1.4-1 depicts the Liquid Radwaste Treatment System and the Laundry Waste Treatment System flow diagram. The Treatment Systems Discharge Pathways are presented in Figure 1.4-2.
d n
i e
i l
i f
L l
l l
! ODCM, Midland, Consumers Power Company miO283-1828b131-25 1.0-25 l
t .
o
- FIGURE 1.0-1 MINIMUM OPERABLE LIQUID RADWASTE TREATMENT SYSTEM 8
i m_ i > r ?.
i yt -
6 T ! II
-O:E :=
a J, 28 r
g!
x e
!$E -I; 5 T a;_
s.l
- s
- s i,
Eliz .Ig 4
I -O-i a != .
!= !agi !. t ggg{g g; jag i jag g g l
- .. . . . A si E!ii ! Elii ! Ilse I t
t-w
- r
--]
23 a e
r I* 4 l l I I
. . . . . . s;* -
- =
ss'
- = ; -* ;
$3
- a J !E .
se :*
!g 8 E8g 8 zy g ::TgI sij-
-- * ! sij.
-- * [ ras, tei
. sase
- l-s mm .. '
3.i3de aewf; N
- -1, bb Y
, a=..
I !!!r II I I I I l I E: Er i s
s s: : _ i .
!!I
.a&I j!?
,, s s ! [III ggt [!!!
ggt {!!!gg; ggg; y _
i -i! I i I;s t r- l l
?!r I. I.
..3.......
- g. !)
If; 24 S'F* [') F 33
- E3 35 6 se Lt.a .'m g38
.g---
V wrs ar ,. m. . . s.n.
13l s: 8l 4
- ., l
- l. r .
- 7 5 :
t gs
.ss:
s Es:s: .r .s.
g 1_ E li 3-s - 8 Ei I*!5 h IE i .
c i s r al; a e 3-s -
.* i
- ss
=s:
I l
l l
ODCM, MIDLAND, CONSUMERS POWER C0. 1.0-26
FI GURE 1.4-2 MINIMUM OPERABLE LIQUID RADWASTE TREATMENT SYSTEM ITREATMENT SYSTEMS OlSCNARGE PATNWAYS)
"i I
sl 35 Eo b
=
s Oi!
-O- -
?.'1 15 gO- a.
6E !rJ
.ig_E ,e, _ .
= 355 Eg 2:0 g E
$ 5
[}.} -O--d E$
gO_ o O .r ,
EE ar 4, == ~
IE"
=50 a- 0-- 585 r-
- s
.tr :sf E8 IU*
- i E O:: 5f"E
=. 318 e:g -O-- --.- IEd o
Si 50-0-. " (> >:a:.
8 - i
=
5 *o E &;E sir Zy.
- E E 58 i; O::l : a=
l
_ _5 _.
E!!
-e- -
[" .
-O O- 5 is i E.n g se g se:= -O st.-
. E. :.
y $ E $
- 2 3E 32 -
j EE
-o i
l l
l 0DCM, MIDLAND, CONSUMERS POWER CO.
1.0-27
. o SECTION 2.0 GASEOUS EFFLUENTS Gaseous effluent monitor setpoints are required only for noble gas monitors; methodology for calculating noble gas monitor setpoints is covered in Sec-tion 2.1. Although setpoint calculations are not required for radioiodine and particulate monitors, the methodology for assuring the potential organ dose rates due to radioiodines, tritium, and particulates in gaseous releases from the site do not exceed the limits of TS 3.11.2.1(b) is presented in the note following 2.2.1.b.
2.1 GASEOUS EFFLUENT MONITOR SETPOINTS The gaseous monitor setpoint values determined in the following sections will be regarded as upper bounds for the actual setpoint adjustments. Setpoint adjustments are not required to be performed if the existing monitor setpoint is lower than the calculated value. Setpoints may be established at values lower than the calculated values if desired.
I If a calculated setpoint is less than the monitor reading associated with the particular release pathway, no release may be made under current conditions.
I Under such circumstances, the number of simultaneous release pathways may be
! reduced or contributing source terms may be reduced and the setpoint recalcu-lated.
For the Midland Plant, gaseous monitor setpoints are calculated for concentra-tions, in pCi/cc. The actual monitor setpoint, which corresponds to the calculated concentration plus background for the particular monitor, is ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-1
o determined from calibration data or from operational data associated with sample analysis data (see Section 2.1.4).
2.1.1 REACTOR CONTAINMENT BUILDING VENT STACK (UNIT 1 AND UNIT 2), AUXILIARY BUILDING VENT STACK NO. 1, AND CONDENSER AIR EJECTOR (UNIT 1 AND UNIT 2)
. Monitors: 1RE-5377, 2RE-6277, ORE-5470, 1RE-3347, 2RE-3447 For the purpose of implementation of TS 3.3.3.10, the alarm setpoint level for these noble gas monitors will be calculated as follows:
Cg = monitor reading of the noble gas monitor at the alarm setpoint concentration, in pCi/cc.
( (FB xF)xR g t xDTB (I
(
= the lesser of ( or (FB x Fg ) x R, x Dss (2) where F
S
= safety factor; a conservative factor applied to each noble gas monitor to compensate for statistical fluctuations and errors of measurement.
(For example, F S
= 0.5 corresponds to a 100 percent variation; value must be between 0 and 1.)
F B
= an administrative allocation factor applied to apportion the release setpoints among all gaseous release discharge pathways to assure that release limits will not be exceeded by simultaneous releases. The allocation factor for a particular pathway may be assigned any desired value between 0 and I under the condition that:
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-2
1
, -. l l
i I (FB )n 51 (3) n In the equation above, n is the number of simultaneous final gaseous release points. Turbine Building release points (condenser air ,
ejectors) are included only if primary-to-secondary leakage exists as determined in accordance with TS 4.4.6.3. Final gaseous release points would normally include Unit 1 Reactor Containment Building Ventilation Exhaust, Unit 2 Reactor Containment Building Ventilation Exhaust, and Auxiliary Building Vent Stack No. 1.
D = dcse rate limit to the total body of an individual in an unrestricted TB area.
= 500 mrem / year R = monitor reading per mrem / year to the total body.
= C + (X/Q) 1 K.Q. 1 1 (4)
C = monitor reading of a noble gas monitor corresponding to grab sample radionuclide concentrations. For batch releases the sample is taken prior to the release. For continuous releases, the cample is taken concurrently with the release. For continuous releases, the monitor setpoint is calculated based on the most recent sample information for the particalar pathway in accordance with TS Table 4.11-2.
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-3
X/Q = the highest annual average relative concentration at or beyond the site boundary.
= (X/Q)g = mixed-mode; applies to Reactor Containment Building Ventilation and Auxilicry Building Ventilation. Containment Building Ventilation includes Containment Purges and Air Room Purges.
Auxiliary Building Ventilation includes Gaseous Radwaste System.
= 2.74 x 10 -6 sec/m3 in the NNE sector.
= (X/Q)g = ground-level; applies to Condenser Air Ejectors.
= 2.55 x 10 -5 sec/m3 in the NNE sector.
Kg = total body dose factor due to gamma emissions from radionuclide i (mrem / year per pCi/m 3 ) from Table 2.1-1.
Qg = rate of release of noble gas radionuclide i (pCi/sec) from the release l
l pathway under consideration, determined by multiplying the release flow rate for the pathway by the concentration of radionuclide i.
= (Qi )g = mixed-mode release; Reactor Containment Building Ventilation (including Containment and Air Room Purges) and Auxiliary Building Ventilation (including Gaseous Radwaste System).
l i
= (Qg )g = ground-level release; Condenser Air Ejectors.
[ ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-4 l
L
'o 'O ~
D,, = dose rate limit to the skin of an individual in an unrestricted area.
= 3000 mrem / year R, = monitor reading per arem/ year to the skin.
= C + (X/Q 1(L; + 1.1 Mf)Q g ) (5) 1 Lj = skin dose factor due to beta emissions from radionuclide i (mrem / year per pCi/m 3) from Table 2.1-1.
1 1.1 = mrem skin dose per mrad air dose.
Mg = air dose factor due to gamma emissions from radionuclide i (mrad / year per pCi/m 3) from Table 2.1-1.
I 2.1.2 AUXILIARY BUILDING VENT STACK NO. 2 (EMERGENCY)
, MONITOR: ORE-5471 Auxiliary Building Vent Stack No. 2 is used during abnormal or accident condi-( tions. Therefore, this monitor serves no routine function. When necessary, a monitor setpoint would be determined following the methodology of Section
'2.1.1.
l ODCM, Midland, Consumers Power Company miO283-1828c131-00 2.0-5 l
I
. +
2.1.3 GASE0US RADWASTE SYSTEM, REACTOR CONTAINMENT BUILDING PURGE, AND AIR ROOM PURGE >
s' Honitors: ORE-0907, 1RE-5377, 2RE-6277, 1RE-5385, 2RE-6285 The Gaseous Radwaste System, Reactor Containment Building Purge, and Air Room Purge are gaseous sources which' discharge to release pathways which are continuously monitored. Although these sources discharge to a release pathway which is equipped with a final monitor, due to the significance of these sources, the methodology for calculating setpoints is presented. Sampling and analyses are completed and setpoints determined-prior to release. These
, setpoints must take into account simultaneous release pathways; the combined alloc. tion factors for contributing pathway monitors must not exceed the tc>ation factor for'the final release pathway monitor to which they ceti . : Mat e .
Downstream monitors must also take into consideration the combinations of J
source terms for the particular release pathway.
2.1.3.1 Gasecys Radwaste System i
! Monitor: ORE-0907 The Gaseous Radwaste System releases exhaust through Auxiliary Building Vent Stack No. 1, therefore, the Gaseous Radwaste monitor is not the final monitor in this release pathway. However, because of the significance of this release pathway and because the Auxiliary Building Vent Stack No. I monitor setpoint would have to accommodate the Gaseous Radwaste release, the setpoint methodology for this monitor is presented.
4 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-6
The methodology presented in Section 2.1.1 applies to this monitor with the following exceptions:
R t
=r t =C+(X/QfKqi) i (6)
C = monitor response of the Gaseous Radwaste System monitor for radionuclide concentrations to be discharged (sample taken and analyzed prior to discharge).
X/Q = (X/Q)3; see Section 2.1.1.
qi = rate of release of noble gas radionuclide i (pCi/sec) from the Waste Gas Decay System, determined by multiplying the expected release rate by the concentration of radionuclide i.
R s *#s=C+[XMf(Lg + 1.1 H )qg ] j (7)
F = a selected value less than the allocation factor for the monitor serving B
the final release pathway to which the particular source discharges, Auxiliary Building Vent Stack No. 1.
When releases are to be made from the Gaseous Radwaste System, it will be necessary to redetermine the setpoint for the Auxiliary Building Vent Stack No. I monitor (0RE-5470) which is downstream from the Gaseous Radwaste monitor (0RE-0907).
Calculation of this setpoint is accomplished by applying the methodology of Section 2.1.1 with the following exceptions:
ODCM, Midland, Consumers Pcwer Company miO263-1828c131-09 2.0-7
- , , - , . . , , - - . . _ . - , - - y-., , ---- - - - - - ,
A new source term, (Q g )AG, is determined which includes the routine Auxiliary Building-Vent Stack No. I source term, Q g, (based on sample results from TS Table 4.11-2) combined with the Gaseous Radwaste tank source term planned for release, q1, as follows:
, (Qg)AG
- Oi + 91 (8)
C = monitor reading corresponding to the concentration resulting from the combined release.
2.1.3.2 Reactor Containment Building Purge System-This section pertains to purges associated with plant shutdown.
Containment purge is a release which discharges to the Reactor Containment Building Ventilation Exhaust System. There is no separate monitor for containment purge releases; purge releases are monitored by the Reactor Containment Building Ventilation monitor (IRE-5377 or 2RE-6277).
When containment purge releases are to be made, setpoints for the Reactor Containment Building Ventilation System monitors must be redetermined to account for the additional source term associated with the purge.
The methodology presented in Section 2.1.1 applies to redetermining the setpoint for this monitor with the following exceptions:
A new source term, (Q1 )CP, is determined which includes the routine Reactor Containment Building Ventilation System source term, Q g, (based on sample ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-8
p results from TS Table 4.11-2) combined with the Containment Purge source term, qi, as follows:
(Oi )CP
- Oi + 9i (9)
C = monitor reading corresponding to the concentration resulting from the combined release.
2.1.3.3 Air Room Purge System Monitors: 1RE-5385 or 2RE-6285 Air Room Purge discharges are released to the Reactor Containment Building Ventilation System; therefore, the Air Room Purge monitor is not the final monitor in this release pathway. However, since this is an additional contributor to the Containment Building Ventilation System discharge pathway, and because the Containment Building Ventilation System monitor would have to accocmodate the Air Room Purge release, the setpoint methodology for this monitor is presented.
The Air Room Exhaust System is utilized also to perform operational contain-ment purge. - When used for this purpose, the air concentration of radioacti-vity and the source term used to determine the setpoint for the Air Room Exhaust System monitor must include the concentration and source term associated with the operational containment purge.
The methodology presented in Section 2.1.1 applies to this monitor with the following exceptions:
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-9
. 0 R
t t
Y (X/O i 9i) (10)
C = monitor response of the Air Room Purge System monitor for radionuclide concentrations to be discharged (sample taken and analyzed prior to discharge)
X/Q = (X/Q)g; see Section 2.1.1 gg = rate of release of noble gas radionuclide i (pCi/sec) from the Air Room Purge System; determined by multiplying the flow rate from the Air Room Purge by the concentration of radionuclide i.
R, =r s =C+[X/Qf(Lg + 1.1 Mg )qi] (11)
F B = a selected value less than the allocation factor for the monitor serving the Reactor Containment Building Vent.
When releases are to be made from the Air Room Purge System, it will be necessary to redetermine the setpoint for the Reactor Containment Building Ventilation monitor (1RE-5377 or 2RE-6277) which is downstream from the Air Room Purge monitor (IRE-5385 or 2RE-6285).
Calculation of this setpoint is accomplished by applying the methodology of Section 2.1.1 with the following exceptions:
A new source term, (Qg )CR, is determined which includes the routine Containment Building Ventilation source term, Qg, (based on sample results ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-10
i from TS Table 4.11-2) combined with the source term for the Air Room Volume and/or the Operational Containment Purge planned for release,og g
, as follows:
(Qi )CR
- 91+9i (I )
C = monitor reading corresponding to the concentration resulting from the combined release.
2.1.4 CONSIDERATION OF BACKGROUND AND MONITOR RESPONSE ADJUSTMENTS IN ESTABLISHING GASE0US MONITOR SETPOINTS The calculated setpoint concentration, C , establishes the base value for the 3
monitor setpoint. However, in establishing the actual monitor setpoint for a particular monitor, background radiation levels and monitor response adjust-ments must be considered.
Contributions to background radiation levels may include ambient background, plant environmental background at monitor locations when plant is in shutdown status, plant environmental background at monitor location when plant is at power, and internal background of monitor due to contamination of sample chamber. Normally, the actual monitor setpoint includes the calculated set-point value plus background. Background levels must be controlled such that radioactivity levels in the effluent stream being monitored can be accurately assessed at or below the calculated setpoint value.
Monitor response adjustments may be necessary to assure that monitor readout 1
accurately reflects radioactivity levels in the monitored effluent stream.
Monitor adjustments (monitor setting) may be based on monitor calibrations, monitor calibration data supplied by the monitor vendor, or by operational r
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-11 I
. . i data which correlates monitor response to sample analyses associated with actual effluent releases. At the Midland Plant the monitor response adjustment which correlates actual monitor response to monitor response expected, based on associated sample analyses, is referred to as the gain factor.
i I
l l
l l
l l
l ODCM, Midland, Consumers Power Company
! miO283-1828c131-09 2.0-12
a e TABLE 2.1-1 Dose Factors for Exposure to a Semi-Infinite Cloud of Noble Gases *
-Nuclide y-Body ***(K) $-Skin ***(L) y-Air **(M) E-Air **(N)
Kr-85m 1.17E+03**** 1.46E+03 1.23E+03 1.97E+03 Kr-85 1.61E+01 1.34E+03 1.72E+01 1.95E+03 Kr-87 5.92E+03 9.73E+03 6.17E+03 1.03E+04 Kr-88 1.47E+04 2.37E+03 1.52E+04 2.93E+03 Kr-89 1.66E+04 1.01E+04 1.73E+04 1.06E+04 Kr-90 1.56E+04 7.29E+03 1.63E+04 7.83E+03 Xe-131m 9.15EiOI 4.76E+02 1.56E+02 1.11E+03 Xe-133m 2.51E+02 9.94E+02 3.27E+02 1.48E+03 Xe-133 2.94E+02 3.06E+02 3.53E+02 1.05E+03 Xe-135m 3.12E+03 7.11E+02 3.36E+03 7.39E+02 Xe-135 1.81E+03 1.86E+03 1.92E+03 2.46E+03 Xe-137 1.42E+03 1.22E+04 1.51E+03 1.27E+04 Xe-138 8.83E+03 4.13E+03 9.21E+03 4.75E+03 Ar-41 8.84E+03 2.69E+03 9.30E+03 3.28E+03
- Values taken from Reference 3, Table B-1.
- m ra d-m3 pCi yr
- mrem-m3 pCi yr
- 1.17E+03 = 1.17 x 103 -
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-13
I
. e 1 l
l 1
I l
2.2 GASEOUS EFFLUENT-DOLE RATE AND DOSE CALCULATIONS 2.2.1 SITE BOUNDARY DOSE RATES 2.2.1.a Dose Rates Due to Noble Gases For the purpose of implementation of TS 3.11.2.1(a), the dose rate at or beyond the site boundary due to noble gases shall be calculated as follows:
Dt = total body dose rate at time of release (mrem / year).
=[(X/Q)g3K(Q)g]+[(E7Q)g{K(Q)g]
f g f g (13) 1 1 D, = skin dose rate at time of release (mrem / year).
=[(X/Q)g{(Li + 1.1 M )(Q i )M i
(IO)Gh(i+I*I"i)(9)Gl i
(I )
1 1 NOTE: Terms defined previously in Section 2.1.1.
In the event of simultaneous releases, dose rates shall be summed to assure that dose rate limits are not exceeded.
2.2.1.b ~ Dose Rates Due to Radioiodines, Tritium, and Particulates Organ dose rates due to inhalation of radioiodines, tritium, and all radioac-tive materials in particulate form with half-lives greater than 8 days, will be calculated for the purpose of implementation of TS 3.11.2.1(b) as follows:
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-14
D, = organ dose rate at time of release (mrem / year).
=[(X/Q)g{P,(Q)3]4 g g [(X/Q)G 3 P g,(Q{}gl 1 1 where X/Q = controlling sector annual average relative concentration at the site boundary for the appropriate pathway.
= (X/Q)g = mixed-mode; applies to Reactor Containment Building Ventilation (including Containment Purge and Air Room Purge) and Auxiliary Building Stack (including Gaseous Radwaste System).
= 2.74 x 10 -6 sec/m3 in the NNE sector.
=
(X/Q)g = ground-level; applies to Condenser Air Ejectors.
-5
= 2.55 x 10 sec/m3 in the NNE sector.
Pg , = organ dose parameter for organ o and radionuclide i, (mrem / year per pCi/m 3 ) for inhalation determined as follows:
P.
to
= K'(BR) DF.lo (16) where '
K' = constant of unit conversion, 106 pCi/pCi.
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-15
BR = breathing rate for child age group.
= 3700 m3 / year (Table 2.2-10 from Reference 3).
-DFf , = inhalation pathway dose factor for child age group for organ o and radionuclide i (from Table 2.2-2).
Qj=releaserateofnon-noblegasradionuclidei(pCi/sec) for the type of release under consideration.
=(Qj)g= mixed-modereleasetype.
=(Qj)G = gr und-level release type.
NOTE: In order to assure that potential dose rates (pre-release) to an organ due to radioiodine, tritium, and particulates in simultaneous gaseous releases from the site do not exceed 1500 mrem / year as specified in TS 3.11.2.1(b), potential organ dose rate, D,, must be limited as follows:
D, + (FB x F S) <-1500 mrem / year (17)
F and F are assigned the sam'e values as were used in Section 2.1 for B S the release source pathway under consideration. To further assure that dose rate limits were not exceeded (post-release), dose rates from simultaneous releases shall be summed.
ODCM, Midland, Consumers Power Company miO283-182Sc131-09 2.0-16
.. =
'2.2.2 AIR DOSE AND DOSE'To INDIVIDUAL 2.2.2.a A_ir Dose For.the purpose of implementation of TS 3.11.2.2 and TS 3.11.2.4, the air dose at or beyond the site boundary shall be determined as follows:
D = air dose due to gamma emissions from noble gases (mrad).
= 3.17 x 10 -8[3Mg(X/Q)g(Q)g+3Mg(X/Q)g(h)G] g (18) i 1 1 where 3.17 x 10 -8 = the fraction of one year per one second.
hg = cumulative release of noble gas radionuclide i over the period of interest'(pCi) for the type of release under consideration.
= (Qg)g = mixed-mode relea'se type.
=-(h)Gg = gr und-level release type.
Mg = defined in Section 2.1.1.
-6 3
, (X/Q)g = 2.74 x 10 sec/m in the NNE sector.
i (X/Q)g = 2.55 x 10-5 ,,cj,3 in the NNE sector.
D = air dose due to beta emissions from noble gases (mrad).
~ ~
= 3.17 x 10 -8[3Ng(X/Q)g(Q)g+{Ng g (X/Q)g(Qg)g] (19) 1 1 i
i ODCM, Midland, Consumers Power Company
, miO283-1828c131-09 2.0-17
Ng = air. dose factor due to beta emissions from noble gas radionuclide i (mrad / year per pCi/m 3 from Table 2.1-1).
2.2.2.b Dose To An Individual Dose to an individual from radioiodines, tritium, and radioactive materials in particulate form will be calculated for the purpose of implementation of TS 3.11.2.3 and TS 3.11.2.4 as follows:
D. = dose to an organ of an individual from radioiodines, tritium, and J
radionuclides in particulate form (mrem)
= 3.17 x 10 ~b I[(WjIR. .Qj)] (20) p i alPJ where 3.17 x 10 -8 = fraction of one year per one second.
= pathway - dependent relative concentration or relative Wh deposition for unrestricted areas at the controlling receptor, defined as follows:
= (X/Q') = annual average relative concentration for location of controlling (critical) receptor for inhalation and all tritium pathways only. (For all tritium pathways, the Qg source term is limited to tritium.)
-8 3
= (X/Q')g = 4.15 x 10 sec/m in the ESE sector for inhalation and all tritium pathways for mixed-mode release type.
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-18
a
-8 3,cj,3 in the ESE sector for inhalation
= (X/Q')g = 8'.41 x 10 and all tritium pathways for ground-level telease type,
= D/Q' = annual average relative deposition for location of con-trolling (critical) receptor for pathways other than inhalation or tritium.
-2
= (D/Q')g = 6.01 x 10~ m in the ESE sector for pathways other than inhalation or tritium for mixed-mode release type.
= (D/Q')G = 7.84 x 10-10 ,-2 in the ESE sector for pathways other than inhalation or tritium for ground-level release type.
NOTE: At the Midland Plant, the Unit 1 Condenser Air Ejector and the Unit 2 Condenser Air Ejector are ground-level releases; all other releases are mixed-mode.
Q{ = cumulative release of radioiodines, tritium, or material in particulate form for radionuclide i over the period of interest (pCi), for the type of release under consideration.
=(Q{}g = mixed-mode release type.
=(Q{)g = ground-level release type.
ODCM, Midland, Consumers Power Congany miO283-1828c131-09 2.0-19
=
= pathway-specific, individual age-specific, organ dose factor for R,gp )
radionuclide i, pathway p, organ j, and individual age group a.
The controlling individual age group and the dose pathways are determined through the Land Use Census for the site.
R, . is determined as follows:
alpj NOTE: At the Midland Plant the controlling receptor is an infant. The dose pathways are inhalation, ground-plane, and grass goat-nilk.
Inhalation Pathway Factor 3
R, = K'(BR), (DFA g)), mrem / year per pCi/m (21) where K' = constant of unit conversion, 106 pCi/pCi.
(BR), = the breathing rate for a particular age group a, in m /3 year from Table 2.2-10 (infant = 1400).
(DFAq), = the inhalation dose factor for ith radionuclide for the receptor in age group a, in mrem /pCi from Tables 2.2-1 through 2.2-4 (infant, Table 2.2-1).
Ground-Plane Pathway Factor
-A.t 1
R g)p = K'K"(SF)(DFGg)((1 - e )/A 1)(m 2mrem / year per pCi/sec) (22) where K' = constant of unit conversion, 106 pCi/pCi.
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-20
y K" = constant of unit conversion, 8760 hr/ year.
SF = shielding factor, 0.7 (dimensionless).
DFG = ground plane dose conversion factor for radionuclide i (same for ij all age groups) (mrem /hr per pCi/m2 ) from Table 2.2-9.
= decay constant for radionuclide i, in sec
~I A; .
t = exposure time, 4.73 x 108 see (15 years).
Grass-Goat-Milk Pathway Factor QF (U ff ps ih -A.t (23)
R,gp y =K'z,,8{)F,(r)(DFL)),[Ps,(1-ff)e 1 w g
p s
]e 1 f (m2 arem/ year per pCi/sec) where NOTE: Midland Plant site-specific values are included in parentheses following each definition.
K' = a constant of unit conversion,108 pCi/pci.
QF = the goat's consumption rate, in kg/ day (wet weight).
(6) 4 ODCM, Midland, Consumers Power Campany +
miO283-1828c131-09 2.0-21
U,p = the receptor's milk consumption rate for age group a, in liters / year from Table 2.2-10.
(infant - 330)
Y p = the agricultural productivity by unit area of pasture feed grass, in kg/m2, (0.26)
Y, = the agricultural productivity by unit area of stored feed, in kg/m2 ,
(0.52)
F, = the stable eluent transfer coefficients, in days / liter.
(see Table 2.2-11) r = fraction of deposited activity retained on feed grass.
(1.0 for radioiodines; 0.2 for particulates)
(DFLg), = the organ ingestion dose factor for the ith radionuclide for the receptor in age group a, in mrem /pCi from Tables 2.2-5 through 2.2-8.
(infant - Table 2.2-5)
~
Ag = the decay constant for the ith radionuclide, in sec .
A, = the decay consta'nt for removal of activity on leaf and plant
~
7 surfaces by weathering, 5.73 x 10 sec'I (corresponding to a 14-day half-life).
~
ODCM, Midland, ConsuSers Power Company
^
miO283-1828c131-09 ,' 2.0-22 f
_ , - ,, ,_ m ._,%_ _ - - ,_, .- --
., ze b
i i
l tg = the transport time from pasture to goat, to milk, to receptor,- ;
in sec.
(1.73 x 105 )
t h = the transport time from pasture to harvest, to goat, to milk, to receptor, in sec.
(7.78 x 106 )
f p
= fraction of the year that the goat is on pasture (dimensionless).
(1)-
f, = fraction of the goat feed that is pasture grass while the goat is on pasture (dimensionless).
- (1)
For tritium in milk, the grass goat-milk pathway factor is a special case due i
to the fact that the concentration of tritium in milk is based on airborne concentration rather than deposition:
~R. 3 alpj
= K'K'"F Q Um F ap(DFL..)a 13 [0.75(0.5/H)] (mrem / year per pCi/m ) (24) where K'" = a constant of unit conversion, 103 gm/kg.
H- = absolute humidity of the atmosphere, in gm/m 3.
(8) 0.75 = the fraction of total feed that is water.
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-23
e .
0.5 = the ratio of the specific activity of the feed grass water to the atmospheric water.
Other parameters and values are given above.
2.2.2,c Dose Calculations to Support Other Specific Technical Specifications For the purpose of implementing TS 6.9.1.12 dose calculations may be performed using the above equations with the substitution of average relative concentra-ticns and relative depositions for the period of the report and the appropri-ate pathway receptor dose factors (R .a;pj).
(Values for Ralpj . . are determined in accordance with Section 2.2.2.d.)
For the purpose of implementing TS 6.9.1.8, dose calculations may be performed using the above equations with the substitution of the relative concentrations (X/Q) and relative depositions (D/Q) which are concurrent with actual releases and the appropriate pathway receptor dose factors (R .. ).
aljp (Values for Raijp are determined in accordance with Section 2.2.2.d.)
For the purpose of implementing TS 3/4.12.2, dose calculations may be performed using the above equations substituting the appropriate pathway receptor dose factors (R .alpj) and the appropriate relative concentrations and relative depositions for the location (s) of interest. Annual average relative concentrations and relative depositions may be used for these calculations.
(Values for Ra13p
.. are determined in accordance with Section 2.2.2.d.)
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-24
2.2.2.d -Additional Pathway Dose Factors For the purpose of implementing TS 6.9.1.12, 16.6.9.1.8 or 3/4.12.2, it may be necessary to calculate individual doses due to gaseous releases via exposure pathways other than ground plane, inhalation, and grass goat-milk pathways presented in Section 2.2.2.b. Methodology for calculating Gases due to gaseous releases via the grass-cow-milk, grass-cow-meat, and the vegetation pathway is the same as was presented in Section 2.2.2.b. However, R . . is alpa pathway-dependent and is calculated for the remaining pathways as follows:
Grass-Cow-Milk Pathway Factor Qp(U ff -Aih t -A.t if (25)
R.
alpj
= K'Ag+A m 8P)F (r)(DFL..)a Y
[Ps, (1 ps
-f f)e )e lj p Y, (m2 mrem / year per pCi/sec) where NOTE: Midland Plant site-specific values are included in parentheses following each definition.
K' = a constant of unit conversion, 106 pCi/pCi.
Qp = the cow's consumption rate, in kg/ day (wet weight).
(50)
U,p = the receptor's milk consumption rate for age group a, in liters / year from Table 2.2-10.
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-25 t
- e Y = the agricultural productivity by unit area of pasture feed grass, p
in kg/m2, (0'26)
Y, = the agricultural productivity by unit area of stored feed, in kg/m2 ,
(0.52)
F, = the stable element transfer coefficients, in days / liter.
(see Table 2.2-11)
- r. = fraction of deposited activity retained on feed grass.
(1.0 for radioiodines, 0.2 for particulates)
(DFLg), = the organ ingestion dose factor for the-ith radionuclide for the receptor in age group a, in mrem /pCi from T-ibles 2.2-5 through 2.2-8.
(Tables 2.2-5 through 2.2-8)
-1 A = the decay constant for the ith radionuclide, in sec .
f A = the decay constant for removal of activity on leaf and plant y
surfaces by weathering, 5.73 x 10 -7 sec -1 (corresponding to a 14-day half-life).
tg = the transport time from pasture to cow, to milk, to receptor, in sec.
(1.73 x 105 )
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-26
t h
= the transport time from pasture, to harvest, to cow, to milk, to receptor, in sec.
(7.78 x 108 )
f = fraction of the year that the cow is on pasture (dimensionless).
p (1) f, = fraction of the cow feed that is pasture grass while the cow is on pasture (dimensionless).
(0.25)
For tritium in .ailk, the grass-cow-milk pathway factor is a special case due to the fact that the concentration of tritium in milk is based on airborne concentration rather than deposition:
3 R. .
= K'K'"F Q Um F ap(DFL.j)a [0.75(0.5/H)] (mrem / year per pCi/m ) (26) alpj t where K'" = a constant of unit conversion, 103 gm/kg.
H = absolute humidity of the atmosphere, in gm/m3 .
(8) 0.75 = the fraction of total feed that is water.
0.5 = the ratio of the specific activity of the feed grass water to the atmospheric water.
Other parameters and values are given above.
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-27
Grass-Cow-Meat Pathway Factor t
Qp(U ff ps ih -A gf t (27)
R..
alpj = K,Af+A 8P)F (r)(DFL..)a [ P, s , (1 1- f f ) e )e y f 13 i p 3 (m2 mrem / year per pCi/sec) where NOTE: Midland Plant site-specific values are included in parentheses following each definition.
K' = a constant of unit conversion, 106 pCi/pCi.
QF = the cow's consumption rate, in kg/ day (wet weight).
(50)
U,p = the receptor's meat consumption rate for age group a, in kg/ year from Table 2.2-10.
Y = the agricultural productivity by unit area of pasture feed grass, p
in kg/m2 ,
(0.26)
Y, = the agricultural productivity by unit area of stored feed, in kg/m2 ,
(0.52)
F f
= the stable element transfer coefficients, in days /kg.
(see Table 2.2-11)
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-28
r = fraction of deposited activity retained on feed grass.
(1.0 for radioiodines, 0.2 for particulates)
(DFL..)a IJ
= the organ ingestion dose factor for the ith radionuclide for the receptor in age group a, in mrem /pCi from Tables 2.2-5 through 2.2-8.
(Tables 2.2-5 through 2.2-8)
-I Ag = the decay constant for the ith radionuclide, in sec .
Ay = the decay constant for ren. oval of activity on leaf and plant
~7 surfaces by weathering, 5.73 x 10 sec ~1 (corresponding to a 14-day half-life).
tg = the transport time from pasture to cow, to meat, to receptor, in sec.
(1.73 x 106 )
t = the transport time from pasture, to harvest, to cow, to meat, h
to receptor, in sec.
(7.78 x 106 )
f p
= fraction of the year that the cow is on pasture (dimensionless).
(1) f, = fraction of the cow feed that is pasture grass 'thile the cow is on pasture (dimensionless).
(0.25)
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-29
For tritium in meat, the grass-cow-meat pathway factor is a special case due to the fact that the concentration of tritium in meat is based on airborne concentration rather than deposition:
R.. 3 alpj = K'K'"F Q Uf F ap(DFL.
13 .)a [0.75(0.5/H)] (mrem / year per pCi/m ) (28) where K'" = a constant of unit conversion, 103 gm/kg.
H = absolute humidity of the atmosphere, in gm/m3 .
(8) 0.75 = the fraction of total feed that is water.
0.5 = the ratio of the specific activity of the feed grass water to the atmospheric water.
Other parameters and values are given above.
Vegetation Pathway Factor
-A.t -A.t 1
R,gp j =0 y(g[,g)(E13),
v i w
[U,g g fe A + U,,fg e i h] (29) where NOTE: Midland Plant site-specific values are included in parentheses following each definition.
K' = a constant of unit conversion, 106 pCi/pci.
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-30 .
I
i U,g = the consumption rate of fresh leafy vegetation by the receptor 1 in age group a, in kg/ year.
(Table 2.2-10)
U,, = the consumption rate-of stored vegetation by the receptor in age group a, in kg/ year.
(Table 2.2-10) fg = the fraction of the annual intake of fresh leafy vegetation grown locally.-
(1.0) fg = the fraction of the annual intake of strored' vegetation grown locally.
(0.76) tg = the average time between harvest of leafy vegetation and its consumption, in sec.
(8.6 x 104 )
t
- h. = the average time between harvest of stored vegetation and its l 1
consumption, in sec.
(5.18 x 106 )
Yy = the vegetation area density, in kg/m 2, (2.4; adjusted in accordance with Table 11.3-25, Footnote 4, Reference 5) i ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-31 l
L. e
(DFLgj), = the organ ingestion dose fact.or for the ith radionuclide for the receptor in age group a, in mrem /pci from Tables 2.2-5 through 2.2-8.
_(Tables 2.2-5 through 2.2-8)
A = the decay constant for the ith radionuclide, in sec"I .
f Ay = the decay constant for removal of activity on leaf and plant surfaces by weathering, 5.73 y, 10 -7 sec ~I (corresponding to a 14-day half-life).
I For tritium in vegetation, the vegetation pathway factor is a special case to the fact that the concentration of tritium in vegetation is based on airborne concentration rather than deposition:
R. .
= K'K'"(U f f alpj af f + Uas g)3(DFL..)a 13 [0.75(0.5/H)] (30)
(mrem / year per pCi/m )
where
= a constant of unit conversion, 103 gm/kg.
K'"
H = absolute humidity of the atmosphere, in gm/m3 .
(8) 0.75 = the fraction of total vegetation that is water.
1 0.5 = the ratio of the specific activity of the vegetation water to the atmospheric water.
Other parameters and values are given above.
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-32
O
- TABLE 2.2-1 Inhalation Dose Factors for Infants *
(Mrem per PCI Inhaled)
Page 1 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 No Data 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 C-14 1.89E-05 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 Na-24 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.5LE-06 7.54E-06 P-32 1.45E-03 8.03E-05 5.53E-05 No Data No Data No Data 1.15E-05 Cr-51 No Data No Data 6.39E-08 4.11E-08 9.45E-09 9.17E-06 2.55E-07 Mn-54 No Data 1.81E-05 3.56E-06 No Data 3.56E-06 7.14E-04 5.04E-06 Mn-56 No Data 1.10E-09 1.58E-10 No Data 7.86E-10 8.95E-06 5.
Fe-55 1.41E-05 8.39E-06 2.38E-06 No Data No Data 6.21E-05 7.
Fe-59 9.69E-06 1.68E-05 6.77E-06 No Data No Data 7.25E-04 1.
Co-58 No Data 8.71E-07 1.30E-06 No Data No Data 5.55E-04 7.95L .
Co-60 No Data 5.73E-06 8.41E-06 No Data No Data 3.22E-03 2.28E-03 Ni-63 2.42E-04 1.46E-05 8.29E-06 No Data No Data 1.49E-04 1.73E-06 Ni-65 1.71E-09 2.03E-10 8.79E-11 No Data No Data 5.80E-06 3.58E-05 Cu-64 No Data 1.34E-09 5.53E-10 No Data 2.84E-09 6.64E-06 1.07E-05 Zn-65 1.38E-05 4.47E-05 2.22E-05 No Data 2.32E-05 4.62E-04 3.67E-05 Zn-69 3.85E-11 6.91E-11 5.13E-12 No Data 2.87E-11 1.05E-06 9.44E-06 Br-83 No Data No Data 2.72E-07 No Data No Data No Data LT E-24 Br-84 No Data No Data 2.86E-07 No Data No Data No Data LT E-24 Br-85 No Data No Data 1.46E-08 No Data No Data No Data LT E-24 Rb-86 No Data 1.36E-04 6.30E-05 No Data No Data No Data 2.17E-06 Rb-88 No Data 3.98E-07 2.05E-07 No Data No Data No Data 2.42E-07 Rb-89 No Data 2.29E-07 1.47E-07 No Data No Data No Data 4.87E-08 Sr-89 2.84E-04 No Data 8.15E-06 No Data No Data 1.45E-03 4.57E-05 Sr-90 2.92E-02 No Data 1.85E-03 No Data No Data 8.03E-03 9.36E-05 Sr-91 6.83E-08 No Data 2.47E-09 No Data No Data 3.76E-05 5.24E-05 Sr-92 7.50E-09 No Data 2.79E-10 No Data No Data 1.70E-05 1.00E-04 Y-90 2.35E-06 No Data 6.30E-08 No Data No Data 1.92E-04 7.43E-05 Y-91M 2.91E-10 No Data 9.90E-12 No Data No Data 1.99E-06 1.68E-06 Y-91 4.20E-04 No Data 1.12E-05 No Data No Data 1.75E-03 5.02E-05 Y-92 1.17E-08 No Data 3.29E-10 No Data No Data 1.75E-05 9.04E-05
- Reference 3, Table E-10 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-33
TABLE 2.2-1 (continued)
Inhalation Dose Factors for Infants (Mrem per PCI Inhaled)
Page 2 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Y-93 1.07E-07 No Data 2.91E-09 No Data No Data 5.46E-05 1.19E-04 Zr-95 8.24E-05 1.99E-05 1.45E-05 No Data 2.22E-05 1.25E-03 .1.55E-05 Zr-97 1.07E-07 1.83E-08' 8.36E-09 No Data 1.85E-08 7.88E-05 1.00E-04 Kb-95 1.12E-05 4.59E-06 2.70E-06 No Data 3.37E-06 3.42E-04 9.05E-06 Mo-99. No Data 1.18E-07 2.31E-08 No Data 1.89E-07 9.63E-05 3.48E-05 Tc-99M 9.98E-13 2.06E-12 2.66E-11 No Data 2.22E-11 5.79E-07 1.45E-06 Tc-101 4.65E-14 5.88E-14 5.80E-13 No Data 6.99E-13 4.17E-07 6.03E-07 Ru-103 1.44E-06 No Data 4.85E-07 No Data 3.03E-06 3.94E-04 1.15E-05 Ru-105 8.74E-10 No Data 2.93E-10 No Data 6.42E-10 1.12E-05 3.46E-05 Ru-106 6.20E-05 No Data 7.77E-06 No Data 7.61E-05 8.26E-03 1.17E-04 Ag-110M 7.13E-06 5.16E-06 3.57E-06 No Data 7.80E-06 2.62E-03 2.36E-05 Te-125M 3.40E-06 1.42E-06 4.70E-07 1.16E-06 No Data 3.19E-04 9.22E-06
.Te-127M 1.19E-05 4.93E-06 1.48E-06 3.48E-06 2.68E-05 9.37E-04 1.95E-05 Te-127 1.59E-09 6.81E-10 3.49E-10 1.32E-09 3.47E-09 7.39E-06 1.74E-05 Te-129M 1.01E-05 4.35E-06 1.59E-06 3.91E-06 2.27E-05 1.20E-03 4.93E-05 Te-129 5.63E-11 2.48E-11 1.34E-11 4.82E-11 1.25E-10 2.14E-06 1.88E-05 Te-131M 7.62E-08 3.93E-08 2.59E-08 6.38E-08 1.89E-07 1.42E-04 8.51E-05 Te-131 1.24E-11 5.87E-12 3.57E-12 1.13E-11 2.85E-11 1.47E-06 5.87E-06 Te-132 2.66E-07 1.69E-07 1.26E-07 1.99E-07 7.39E-07 2.43E-04 3.15E-05 I-130. 4.54E-06 9.91E-06 3.98E-06 1.14E-03 1.09E-05 No Data 1.42E-06 I-131 2.71E-05 3.17E-05 1.40E-05 1.06E-02 3.70E-05 No Data 7.56E-07 I-132 1.21E-06 2.53E-06 8.99E-07 1.21E-04 2.82E-06 No Data 1.36E-06 I-133 9.46E-06 1.37E-05 4.00E-06 2.54E-03 1.60E-05 No Data 1.54E-06 I-134 6.58E-07 1.34E-06 4.75E-07 3.18E-05 1.49E-06 No Data 9.21E-07 i
- I-135 2.76E-06 5.43E-06 1.98E-06 4.97E-04 6.05E-06 No Data 1.31E-06 i Cs-134 2.83E-04 5.02E-04 5.32E-05 No Data 1.36E-04 5.69E-05 9.53E-07 Cs-136 3.45E-05 9.61E-05 3.78E-05 No Data 4.03E-05 8.40E-06 1.02E-06 Cs-137 3.92E-04 4.37E-04 3.25E-05 No Data 1.23E-04 5.09E-05 9.53E-07 i Cs-138 3.61E-07 5.58E-07 2.84E-07 No Data 2.93E-07 4.67E-08 6.26E-07 l Ba-139. 1.06E-09 7.03E-13 3.07E-11 No Data 4.23E-13 4.25E-06 3.64E-05 i Ba-140 4.00E-05 4.00E-08 2.07E-06 No Data 9.59E-09 1.14E-03 2.74E-05 i Ba-141 1.12E-10 7.70E-14 3.55E-12 No Data 4.64E-14 2.12E-06 3.39E-06 Ba-142 2.84E-11 2.36E-14 1.40E-12 No Data 1.36E-14 1.11E-06 4.95E-07 La-140 3.61E-07 1.43E-07 3.68E-08 No Data No Data 1.20E-04 6.06E-05 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-34
, .- n . . , , , . . . , - - - , . . - - , , , . . , - . - - av,,, ,,e-n,-- ,nm,-- ,,--w, -, ,n ,,g ,e < m v
TABLE 2.2-1 (continued)
Inhalation Dose Factors for Infants (Mrem per PCI Inhaled)
Page 3 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI La-142 7.36E-10 '2.69E-10 6.46E-11 No Data No Data 5.87E-06 4.25E-05 Ce-141 1.98E-05 1.19E-05 1.42E-06 No Data 3.75E-06 3.69E-04 1.54E-05 Ce-143 2.09E-07 1.38E-07 1.58E-08 No Data 4.03E-08 8.30E-05 3.55E-05 Ce-144 2.28E-03 8.65E-04 1.26E-04 No Data 3.84E-04 7.03E-03 1.06E-04 Pr-143 1.00E-05 3.74E-06 4.99E-07 No Data 1.41E-06 3.09E-04 2.66E-05 Pr-144 3.42E-11 1.32E-11 1.72E-12 No Data 4.80E-12 1.15E-06 3.06E-06 Nd-147 5.67E-06 5.81E-06 3.57E-07 No Data 2.25E-06 2.30E-04 2.23E-05 W-187 9.26E-09 6.44E-09 2.23E-09 No Data No Data 2.83E-05 2.54E-05 Np-239 2.65E-07 2.37E-08 1.34E-08 No Data 4.73E-08 4.25E-05 1.78E-05 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-35
TABLE 2.2-2 Inhalation Dose Factors for Children *
(Mrem per PCI Inhaled)
Page 1 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 No Data 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 C-14 9.70E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 Na-24 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 P-32 7.04E-04 3.09E-05 2.67E-05 No Data No Data No Data 1.14E-05 Cr-51 No Data No Data 4.17E-08 2.31E-08 6.57E-09 4.59E-06 2.93E-07 Mn-54 No Data 1.16E-05 2.57E-06 No Data 2.71E-06 4.26E-04 6.19E-06 Mn-56 No Data 4.48E-10 8.43E-11 No Data 4.52E-10 3.55E-06 3.33E-05 Fe-55 1.28E-05 6.80E-06 2.10E-06 No Data No Data 3.00E-05 7.75E-07 Fe-59 5.59E-06 9.04E-06 4.51E-06 No Data No Data 3.43E-04 1.91E-05 Co-58 No Data 4.79E-07 8.55E-07 No Data No Data 2.99E-04 9.29E-06 Co-60 No Data 3.55E-06 6.12E-06 No-Data No Data 1.91E-03 2.60E-05 Ni-63 2.22E-04 1.25E-05 7.56E-06 No Data No Data 7.43E-05 1.71E-06 Ni-65 8.08E-10 7.99E-11 4.44E-11 No Data No Data 2.21E-06 2.27E-05 Cu-64 No Data 5.39E-10 2.90E-10 No Data 1.63E-09 2.59E-06 9.92E-06 Zn-65 1.15E-05 3.06E-05 1.90E-05 No Data 1.93E-05 2.69E-04 4.41E-06 2n-69 1.81E-11 2.61E-11 2.41E-12 No Data 1.58E-11 3.84E-07 2.75E-06 Br-83 No Data No Data 1.28E-07 No Data No Data No Data LT E-24 Br-84 No Data No Data 1.48E-07 No Data No Data No Data LT E-24 Br-85 No Data No Data 6.84E-09 No Data No Data No Data LT E-24 Rb-86 No Data 5.36E-05 3.09E-05 No Data No Data No Data 2.16E-06 Rb-88 No Data 1.52E-07 9.90E-08 No Data No Data No Data 4.66E-09 Rb-89 No Data 9.33E-08 7.83E-08 No Data No Data No Data 5.11E-10 Sr-89 1.62E-04 No Data 4.66E-06 No Data No Data 5.83E-04 4.52E-05 Sr-90 2.73E-02 No Data 1.74E-03 No Data No Data 3.99E-03 9.28E-05 Sr-91 3.28E-08 No Data 1.24E-09 No Data No Data 1.44E-05 4.70E-05 Sr-92 3.54E-09 No Data 1.42E-10 No Data No Data 6.49E-06 6.55E-05 Y-90 1.11E-06 No Data 2.99E-08 No Data No Data 7.07E-05 7.24E-05 Y-91M 1.37E-10 No Data 4.98E-12 No Data No Data 7.60E-07 4.64E-07 Y-91 2.47E-04 No Data 6.59E-06 No Data No Data 7.10E-04 4.97E-05 Y-92 5.50E-09 No Data 1.57E-10 No Data No Data 6.46E-06 6.46E-05
- Reference 3, Table E-9 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-36
TABLE 2.2-2 (continued)
Inhalation Dose Factors for Children (Mrem per PCI Inhaled) o Page 2 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Y-93 5.04E-08 No Data 1.38E-09 No Data No Data 2.01E-05 1.05E-04 Zr-95 5.13E-05 1.13E-05 1.00E-05 No Data 1.61E-05 6.03E-04 1.65E-05 Zr-97 5.07E-08 7.34E-09 4.32E-09 No Data 1.05E-08 3.06E-05 9.49E-05 Nb-95 6.35E-06 2.48E-06 1.77E-06 No Data 2.33E-06 1.66E-04 1.00E-05 Mo-99 No Data 4.66E-08 1.15E-08 No Data 1.06E-07 3.66E-05 3.42E-05 Tc-99M 4.81E-13 9.41E-13 1.56E-11 No Data 1.37E-11 2.57E-07 1.30E-06 Tc-101 2.19E-14 2.30E-14 2.91E-13 No Data 3.92E-13 1.58E-07 4.41E-09 Ru-103 7.55E-07 No Data 2.90E-07 No Data 1.90E-06 1.79E-04 1.21E-05 Ru-105 4.13E-10 No Data 1.50E-10 No Data 3.63E-10 4.30E-06 2.69E-05 Ru-106 3.68E-05 No Date 4.57E-06 No Data 4.97E-05 3.87E-03 1.16E-04 Ag-110M 4.56E-06 3.08E-06 2.47E-06 No Data 5.74E-06 1.48E-03 2.71E-05 Te-125M 1.82E-06 6.29E-07 2.47E-07 5.20E-07 No Data 1.29E-04 9.13E-06 Te-127M 6.72E-06 2.31E-06 8.16E-07 1.64E-06 1.72E-05 4.00E-04 1.93E-05 Te-127 7.49E-10 2.57E-10 1.65E-10 5.30E-10 1.91E-09 2.71E-06 1.52E-05 Te-129M 5.19E-06 1.85E-06 8.22E-07 1.71E-06 1.36E-05 4.76E-04 4.91E-05 Te-129 2.64E-11 9.45E-12 6.44E-12 1.93E-11 6.94E-11 7.93E-07 6.89E-06 Te-131H 3.63E-08 1.60E-08 1.37E-08 2.64E-08 1.08E-07 5.56E-05 8.32E-05 Te-131 5.87E-12 2.28E-12 1.78E-12 4.59E-12 1.59E-11 5.55E-07 3.60E-07 Te-132 1.30E-07 7.36E-08 7.12E-08 8.58E-08 4.79E-07 1.02E-04 3.72E-05 I-130 2.21E-06 4.43E-06 2.28E-06 4.99E-04 6.61E-06 No Data 1.38E-06 I-131 1.30E-05 1.30E-05 7.37E-06 4.39E-03 2.13E-05 No Data 7.68E-07 I-132 5.72E-07 1.10E-06 5.07E-07 5.23E-05 1.69E-06 No data 8.65E-07 I-133 4.48E-06 5.49E-06 2.08E-06 1.04E-03 9.13E-06 No Data 1.48E-06 I-134 3.17E-07 5.84E-07 2.69E-07 1.37E-05 8.92E-07 No Data 2.58E-07 I-135 1.33E-06 2.36E-06 1.12E-06 2.14E-04 3.62E-06 No Data 1.20E-06 Cs-134 1.76E-04 2.74E-04 6.07E-05 No Data 8.93E-05 3.27E-05 1.04E-06 Cs-136 1.76E-05 4.62E-05 3.14E-05 No Data 2.58E-05 3.93E-06 1.13E-06 Cs-137 2.45E-04 2.23E-04 3.47E-05 No Data 7.63E-05 2.81E-05 9.78E-07 Cs-138 1.71E-07 2.27E-07 1.50E-07 No Data 1.68E-07 1.84E-08 7.29E-08 Ba-139 4.98E-10 2.66E-13 1.45E-11 No Data 2.33E-13 1.56E-06 1.56E-05 Ba-140 2.00E-05 1.75E-08 1.17E-06 No Data 5.71E-09 4.71E-04 2.75E-05 Ba-141 5.29E-11 2.95E-14 1.72E-12 No Data 2.56E-14 7.89E-07 7.44E-08 Ba-142 1.35E-11 9.73E-15 7.54E-13 No Data 7.87E-15 4.44E-07 7.41E-10 La-140 1.74E-07 6.08E-08 2.04E-08 No Data No Data 4.94E-05 6.10E-05 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-37
TABLE 2.2-2 (continued)
Inhalation Dose Factors for Children (Mrem per PCI Inhaled)
Page 3 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI La-142 3.50E-10 1.11E-10 3.49E-11 No Data No Data 2.35E-06 2.05E-05 Ce-141 1.06E-05 5.28E-06 7.83E-07 No Data 2.31E-06 1.47E-04 1.53E-05 Ce-143 9.89E-08 5.37E-08 7.77E-09 No Data 2.26E-08 3.12E-05 3.44E-05 Ce-144 1.83E-03 5.72E-04 9.77E-05 No Data 3.17E-04 3.23E-03 1.05E-04 Pr-143 4.99E-06 1.50E-06 2.47E-07 No Data 8.11E-07 1.17E-04 2.63E-05 Pr-144 1.61E-11 4.99E-12 8.10E-13 No Data 2.64E-12 4.23E-07 5.32E-08 Nd-147 2.92E-06 2.36E-06 1.84E-07 No Data 1.30E-06 8.87E-05 2.22E-05 W-187 4.41E-09 2.61E-09 1.17E-09 No Data No Data 1.11E-05 2.46E-05 Np-239 1.26E-07 9.04E-09 6.35E-09 No Data 2.63E-08 1.57E-05 1.73E-05
.i I
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-38
. =
TABLE 2.2-3 Inhalation Dose Factors for Teenagers *
(Mrem per PCI Inhaled)
Page 1 of 3 Nuclide Bone Liver T Body Thyrcid Kidney Lung GI-LLI H-3 No Data 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 C-14 3.25E-06 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 Na-24 1.72E-36 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 <
P-32 2.36E-04 1.37E-05 8.95E-06 No Data No Data No Data 1.16E-05 Cr-51 No Data No Data 1.69E-08 9.37E-09 3.84E-09 2.62E-06 3.75E-07 Mn-54 No Data 6-39E-06 1.05E-06 No Data 1.59E-06 2.48E-04 8.35E-06 Mn-56 No Data 2.12E-10 3.15E-11 No Data 2.24E-10 1.90E-06 7.18E-06 Fe-55 4.18E-06 2.98E-06 6.93E-07 No Data No Data 1.55E-05 7.99E-07 Fe-59 1.99E-06 4.62E-06 1.79E-06 No Data No Data 1.91E-04 2.23E-05 Co-58 No Data 2.59E-07 3.47E-07 No Data No Data 1.68E-04 1.1" Co-60 No Data 1.89E-06 2.48E-06 No Data No Data 1.09E-03 3-Ni-63 7.25E-05 5.43E-06 2.47E-06 No Data No Data 3.84E-05 }-
Ni-65 2.73E-10 3.66E-11 1.59E-11 No Data No Data 1.17E-06 .
Cu-64 No Data 2.54E-10 1.06E-10 No Data 8.01E-10 1.39E-06 7 . i. ; .
Zn-65 4.82E-06 1.67E-05 7.80E-06 No Data 1.08E-05 1.55E-04 5.83E-06 Zn-69 6.04E-12 1.15E-11 8.07E-13 No Data 7.53E-12 1.98E-07 3.56E-08 Br-83 No Data No Data 4.30E-08 No Data No Data No Data LT E-24 Br-84 No Data No Data 5.41E-08 No Data No Data No Data LT E-24 Br-85 No Data No Data 2.29E-09 No Data No Data No Data LT E-24 Rb-86 No Data 2.38E-05 1.05E-05 No Data No Data No Data 2.21E-06 Rb-88 No Data 6.82E-08 3.40E-08 No Data No Data No Data 3.65E-15 Rb-89 No Data 4.40E-08 2.91E-08 No Data No Data No Data 4.22E-17 Sr-89 5.43E-05 No Data 1.56E-06 No Data No Data 3.02E-04 4.64E-05 Sr-90 1.35E-02 No Data 8.35E-04 No Data No Data 2.06E-03 9.56E-05 Sr-91 1.10E-08 No Data 4.39E-10 No Data No Data 7.59E-06 3.24E-05 Sr-92 1.19E-09 No Data 5.08E-11 No Data No Data 3.43E-06 1.49E-05 Y-90 3.73E-07 No Data 1.00E-08 No Data No Data 3.66E-05 6.99E-05 Y-91M 4.63E-11 No Data 1.77E-12 No Data No Data 4.00E-07 3.77E-09 Y-91 8.26E-05 No Data 2.21E-06 No Data No Data 3.67E-04 5.11E-05 Y-92 1.84E-09 No Data 5.36E-11 No Data No Data 3.35E-06 2.06E-05
- Reference 3, Table E-8 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-39
TABLE 2.2-3 (continued)
Inhalation Dose Factors for Teenagers (Mrem per PCI Inhaled)
Page 2 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Y-93 1.69E-08 No Data 4.65E-10 No Data No Data 1.04E-05 7.24E-05 Zr-95 1.82E-05 5.73E-06 3.94E-06 No Data 8.42E-06 3.36E-04 1.86E-05 Zr-97 1.72E-08 3.40E-09 1.57E-09 No Data 5.15E-09 1.62E-05 7.88E-05 Nb-95 2.32E-06 1.29E-06 7.08E-07 No Data 1.25E-06 9.39E-05 1.21E-05 Mo-99 No Data 2.11E-08 4.03E-09 No Data 5.14E-08 1.92E-05 3.36E-05 Tc-99M 1.75E-13 4.83E-13 6.24E-12 No Data 7.20E-12 1.44E-07 7.66E-07 Tc-101 7.40E-15 1.05E-14 1.03E-13 No Data 1.90E-13 8.34E-08 1.09E-16 Ru-103 2.63E-07 No Data 1.12E-07 No Data 9.29E-07 9.79E-05 1.36E-05 Ru-105 1.40E-10 No Data 5.42E-11 No Data 1.76E-10 2.27E-06 1.13E-05 Ru-106 1.23E-05 No Data 1.55E-06 No Data 2.38E-05 2.01E-03 1.20E-04 Ag-110M 1.73E-06 1.64E-06 9.99E-07 No Data 3.13E-06 8.44E-04 3.41E-05 Te-125M 6.10E-07 2.80E-07 8.34E-08 1.75E-07 No Data 6.70E-05 9.38E-06 Te-127M 2.25E-06 1.02E-06 2.73E-07 5.48E-07 8.17E-06 2.07E-04 1.99E-05 Te-127 2.51E-10 1.14E-10 5.52E-11 1.77E-10 9.10E-10 1.40E-06 1.01E-05 Te-129M 1.74E-06 8.23E-07 2.81E-07 5.72E-07 6.49E-06 2.47E-04 5.06E-05 Te-129 8.87E-12 4.22E-12 2.20E-12 6.48E-12 3.32E-11 4.12E-07 2.02E-07 Te-131M 1.23E-08 7.51E-09 5.03E-09 9.06E-09 5.49E-08 2.97E-05 7.76E-05 Te-131 1.97E-12 1.04E-12 6.30E-13 1.55E-12 7.72E-12 2.92E-07 1.89E-09 Te-132 4.50E-08 3.63E-08 2.74E-08 3.07E-08 2.44E-07 5.61E-05 5.79E-05 I-130 7.80E-07 2.24E-06 8.96E-07 1.86E-04 3.44E-06 No Data 1.14E-06 I-131 4.43E-06 6.14E-06 3.30E-06 1.83E-03 1.05E-05 No Data 8.11E-07 I-132 1.99E-07 5.47E-07 1.97E-07 1.89E-05 8.65E-07 No Data 1.59E-07
! I-133 1.52E-06 2.56E-06 7.78E-07 3.65E-04 4.49E-06 No Data 1.29E-06 I-134 1.11E-07 2.90E-07 1.05E-07 4.94E-06 4.58E-07 No Data 2.55E-09 I-135 4.62E-07 1.18E-06 4.36E-07 7.76E-05 1.86E-06 No Data 8.69E-07 Cs-134 6.28E-05 1.41E-04 6.86E-05 No Data 4.69E-05 1.83E-05 1.22E-06 Cs-136 6.44E-06 2.42E-05 1.71E-05 No Data 1.38E-05 2.22E-06 1.36E-06 Cs-137 8.38E-05 1.06E-04 3.89E-05 No Data 3.80E-05 1.51E-05 1.06E-06 Cs-138 5.82E-08 1.07E-07 5.58E-08 No Data 8.28E-08 9.84E-09 3.38E-11 Ba-139 1.67E-10 1.18E-13 4.87E-12 No Data 1.11E-13 8.08E-07 8.06E-07 Ba-140 6.84E-06 8.38E-09 4.40E-07 No Data 2.85E-09 2.54E-04 2.86E-05 Ba-141 1.78E-11 1.32E-14 5.93E-13 No Data 1.23E-14 4.11E-07 9.33E-14 Ba-142 4.62E-12 4.63E-15 2.84E-13 No Data 3.92E-15 2.39E-07 5.99E-20 La-140 5.99E-08 2.95E-08 7.82E-09 No Data No Data 2.68E-05 6.09E-05 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-40
4 . .
TABLE 2.2-3 (continued)
Inhalation Dose Factors for Teenagers (Mrem per PCI Inhaled)
Page 3 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI La-142 1.20E-10 5.31E-11 1.32E-11 No Data No Data 1.27E-06 1.50E-06 Ce-141 3.55E-06 2.37E-06 2.71E-07 No Data 1.11E-06 7.67E-05 1.58E-05 Ce-143 3.32E-08 2.42E-08 2.70E-09 No Data 1.08E-08 1.63E-05 3.19E-05 Ce-144 6.11E-04 2.53E-04 3.28E-05 No Data 1.51E-04 1.67E-03 1.08E-04 Pr-143 1.67E-06 6.64E-07 8.28E-08 No Data 3.86E-07 6.04E-05 2.67E-05 Pr-144 5.37E-12 2.20E-12 2.72E-13 No Data 1.26E-12 2.19E-07 2.94E-14 Nd-147 9.83E-07 1.07E-06 6.41E-08 No Data 6.28E-07 4.65E-05 2.28E-05 W-187 1.50E-09 1.22E-09 4.29E-10 No Data No Data 5.92E-06 2.21E-05 Np-239 4.23E-08 3.99E-09 2.21E-09 No Data 1.25E-08 8.11E-06 1.65E-05 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-41
4 1
TABLE 2.2-4 Inhalation Dose Factors for Adults *
(Mrem per PCI Inhaled)
Page 1 of 3 Nuclide Bone -Liver T Body Thyroid Kidney Lung GI-LLI H-3 No Data 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07 C-14 2.27E-06 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 Na-24 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 P-32 1.65E-04 9.64E-06 6.26E-06 No Data No Data No Data 1.08E-05 Cr-51 No Data No Data 1.25E-08 7.44E-09 2.85E-09 1.80E-06 4.15E-07 Mn-54 No Data 4.95E-06 7.87E-07 No Data 1.23E-06 1.75E-04 9.67E-06 Mn-56 No Data 1.55E-10 2.29E-:1 No Data 1.63E-10 1.18E-06 2.53E-06 Fe-55 3.07E-06 2.12E-06 4.93E-07 No Data No Data 9.01E-06 7.54E-07 Fe-59 1.47E-06 3.47E-06 1.32E-06 No Data No Data 1.27E-04 2.35E-05 Co-58 No Data 1.98E-07 2.59E-07 No Data No Data 1.16E-04 1.33E-05 Co-60 No Data 1.44E-06 1.85E-06 No Data No Data 7.46E-04 3.56E-05 Ni-63 5.40E-05 3.93E-06 1.81E-06 No Data No Data 2.23E-05 1.67E-06 Ni-65 1.92E-10 2.62E-11 1.14E-11 No Data No Data 7.00E-07 1.54E-06 Cu-64 No Data 1.83E-10 7.69E-11 No Data 5.78E-10 8.48E-07 6.12E-06 Zn-65 4.05E-06 1.29E-05 5.82E-06 No Data 8.62E-06 1.08E-04 6.68E-06 Zn-69 4.23E-12 8.14E-12 5.65E-13 No Data 5.27E-12 1.15E-07 2.04E-09 Br-83 No Data No Data 3.01E-08 No Data No Data No Data 2.90E-08 Br-84 No Data No Data 3.91E-08 No Data No Data No Data 2.05E-13 Br-85 No Data No Data 1.60E-09 No Data No Data No Data LT E-24 Rb-86 No Data 1.69E-05 7.37E-06 No Data No Data No Data 2.08E-06 Rb-88 No Data 4.84E-08 2.41E-08 No Data No Data No Data 4.18E-19 Rb-89 No Data 3.20E-08 2.12E-08 No Data No Data No Data 1.16E-21 Sr-89 3.80E-05 No Data 1.09E-06 No Data No Data 1.75E-04 4.37E-05 Sr-90 1.24E-02 No Data 7.62E-04 No Data No Data 1.20E-03 9.02E-05 Sr-91 7.74E-09 No Data 3.13E-10 No Data No Data 4.56E-06 2.39E-05 Sr-92 8.43E-10 No Data 3.64E-11 No Data No Data 2.06E-06 5.38E-06 Y-90 2.61E-07 No Data 7.01E-09 No Data No Data 2.12E-05 6.32E-05 Y-91M 3.26E-11 No Data 1.27E-12 No Data No Data 2.40E-07 1.66E-10 Y-91 5.78E-05 No Data 1.55E-06 No Data No Data 2.13E-04 4.81E-05 Y-92 1.29E-09 No Data 3.77E-11 No Data No Data 1.96E-06 9.19E-06
- Reference 3, Table E-7 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-42 l
TABLE 2.2-4 (continued)
Inhalation Dose Factors for Adults (Mrem per PCI Inhaled)
Page 2 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Y-93 1.18E-08 No Data 3.26E-10 No Data No Data 6.06E-06 5.27E-05 2r-95 1.34E-05 4.30E-06 2.91E-06 No Data 6.77E-06 2.21E-04 1.88E-05 Zr-97 1.21E-08 2.45E-09 1.13E-09 No Data 3.71E-09 9.84E-06 6.54E-05 Nb-95 1.76E-06 9.77E-07 5.26E-07 No Data 9.67E-07 6.31E-05 1.30E Mo-99 No Data '1.51E-08 2.87E-09 No Data 3.64E-08 1.16E-05 3.10E-05 Tc-99M 1.29E-13 3.64E-13 4.63E-12 No Data 5.52E-12 9.55E-08 5.20E-07 Tc-101 5.22E-15 7.52E-15 7.38E-14 No Data 1.35E-13 4.99E-08 1.36E-21 Ru-103 1.91E-07 No Data 8.23E-08 No Data 7.29E-07 6.31E-05 1.38E-05 Ru-105 9.88E-11 No Data 3.89E-11 No Data 1.27E-10 1.37E-06 6.02E-06 Ru-106 8.64E-06 No Data- 1.09E-06 No Data 1.67E-05 1.17E-03 1.14E-04 Ag-110M 1.35E-06 1.25E-06 7.43E-07 No Data 2.46E-06 5.79E-04 3.78E-05 Te-125M 4.27E-07 1.98E-07 5.84E-08 1.31E-07 1.55E-06 3.92E-05 8.83E-06 Te-127M 1.58E-06 7.21E-07 1.96E-07 4.11E-07 5.72E-06 1.20E-04 1.87E-05 Te-127 1.75E-10 8.03E-11 3.87E-11 1.32E-10 6.37E-10 8.14E-07 7.17E-06 Te-129M 1.22E-06 5.84E-07 1.98E-07 4.30E-07 4.57E-06 1.45E-04 4.79E-05 Te-129 6.22E-12 2.99E-12 1.55E-12 4.87E-12 2.34E-11 2.42E-07 1.96E-08 Te-131M 8.74E-09 5.45E-09 3.63E-09 6.88E-09 3.86E-08 1.82E-05 6.95E-05 Te-131 1.39E-12 7.44E-13 4.49E-13 1.17E-12 5.46E-12 1.74E-07 2.30E-09 Te-132 3.25E-08 2.69E-08 2.02E-08 2.37E-08 1.82E-07 3.60E-05 6.37E-05 I-130 5.72E-07 1.68E-06 6.60E-07 1.42E-04 2.61E-06 No Data 9.61E-07 I-131 3.15E-06 4.47E-06 2.56E-06 1.49E-03 7.66E-06 No Data 7.85E-07 l I-132 1.45E-07 4.07E-07 1.45E-07 1.43E-05 6.48E-07 No Data 5.08E-08 I-133 1.08E-06 1.85E-06 5.65E-07 2.69E-04 3.23E-06 No Data 1.11E-06 I-134 8.05E-08 2.16E-07 7.69E-08 3.73E-06 3.44E-07 No Data 1.26E-10 I-135 3.35E-07 8.73E-07 3.21E-07 5.60E-05 1.39E-06 No Data 6.56E-07 Cs-134 4.66E-05 1.06E-04 9.10E-05 No Data 3.59E-05 1.22E-05 1.30E-06 Cs-136 4.88E-06 1.83E-05 1.38E-05 No Data 1.07E-05 1.50E-06 1.46E-06 Cs-137 5.98E-05 7.76E-05 5.35E-05 No Data 2.78E-05 9.40E-06 1.05E-06 Cs-138 4.14E-08 7.76E-08 4.05E-08 No Data 6.00E-08 6.07E-09 2.33E-13
, Ba-139 1.17E-10 8.32E-14 3.42E-12 No Data 7.78E-14 4.70E-07 1.12E-07 Ba-140 4.88E-06 6.13E-09 3.21E-07 No Data 2.09E-09 1.59E-04 2.73E-05 Ba-141 1.25E-11 9.41E-15 4.20E-13 No Data 8.75E-15 2.42E-07 1.45E-17 Ba-142 3.29E-12 3.38E-15 2.07E-13 No Data 2.86E-15 1.49E-07 1.96E-26 La-140 4.30E-08 2.17E-08 5.73E-09 No Data No Data 1.70E-05 5.73E-05 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-43 L
TABLE 2.2-4 (continued)
Inhalation Dose Factors for Adults (Mrem per PCI Inhaled)
Page 3 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI La-142 8.54E-11 3.88E-11 9.65E-12 No Data No Data 7.91E-07 2.64E-07 Ce-141 2.49E-06 1.69E-06 1.91E-07 No Data 7.83E-07 4.52E-05 1.50E-05 Ce-143 2.33E-08 1.72E-08 1.91E-09 No Data 7.60E-09 9.97E-06 2.83E-05 .
Ce-144 4.29E-04 1.79E-04 2.30E-05 No Data 1.06E-04 9.72E-04 1.02E-04 Pr-143 1.17E-06 4.69E-07 5.80E-08 No Data 2.70E-07 3.51E-05 2.50E-05 Pr-144 3.76E-12 1.56E-12 1.91E-13 No Data 8.81E-13 1.27E-07 2.69E-18 Nd-147 6.59E-07 7.62E-07 4.56E-08 No Data 4.45E-07 2.76E-05 2.16E-05 W-187 '1.06E-09 8.85E-10 3.10E-10 No Data No Data 3.63E-06 1.94E-05 Np-239 2.87E-08 2.82E-09 1.55E-09 No Data 8.75E-09 4.70E-06 1.49E-05 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-44
. . _ _ . - - - - _ _ - - - . . -- , - -= - . - ,
TABLE 2.2-5 Ingestion Dose Factors for Infants *
(Mrem per PCI Ingested)
Page 1 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 No Data 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.08E-07 C-14 2.37E-05 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06 Na-24 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05 P-32 1.70E-03 1.00E-04 6.59E-05 No Data No Data No Data 2.30E-05 Cr-51 No Data No Data 1.41E-08 9.20E-09 2.01E-09 1.79E-08 4.11E-07 Mn-54 No Data 1.99E-05 4.51E-06 No Data 4.41E-06 No Data 7.31E-06 Mn-56 No Data 8.18E-07 1.41E-07 No Data 7.03E-07 No Data 7.43E-05 Fe-55 1.39E-05 8.98E-06 2.40E-06 No Data No Data 4.39E-06 1.14E-06 Fe-59 3.08E-05 5.38E-05 2.12E-05 No Data No Data 1.59E-05 2.57E-05 Co-58 No Data 3.60E-06 8.98E-06 No Data No Data No Data 8.97E-06 Co-60 No Data 1.08E-05 2.55E-05 No Data No Data No Data 2.57E-05 Ni-63 6.34E-04 3.92E-05 2.20E-05 No Data No Data No Data 1.95E-06 Ni-65' 4.70E-06 5.32E-07 2.42E-07 No Data No Data No Data 4.05E-05 Cu-64 No Data 6.09E-07 2.82E-07 No Data 1.03E-06 No Data 1.25E-05 Zn-65 1.84E-05 6.31E-05 2.91E-05 No Data 3.06E-05 No Data 5.33E-05 Zn-69 9.33E-08 1.68E-07 1.25E-08 No Data 6.98E-08 No Datt 1.37E-05 Br-83 No Data No Data 3.63E-07 No Data No Data No Data LT E-24 Br-84 No Data No Data 3.82E-07 No Data No Data No Data LT E-24 Br-85 No Data No Data 1.94E-08 No Data No Data No Data LT E-24 Rb-86 No Data 1.70E-04 8.40E-05 No Data No Data No Data 4.35E-06 Rb-88 No Data 4.98E-07 2.73E-07 No Data No Data No Data 4.85E-07 Rb-89 No Data 2.86E-07 1.97E-07 No Data No Data No Data 9.74E-08 Sr-89 2.51E-03 No Data 7.20E-05 No Data No Data No Data 5.16E-05 Sr-90 1.85E-02 No Data 4.71E-03 No Data No Data No Data 2.31E-04 Sr-91 5.00E-05 No Data 1.81E-06 No Data No Data No Data 5.92E-05 Sr-92 1.92E-05 No Data 7.13E-07 No Data No Data No Data 2.07E-04 Y-90 8.69E-08 No Data 2.33E-09 No Data No Data No Data 1.20E-04 Y-91M 8.10E-10 No Data 2.76E-11 No Data No Data No Data 2.70E-05 Y-91 1.13E-06 No Data 3.01E-08 No Data No Data No Data 8.10E-05 Y-92 7.65E-09 No Data 2.15E-10 No Data No Data No Data 1.46E-04
- Reference 3, Table E-14 CDCM, Midland, Consumers Power Compar.y miO283-1828c131-09 2.0-45
I TABLE 2.2-5 (continued)
Ingestion Dose Factors for Infants (Mrem per PCI Ingested)
Page 2 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Y-93 -2.43E-08 No Data 6.62E-10 No Data No Data No Data 1.92E-04 Zr-95 2.06E-07 5.02E-08 3.56E-08 No Data 5.41E-08 No Data 2.50E-05 Zr-97 1.48E-08 2.54E-09 1.16E-09 No Data 2.56E-09 No Data 1.62E-04 Nb-95 4.20E-08 1.73E-08 1.00E-08 No Data 1.24E-08 No Data 1.46E-05 Mo-99 No Data 3.40E-05 6.63E-06 No Data 5.08E-05 No Data 1.12E-05 Tc-99M 1.92E-09 3.96E-09 5.10E-08 No Data 4.26E-08 2.07E-09 1.15E-06 Tc-101 2.27E-09 2.86E-09 2.83E-08 No Data 3.40E-08 1.55E-09 4.86E-07 Ru-103 1.48E-06 No Data 4.95E-07 No Data 3.08E-06 No Data 1.80E-05 Ru-105 1.36E-07 No Data 4.58E-08 No Data 1.00E-06 No Data 5.41E-05 Ru-106 2.41E-05 No Data 3.01E-06 No Data 2.85E-05 No Data 1.83E-04 Ag-110M 9.96E-07 7.27E-07 4.81E-07 No Data 1.04E-06 No Data 3.77E-05 Te-125M 2.33E-05 7.79E-06 3.15E-06 7.84E-06 No Data No Data 1.11E-05 Te-127M 5.85E-05 1.94E-05 7.08E-06 1.69E-05 1.44E-04 No Data 2.36E-05 Te-127 1.00E-06 3.35E-07 2.15E-07 8.14E-07 2.44E-06 No Data 2.10E-05 Te-129M 1.00E-04 3.43E-05 1.54E-05 3.84E-05 2.50E-04 No Data 5.97E-05 Te-129 2.84E-07 9.79E-08 6.63E-08 2.38E-07 7.07E-07 No Data 2.27E-05 Te-131M 1.52E-05 6.12E-06 5.05E-06 1.24E-05 4.21E-05 No Data 1.03E-04 Te-131 1.76E-07 6.50E-08 4.94E-08 1.57E-07 4.50E-07 No Data 7.11E-06 Te-132 2.08E-05 1.03E-05 9.61E-06 1.52E-05 6.44E-05 No Data 3.81E-05 I-130 6.00E-06 1.32E-05 5.30E-06 1.48E-03 1.45E-05 No Data 2.83E-06 I-131 3.59E-05 4.23E-05 1.86E-05 1.39E-02 4.94E-05 No Data 1.51E-06 I-132 1.66E-06 3.37E-06 1.20E-06 1.58E-04 3.76E-06 No Data 2.73E-06 I-133 1.25E-05 1.82E-05 5.33E-06 3.31E-03 2.14E-05 No Data 3.08E-06 I-134 8.69E-07 1.78E-06 6.33E-07 4.15E-05 1.99E-06 No Data 1.84E-06 I-135 3.64E-06 7.24E-06 2.64E-06 6.49E-04 8.07E-06 No Data 2.62E-06 Cs-134 3.77E-04 7.03E-04 7.10E-05 No Data 1.81E-04 7.42E-05 1.91E-06 Cs-136 4.59E-05 1.35E-04 5.04E-05 No Data 5.38E-05 1.10E-05 2.05E-06 Cs-137 5.22E-04 6.11E-04 4.33E-05 No Data 1.64E-04 6.64E-05 1.91E-06 Cs-138 4.81E-07 7.82E-07 3.79E-07 No Data 3.90E-07 6.09E-08 1.25E-06 Ba-139 8.81E-07 5.84E-10 2.55E-08 No Data 3.51E-10 3.54E-10 5.58E-05 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-46
e TABLE 2.2-5 (continued)
Ingestion Dose Factors for Infants (Mrem per PCI Ingested)
Page 3 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Ba-140 1.71E-04 1.71E-07 8.81E-06 No Data 4.06E-08 1.05E-07 4.20E-05 Ba-141 4.25E-07 2.91E-10 1.34E-08 No Data 1.75E-10 1.77E-10 5.19E-06 Ba-142 1.84E-07 1.53E-10 9.06E-09 No Data 8.81E-11 9.26E-11 7.59E-07 La-140 2.11E-08 8.32E-09 2.14E-09 No Data No Data- No Data 9.77E-05 La-142 1.10E-09 4.04E-10 9.67E-11 No Data No Data No Data 6.86E-05 Ce-141 7.87E-08 4.80E-08 5.65E-09 No Data 1.48E-08 No Data 2.48E-05 Ce-143 1.48E-08 9.82E-06 1.12E-09 No Data 2.86E-09 No Data 5.73E-05 Ce-144 2.98E-06 1.22E-06 1.67E-07 No Data 4.93E-07 No Data 1.71E-04 Pr-143 8.13E-08 3.04E-08 4.03E-09 No Data 1.13E-08 No Data 4.29E-05 Pr-144 2.74E-10 1.06E-10 1.38E-11 No Data 3.84E-11 No Data 4.93E-Of Nd-147 5.53E-08 5.68E-08 3.48E-09 No Data 2.19E-08 No Data 3.60E-0 W-187 9.03E-07 6.28E-07 2.17E-07 No Data No Data No Data 3.69E-0; Np-239 1.11E-08 9.93E-10 5.61E-10 No Data 1.98E-09 No Data 2.87E-05 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-47 4
. =
1 TABLE 2.2-6 Ingestion Dose Factors for Children *
(Mrem per PCI Ingested)
Page 1 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 No Data 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 C-14 1.21E-05 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 Na-24 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 P-32 8.25E-04 3.8CE-05 3.18E-05 No Data No Data No Data 2.28E-05 Cr-51 No Data No Data 8.90E-09 4.94E-09 1.35E-09 9.02E-09 4.72E-07 Mn-54 No Data 1.07E-05 2.85E-06 No Data 3.00E-06 No Data 8.98E-06 Mn-56 No Data 3.34E-07 7.54E-08 No Data 4.04E-07 No Data 4.84E-05 Fe-55 1.15E-05 6.10E-06 1.89E-06 No Data No Data 3.45E-06 1.13E-06 Fe-59 1.65E-05 2.67E-05 1.33E-05 No Data No Data 7.74E-06 2.78E-05 Co-58 No Data 1.80E-06 5.51E-06 No Data No Data No Data 1.05E-05 Co-60 No Data 5.29E-06 1.56E-05 No Data No Data No Data 2.93E-05 Ni-63 5.38E-04 2.88E-05 1.83E-05 No Data No Data No Data 1.94E-06 Ni-65 2.22E-06 2.09E-07 1.22E-07 No Data No Data No Data 2.56E-05 Cu-64 No Data -2.45E-07 1.48E-07 No Data 5.92E-07 No Data 1.15E-05 Zn-65 1.37E-05 3.65E-05 2.27E-05 No Data 2.30E-05 No Data 6.41E-06 Zn-69 4.38E-08 6.33E-08 5.85E-09 No Data 3.84E-08 No Data 3.99E-06 Br-83 No Data No Data 1.71E-07 No Data No Data No Data LT E-24 Br-84 No Data No Data 1.98E-07 No Data Fo Data No Data LT E-24 Br-85 No Data No Data 9.12E-09 No Data No Data No Data LT E-24 Rb-86 No Data 6.70E-05 4.12E-05 No Data No Data No Data 4.31E-06 E5-88 No Data 1.90E-07 1.32E-07 No Data No Data No Data 9.32E-09 Ri-89 No Data 1.17E-07 1.04E-07 No Data No Data No Data 1.02E-09 Sr-89 1.32E-03 No Data 3.77E-05 No Data No Data No Data 5.11E-05 Sr-90 1.70E-02 No Data 4.31E-03 No Data No Data No Data 2.29E-04 Sr-91 2.40E-05 No Data 9.06E-07 No Data No Data No Data 5.30E-05 Sr-92 9.03E-06 No Data 3.62E-07 No Data No Data No Data 1.71E-04 Y-90 4.11E-08 No Data 1.10E-09 No Data No Data No Data 1.17E-04 Y-91M 3.82E-10 No Data 1.39E-11 No Data No Data No Data 7.48E-07 Y-91 6.02E-07 No Data 1.61E-08 No Data No Data No Data 8.02E-05 Y-92 3.60E-09 No Data 1.03E-10 No Data No Data No Data 1.04E-04
- Reference 3, Table E-13 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-48
e TABLE 2.2-6 (continued)
Ingestion Dose Factors for Children (Mrem per PCI Ingested)
Page 2 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Y-93 1.14E-06 No Data 3.13E-10 No Data No Data No Data 1.70E-04 Zr-95 1.16E-07 2.55E-08 2.27E-08 No Data 3.65E-08 No Data 2.66E-05 '
Zr-97 6.99E-09 1.01E-09 5.96E-10 No Data 1.45E-09 No Data 1.53E-04 Nb-95 2.25E-08 8.76E-09 6.26E-09 No Data 8.23E-09 No Data 1.62E-05 Mo-99 No Data 1.33E-05 3.29E-06 No Data 2.84E-05 No Data '1.10E-05 Tc-99M 9.23E-10 1.81E-09 3.00E-08 No Data 2.63E-08 9.19E-10 l'.03E-06 Tc-101 1.07E-09 1.12E-09 1.42E-08 No Data 1.91E-08 5.92E-10 3.56E-09 Ru-103 7.31E-07 No Data 2.81E-07 Na Data 1.84E-06 No Data 1.89E-05 Ru-105 6.45E-08 No Data 2.34E-08 No Data 5.67E-07 No Data 4.21E-05 Ru-106 1.17E-05 No Data 1.46E-06 No Data 1.58E-05 No Data 1.82E-04 Ag-110M 5.39E-07 3.64E-07 2.91E-07 No Data 6.78E-07 No Data 4.33E-05 Te-125M 1.14E-05 3.09E-06 1.52E-06 3.20E-06 No Data No Data 1.10E-'05 ,,
Te-127M 2.89E-05 7.78E-06 3.43E-06 6.91E-06 8.24E-05 No Data 2.34E-05 -
Te-127 4.71E-07 1.27E-07 1.01E-07 3.26E-07 1.34E-06 No Data 1.84E-05 Te-129M 4.87E-05 1.36E-05 7.56E-06 1.57E-05 1.43E-04 No Data 5.94E-05 Te-129 1.34E-07 3.74E-08 3.18E-08 9.56E-08 3.92E-07 No Data f.'34E-06 . . .
^
Te-131M 7.20E-06 2.49E-06 2.65E-06 5.12E-06 2.41E-05 No Data 1.01E-04 -
Te-131 8.30E-08 2.53E-08 2.47E-08 6.35E-08 2.51E-07 No Data 4.36E-07 --
Te-132 1.01E-05 4.47E-06 5.40E-06 6.51E-06 4.15E-05 No Data 4.50E-05 I-130 2.92E-06 5.90E-06 3.04E-06 6.50E-04 8.82E-06 No Data 2.76E-06 I-131 1.72E-05 1.73E-05 9.85E-06 5.72E-03 2.84E-05 No Data .1.54E-06 I-132 8.00E-07 1.47E-06 6.76E-07 6.82E-05 2.25E-06 No Data 1.73E-06 l I-133 5.92E-06 7.32E-06 2.77E-06 1.36E-03 1.22E-05 No Data 2.95E-06 I-134 4.19E-07 7.78E-07 3.58E-07 1.79E-05 1.19E-06 No Data 5.16E-07 I-135 1.75E-06 3.15E-06 1.49E-06 2.79E-04 4.83E-06 No Data 2.4hE-06 Cs-134 2.34E-04 3.84E-04 8.10E-05 No Data 1.19E-04 4.27E-05 2.07E-06 Cs-136 2.35E-05 6.46E-05 4.18E-05 No Data 3.44E-05 5.13E-06 2.27E-06 Cs-137 3.27E-04 3.13E-04 4.62E-05 No Data 1.02E-04 3.67E-05 1.96E-06 Cs-138 2.28E-07 3.17E-07 2.01E-07 No Data 2.23E-07 2.40E-08 1.46E-07 Ba-139 4.14E-07 2.21E-10 1.20E-08 No Data 1.93E-10 1.30E-10 2.39E-05 Ba-140 8.31E-05 7.28E-08 4.85E-06 No Data 2.37E-08 4.34E-08 4.21E-05 ~
Ba-141 2.00E-07 1.12E-10 6.51E-09 No Data 9.69E-11 6.58E-10 1.14E-07 Ba-142 8.74E-08 6.29E-11 4.88E-09 No Data 5.09E-11 3.70E-11 1.14E-09
l ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-49 L
x .-
- i
~
-a /
7' ~
TABLE 2.2-6.(continued)
Ingestion Dose Factors f2r Children
,v. [' s : -; (Mrem per PCI Ingested)
.' Page 3 of 3
s' Eclide . Bone Liver T Body Thyroid ' Kidney Lung GI-LLI
' ~
La-140 1.01E-08 3.53E-09 1.19E-09 No Data .a Data No Data 9.84E-05 La-142 5.24E-10 1.67E-10 5.23E-11 No Dat'a, No Data No Data 3.31E-05 3.97E-08 1.98E-08 2.94E-09 No Data 8.68E-09 No Data 2.47E-05 Ce-141 Ce-143 6.99E-09 3.79E-06 5.49E-10 N6 Data 1:59E-09 No Data 5.55E-05
. - Ce-144 ' .~
2.08E-06 6.52E-07 1.11E-07 No Data 3.61E-07 No Data 1.70E-04 Pr-143 3.93E-08 1.18E-08 1.95E-09 No Data 6.39E-09 No Data 4.24E-05 Pr-144 ~1 29E-10 3.99E-11 6.49E-12 No Data 2.11E-11 No Data 8.59E-08 Nd-147 2.79E-08 2.26E-08 1.75E-09 No Data 1.24E-08 No Data 3.56E-05 W-187 4.29E-07 2.54E-07 ~
1.14E-07 No-Data _ No' Data No Data 3.57E-05
~ s
,. Np-239 5.25E-09 3.77 Ell'0 2.65E-19 No Data 1.09E-09 No Data 2.79E-05
% s. . ;. .s
- N'
,\ ,.
s s
-~
3 s
, s ." ~.
D s
t e
A;- -
,. N g, s u I's't i
~ ~
~
. . . .p 3 ,_ _
r , ;
~ $_ -
- N -
A
\
~
g1 x .
~'
ODCM,-Midland, Consumers Power Company
. miO283-1828c131-09 2.0-50 I
L
1 e
- TABLE 2.2-7 Ingestion Dose Factors for Teenagers *
(Mrem por PCI Ingested)
Page 1 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 No Data 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07 C-14 4.06E-06 8.12E-07 8.12E-07 8.12E-07 8.12E-07 8.12E-07 8.12E-07 Na-26 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 P-32 2.76E-04 1.71E-05 1.07E-05 No Data No Data No Data 2.32E-05 Cr-51 No Data No Data 3.60E.09 2.00E-09 7.89E-10 5.14E-09 6.05E-07 Mn-54 No Data 5.90E-06 1.17E-06 No Data 1.76E-06 No Data 1.21E-05 Mn-56 No Data 1.58E-07 2.81E-08 No Data 2.00E-07 No Data 1.04E-05 Fe-55 3.78E-06 2.68F-06 6.25E-07 No Data No Data 1.70E-06 1.16E-06 Fe-59 5.87E-06 1.37E-05 5.29E-06 No Data No Data 4.32E-06 3.24E-05 Co-58 No Data 9.72E-07 2.24E-06 No Data No Data No Data 1.34E.r-Co-60 No Data 2.81E-06 6.33E-06 No Data No Data No Data 3.66E-Ni-63 1.77E-04 1.25E-05 6.00E-06 No Data No Data No Data 1.99E-Ni-65 7.49E-07 9.57E-08 4.36E-08 No Data No Data No Data 5.19E-06 Cu-64 No Data 1.15E-07 5.41E-08 No Data 2.91E-07 No Data 8.92E-06 Zn-65 5.76E-06 2.00E-05 9.33E-06 No Data 1.28E-05 No Data 8.47E-06 Zn-69 1.47E-08 2.80E-08 1.96E-09 No Data 1.83E-08 No Data 5.16E-08 Br-83 No Data No Data 5.74E-08 No Data No Data No Data LT E-24 Br-84 No Data No Data 7.22E-08 No Data No Data No Data LT E-24
! Br-85 No Data No Data 3.05E-09 No Data No Data No Data LT E-24 Rb-86 No Data 2.98E-05 1.40E-05 No Data No Data No Data 4.41E-06 Rb-88 No Data 8.52E-08 4.54E-08 No Data No Data No Data 7.30E-15 Rb-89 No Data 5.50E-08 3.89E-08 No Data No Data No Data 8.43E-17 Sr-89 4.40E-04 No Data 1.26E-05 No Data No Data No Data 5.24E-05 Sr-90 8.30E-03 No Data 2.05E-03 No Data No Data No Data- 2.33E-04 Sr-91 8.07E-06 No Data 3.21E-07 No Data No Data No Data 3.66E-05 Sr-92 3.05E-06 No Data 1.30E-07 No Data No Data No Data 7.77E-05 Y-90 1.37E-08 No Data 3.69E-10 No Data No Data No Data 1.13E-04 Y-91M 1.29E-10 No Data 4.93E-12 No Data No Data No Data 6.09E-09 Y-91 2.01E-07 No Data 5.39E-09 No Data No Data No Data 8.24E-05 Y-92 1.21E-09 No Data 3.50E-11 No Data No Data No Data 3.32E-05
- Reference 3, Table E-12 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-51 L
TABLE 2.2-7 (continued)
Ingestion Dose Factors for Teenagers (Mrem per Pci Ingested)
Page 2 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Y-93 3.83E-09 No Data 1.05E-10 No Data No Data No Data 1.17E-04 Zr-95 4.12E-08 1.30E-08 8.94E-09 No Data 1.91E-08 No Data 3.00E-05 Zr-97 2.37E-09 4.69E-10 2.16E-10 No Data 7.11E-10 No Data 1.27E-04 Nb-95 8.22E-09 4.56E-09 2.51E-09 No Data 4.42E-09 No Data 1.95E-05 Mo-99 No Data 6.03E-06 1.15E-06 No Data 1.38E-05 No Data 1.08E-05 Tc-99M 3.32E-10 9.26E-10 1.20E-08 No Data 1.38E-08 5.14E-10 6.08E-07 Tc-101 3.60E-10 5.12E-10 5.03E-09 No Data 9.26E-09 3.12E-10 8.73E-17 Ru-103 2.55E-07 No Data 1.09E-07 No Data 8.99E-07 No Data 2.13E-05 Ru-105 2.18E-08 No Data 8.46E-09 No Data 2.75E-07 No Data 1.76E-05 Ru-106 3.92E-06 No Data 4.94E-07 No Data 7.56E-06 No Data 1.88E-04 Ag-110M 2.05E-07 1.94E-07 1.18E-07 No Data 3.70E-07 No Data 5.45E-05 Te-125M 3.83E-06 1.38E-06 5.12E-07 1.07E-06 No Data No Data 1.13E-05 Te-127M 9.67E-06 3.43E-06 1.15E-06 2.30E-06 3.92E-05 No Data 2.41E-05 Te-127 1.58E-07 5.60E-08 3.40E-08 1.09E-07 6.40E-07 No Data 1.22E-05 Te-129M 1.63E-05 6.05E-06 2.58E-06 5.26E-06 6.82E-05 No Data 6.12E-05 Te-129 4.48E-08 1.67E 08 1.09E-08 3.20E-08 1.88E-07 No Data 2.45E-07 Te-131M 2.44E-06 1.17E-06 9.76E-07 1.76E-06 1.22E-05 No Data 9.39E-05 Te-131 2.79E-08 1.15E-08 8.72E-09 2.15E-08 1.22E-07 No Data 2.29E-09 Te-132 3.49E-06 2.21E-06 2.08E-06 2.33E-06 2.12E-05 No Data 7.00E-05 I-130 1.03E-06 2.98E-06 1.19E-06 2.43E-04 4.59E-06 No Data 2.29E-06 I-131 5.85E-06 8.19E-06 4.40E-06 2.39E-03 1.41E-05 No Data 1.62E-06 I-132 2.79E-07 7.30E-07 2.62E-07 2.46E-05 1.15E-06 No Data 3.18E-07 I-133 2.01E-06 3.41E-06 1.04E-06 4.76E-04 5.98E-06 No Data 2.58E-06 I-134 1.46E-07 3.87E-07 1.39E-07 6.45E-06 6.10E-07 No Data 5.10E-09 I-135 6.10E-07 1.57E-06 5.82E-07 1.01E-04 2.48E-06 No Data 1.74E-06 Cs-134 8.37E-05 1.97E-04 9.14E-05 No Data 6.26E-05 2.39E-05 2.45E-06 Cs-136 8.59E-06 3.38E-05 2.27E-05 No Data 1.84E-05 2.90E-06 2.72E-06 Cs-137 1.12E-04 1.49E-04 5.19E-05 No Data 5.07E-05 1.97E-05 2.12E-06 Cs-138 7.76E-08 1.49E-07 7.45E-08 No Data 1.10E-07 1.28E-08 6.76E-11 Ba-139 1.39E-07 9.78E-11 4.05E-09 No Data 9.22E-11 6.74E-11 1.24E-06 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-52 l
l l
=
a l
TABLE 2.2-7 (continued)
Ingestion Dose Factors for Teenagers (Mrem per PCI Ingested)
Page 3 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Ba-140 2.84E-05 3.48E-08 1.83E-06 No Data 1.18E-08 2.34E-08 4.38E-05 Ba-141 6.71E-08 5.01E-11 2.24E-09 No Data 4.65E-11 3.43E-11 1.43E-13 Ba-142 2.99E-08 2.99E-11 1.84E-09 No Data 2.53E-11 1.99E-11 9.18E-20 La-140 3.48E-09 1.71E-09 4.55E-10 No Data No Data No Data 9.82E-05 La-142 1.79E-10 7.95E-11 1.98E-11 No Data No Data No Data 2.42E-06 Ce-141 1.33E-08 8.88E-09 1.02E-09 No Data 4.18E-09 No Data 2.54E-05 Ce-143 2.35E-09 1.71E-06 1.91E-10 No Data 7.67E-10 No Data 5.14E-05 Ce-144 6.96E-07 2.88E-07 3.74E-08 No Data 1.72E-07 No Data 1.75E-04 Pr-143 1.31E-08 5.23E-09 6.52E-10 No Data 3.04E-09 No Data 4.31E-05 Pr-144 4.30E-11 1.76E-11 2.18E-12 No Data 1.01E-11 No Data 4.74E-14 Nd-147 9.38E-09 1.02E-08 6.11E-10 No Data 5.99E-09 No Data 3.68E-05 W-187 1.46E-07 1.19E-07 4.17E-08 No Data No Data No Data 3.22E-05 Np-239 1.76E-09 1.66E-10 9.22E-11 No Data 5.21E-10 No Data 2.67E-05 ODCM,1:idland, Consumers Power Company miO283-1828c131-09 2.0-53
s l
. l l
l l
TABLE 2.2-8 Ingestion Dose Factors for Adults *
(Mrem per PCI Ingested)
Page 1 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 No Data 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 C-14 2.84E-06 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 Na-24 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 ,
P-32 1.93E-04 1.20E-05 7.46E-06 No Data No Data No Data 2.17E-05 Cr-51 No Data No Data 2.66E-09 1.59E-09 5.86E-10 3.53E-09 6.69E-07 Mn-54 No Data 4.57E-06 8.72E-07 No Data 1.36E-06 No Data 1.40E-05 Mn-56 No Data 1.15E-07 2.04E-08 No Data 1.46E-07 No Data 3.67E-06 Te-55 2.75E-06 1.90E-06 4.43E-07 No Data No Data 1.06E-06 1.09E-06 Fe-59 4.34E-06 1.02E-05 3.91E-06 No Data No Data 2.85E-06 3.40E-05 Co-58 No Data 7.45E-07 1.67E-06 No Data No Data No Data 1.51E-05 Co-60 No Data 2.14E-06 4.72E-06 No Data No Data No Data 4.02E-05 Ni-63 1.30E-04 9.01E-06 4.36E-06 No Data No Data No Data 1.88E-06 Ni-65 5.28E-07 6.86E-08 3.13E-08 No Data No Data No Data 1.74E-06 Cu-64 No Data 8.33E-08 3.91E-08 No Data 2.10E-07 No Data 7.10E-06 Zn-65 4.84E-06 1.54E-05 6.96E-06 No Data 1.03E-05 No Data 9.70E-06 Zn-69 1.03E-08 1.97E-08 1.37E-09 No Data 1.28E-08 No Data 2.96E-09 Br-83 No Data No Data 4.02E-08 No Data No Data No Data 5.79E-08 Br-84 No Data No Data 5.21E-08 No Data No Data No Data 4.09E-13 Br-85 No Data No Data 2.14E-09 No Data No Data No Data LT E-24 Rb-86 No Data 2.11E-05 9.83E-06 No Data No Data No Data 4.16E-06 Rb-88 No Data 6.05E-08 3.21E-08 No Data No Data No Data 8.36E-19 Rb-89 No Data 4.01E-08 2.82E-08 No Data No Data No Data 2.33E-21 Sr-89 3.08E-04 No Data 8.84E-06 No Data No Data No Data 4.94E-05 Sr-90 7.58E-03 No Data 1.86E-03 No Data No Data No Data 2.19E-04 Sr-91 5.67E-06 No Data 2.29E-07 No Data No Data No Data 2.70E-05 Sr-92 2.15E-06 No Data 9.30E-08 No Data No Data No Data 4.26E-05 Y-90 9.62E-09 No Data 2.58E-10 No Data No Data No Data 1.02E-04 Y-91M 9.09E-11 No Data 3.52E-12 No Data No Data No Data 2.67E-10 Y-91 1.41E-07 No Data 3.77E-09 No Data No Data No Data 7.76E-05 Y-92 8.45E-10 No Data 2.47E-11 No Data No Data No Data 1.48E-05
- Reference 3, Table E-11 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-54 L
s
- TABLE 2.2-8 (continued)
Ingestion Dose Factors for Adults (Mrem per PCI Ingested)
Page 2 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Y-93 2.68E-09 No Data 7.40E-11 No Data No Data No Data 8.50E-05 Zr-95 3.04E-08 9.75E-09 6.60E-09 No Data 1.53E-08 No Data 3.09E-05 Zr-97 1.68E-09 3.39E-10 1.55E-10 No Data 5.12E-10 No Data 1.05E-04 Nb-95 6.22E-09 3.46E-09 1.86E-09 No Data 3.42E-09 No Data 2.10E-05 Mo-99 No Data 4.31E-06 8.20E-07 No Data 9.76E-06 No Data 9.99E-06 Tc-99M 2.47E-10 6.98E-10 8.89E-09 No Data 1.06E-08 3.42E-10 4.13E-07 Tc-101 2.54E-10 3.66E-10 3.59E-09 No Data 6.59E-09 1.87E-10 1.10E-21 Ru-103 1.85E-07 No Data 7.97E-08 No Data 7.06E-07 No Data 2.16E-05 Ru-105 1.54E-08 No Data 6.08E-09 No Data 1.99E-07 No Data 9.42E-06 Ru-106 2.75E-06 No Data 3.48E-07 No Data 5.31E-06 No Data 1.78E-04 Ag-110M 1.60E-07 1.48E-07 8.79E-08 No Data 2.91E-07 No Data 6.04E-05 Te-125M 2.68E-06 9.71E-07 3.59E-07 8.06E-07 1.09E-05 No Data 1.07E-05 Te-127M 6.77E-06 2.42E-06 8.25E-07 1.73E-06 2.75E-05 No Data 2.27E-05 Te-127 1.10E-07 3.95E-08 2.38E-08 8.15E-08 4.48E-07 No Data 8.68E-06 Te-129M 1.15E-05 4.29E-06 1.82E-06 3.95E-06 4.80E-05 No Data 5.79E-05 Te-129 3.14E-08 1.18E-08 7.65E-09 2.41E-08 1.32E-07 No Data 2.37E-08 Te-131M 1.73E-06 8.46E-07 7.05E-07 1.34E-06 8.57E-06 No Data 8.40E-05 Te-131 1.97E-08 8.23E-09 6.22E-09 1.62E-08 8.63E-08 No Data 2.79E-09 Te-132 2.52E-06 1.63E-06 1.53E-06 1.80E-06 1.57E-05 No Data 7.71E-05 I-130 7.56E-07 2.23E-06 8.80E-07 1.89E-04 3.48E-06 No Data 1.92E-06 I-131 4.16E-06 5.95E-06 3.41E-06 1.95E-03 1.02E-05 No Data 1.57E-06 I-132 2.03E-07 5.43E-07 1.90E-07 1.90E-05 8.65E-07 No Data 1.02E-07 I-133 1.42E-06 2.47E-06 7.53E-07 3.63E-04 4.31E-06 No Data 2.22E-06 I-134 1.06E-07 2.88E-07 1.03E-07 4.99E-06 4.58E-07 No Data 2.51E-10 I-135 4.43E-07 1.16E-06 4.28E-07 7.65E-05 1.86E-06 No Data 1.31E-06 Cs-134 6.22E-05 1.48E-04 1.21E-04 No Data 4.79E-05 1.59E-05 2.59E-06 Cs-136 6.51E-06 2.57E-05 1.85E-05 No Data 1.43E-05 1.96E-06 2.92E-06 Cs-137 7.97E-05 1.09E-04 7.14E-05 No Data 3.70E-05 1.23E-05 2.11E-06 Cs-138 5.52E-08 1.09E-07 5.40E-08 No Data 8.01E-08 7.91E-09 4.65E-13 Ba-139 9.70E-08 6.91E-11 2.84E-09 No Data 6.46E-11 3.92E-11 1.72E-07 Ba-140 2.03E-05 2.55E-08 1.33E-06 No Data 8.67E-09 1.46E-08 4.18E-05 Ba-141 4.71E-08 3.56E-11 1.59E-09 No Data 3.31E-11 2.02E-11 2.22E-17 Ba-142 2.13E-08 2.19E-11 1.34E-09 No Data 1.85E-11 1.24E-11 3.00E-26 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-55
TABLE 2.2-8 (continued)
Ingestion Dose Factors for Adults (Mrem per PCI Ingested)
Page 3 of 3 Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI La-140 2.50E-09 1.26E-09 3.33E-10 No Data No Data No Data 9.25E-05 La-142 1.28E-10 5.82E-11 1.45E-11 No Data No Data No Data 4.25E-07 Ce-141 9.36E-09 6.33E-09 7.18E-10 No Data 2.94E-09 No Data 2.42E-05 Ce-143 1.65E-09 1.22E-06 1.35E-10 No Data 5.37E-10 No Data 4.56E-05 Ce-144 4.88E-07 2.04E-07 2.62E-08 No Data 1.21E-07 No Data 1.65E-04 Pr-143 9.20E-09 3.69E-09 4.56E-10 No Data 2.13E-09 No Data 4.03E-05 Pr-144' 3.01E-11 1.25E-11 1.53E-12 No Data 7.05E-12 No Data 4.33E-18 Nd-147 6.29E-09 7.27E-09 4.35E-10 No Data 4.25E-09 No Data 3.49E-05 W-187 1.03E-07 8.61E-08 3.01E-08 No Data No Data No Data' 2.82E-05 Np-239 1.19E-09 1.17E-10 6.45E-11 No Data 3.65E-10 No Data 2.40E-05 ODCM, Midland, Consumers Fever Company miO283-1828c131-09 2.0-56
. o TABLE 2.2-9 External Dose Factors for Standing on Contaminated Ground *
(mrem /hr per pCi/m2 )
Page 1 of 3 Element Total Body Skin H-3 0.0 0.0 C 0.0 0.0 Na-24 2.50E-08 2.90E-08 P-32 0.0 0.0 Cr-51 2.20E-10 2.60E-10 Mn-54 5.80E-09 6.80E-09 Mn-56 1.10E-08 1.30E-08 Fe-55 0.0 0.0 Fe-59 8.00E-09 9.40E-09 Co-58 7.00E-09 8.20E-09 Co-60 1.70E-08 2.00E-08 Ni-63 0.0 0.0 Ni-65 3.70E-09 4.30E-09 Cu-64 1.50E-09 1.70E-09 Zn-65 4.00E-09 4.60E-09 Zn-69 0.0 0.0 Br-83 6.40E-11 9.30E-11 Br-84 1.20E-08 1.40E-08 Br-85 0.0 0.0 Rb-86 6.30E-10 7.20E-10 Rb-88 3.50E-09 4.00E-09 Rb-89 1.50E-08 1.80E-08 Sr-89 5.60E-13 6.50E-13 Sr-91 7.10E-09 8.30E-09 Sr-92 9.00E-09 1.00E-08 Y-90 2.20E-12 2.60E-12 Y-91M 3.80E-09 4.40E-09 Y-91 2.40E-11 2.70E-11 Y-92 1.60E-09 1.90E-09 Y-93 5.70E-10 7.80E-10 l
- Reference 3, Table E-6 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-57 l
l TABLE 2.2-9 (continued)
External Dose Factors for Standing on Contaminated Ground *
(mrem /br per pCi/m2 )
Page 2 of 3-Element Total Body Skin Zr-95 5.00E-09 5.80E-09 Zr 17 5.50E-09 6.40E-09 Fb-95 5.10E-09 6.00E-09 Mo-99 1.90E-09 2.20E-09 Tc-99M 9.60E-10 1.10E-09 Tc-101 2.70E-09 3.00E-09 Ru-103 3.60E-09 4.20E-09 Ru-105 4.50E-09 5.10E-09 Ru-106 1.50E-09 1.80E-09 Ag-110M 1.80E-08 2.10E-08 Te-125M 3.50E-11 4.80E-11 Te-127M 1.10E-12 1.30E-12 Te-127 1.00E-11 1.10E-11 Te-129M 7.70E-10 9.00E-10 Te-129 7.10E-10 8.40E-10 Te-131M 8.40E-09 9.90E-09 Te-131 2.20E-09 2.60E-06 Te-132 1.70E-09 2.00E-09 I-130 1.40E-08 1.70E-08 I-131 2.80E-09 3.40E-09 I-132 1.70E-08 2.00E-08 I-133 3.70E-09 4.50E-09 I-134 1.60E-08 1.90E-08 I-135 1.20E-08 1.40E-08 Cs-134 1.20E-08 1.40E-08 Cs-136 1.50E-08 1.70E-08 Cs-137 4.20E-09 4.90E-09 Cs-138 2.10E-08 2.40E-08 Ba-139 2.40E-09 2.70E-09 Ba-140 2.10E-09 2.40E-09 Ba-141 4.30E-09 4.90E-09 Ba-142 7.90E-09 9.00E-09 La-140 1.50E-08 1.70E-08 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-58
e
- TABLE 2.2-9 (continued)
External Dose Factors for Standing on Contaminated Ground *
(mrem /hr per pCi/m2 )
Page 3 of 3 Element Total Body Skin La-142 1.50E-08 1.80E-08 Ce-141 5.50E-10 6.20E-10 Cc-143 2.20E-09 2.50E-09 Ce-144 3.20E-10 3.70E-10 Pr-143 0.0 0.0 Pr-144 2.00E-10 2.30E-10 Nd-147 1.00E-09 1.20E-09 W-187 3.10E-09 3.60E-09 Np-239 9.50E-10 1.10E-09 i
t ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-59
t TABLE 2.2-10 Individual Usage Factors
- Infant Child Teenager Adult Milk Consumption Rate, 330 330 400 310 U,p (liters / year)
Meat Consumption Rate, 0 41 65 110 U,p (kg/ year)
Fresh Leafy Vegetation 0 26 42 64 Consumption Rate, U,g (kg/ year)
Stored Vegetation 0 520 630 520 Consumption Rate, U,,(kg/ year)
Rate, 1400 3700 8000 8000.
Breathing (BR),(m / year)
I
- Reference 3, Table E-5 ODCM, Midland, Consumers Power Company
- miO283-1828c131-09 2.0-60
s
- TABLE 2.2-11 Stable Element Transfer Data
- F,- Hilk (Cow) F,- Hilk (Goat) F - Heat f
Element (days / liter) (days / liter) (days /,kg)
H 1.0E-02 1.7E-01 1.2E-02 C 1.2E-02 1.0E-01 3.1E-02 Na 4.0E-02 4.0E-02 3.0E-02 P 2.5E-02 2.5E-01 4.6E-02 Cr 2.2E-03 2.2E-03 2.4E-03 Mn 2.5E-04 2.5E-04 8.0E-04 Fe 1.2E-03 1.3E-04 4.0E-02 Co 1.0E-03 1.0E-03 1.3E-02 Ni 6.7E-03 6.7E-03 5.3E-02 Cu 1.4E-02 1.3E-02 8.0E-03 Zn 3.9E-02 3.9E-02 3.0E-02 Rb 3.0E-02 3.0E-02 3.1E-02 Sr 8.0E-04 1.4E-02 6.0E-04 Y 1.0E-05 1.0E-05 4.6E-03 Zr 5.0E-06 5.0E-06 3.4E-02 Nb 2.5E-03 2.5E-03 2.8E-01 Mo 7.5E-03 7.5E-03 8.0E-03 Tc 2.5E-02 2.5E-02 4.0E-01 Ru 1.0E-06 1.0E-06 4.0E-01 Rh 1.0E-02 1.0E-02 1.5E-03 Ag 5.0E-02 5.0E-02 1.7E-02 Te 1.0E-03 1.0E-03 7.7E-02 I 6.0E-03 6.0E-02 2.9E-03 Cs 1.2E-02 3.0E-01 4.0E-03 Ba 4.0E-04 4.0E-04 3.2E-03 La 5.0E-06 5.0E-06 2.0E-04 Ce 1.0E-04 1.0E-04 1.2E-03 Pr 5.0E-06 5.0E-06 4.7E-03 Nd 5.0E-06 5.0E-06 3.3E-03 W 5.0E-04 5.0E-04 1.3E-03 Np 5.0E-06 5.0E-06 2.0E-04
- Reference 3, Table E-1 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-61
TABLE 2.2-12 Controlling Receptors, Locations, and Pathways *
(For Dose Calculations required by Technical Specifications 4.11.2.4.1, 6.9.1.8, 6.9.1.12, and 3.12.2)
Distance Sector (Miles) Pathway Age Group N 1.52 Vegetation- Child NNE 1.40 Vegetation Child ,
NE 1.29 Vegetation Child ENE 3.96 Grass / cow / milk Infant E 3.37 Grass / cow / milk Infa; ESE 5.00 Grass / goat /nilk Infant SE 3.96 Grass / cow / milk Infant SSE 2.50 Vegetation Child S 1.25 Vegetation Child SSW 1.29 Vegetation Child SW 1.02 Vegetation Child WSW 0.80 Vegetation Child W 0.87 Vegetation Child WNW 1.40 Vegetation Child NW 2.10 Vegetation Child NNW 1.86 Vegetation Child
- Reference 5 ODCM,-Midland, Consumers Power Company miO283-1828c131-09 2.0-62
TABLE 2.2-13 Relative Concentrations and Relative Depositions *
(For Technical Specifications 3.11.2.3, 3.11.2.4, 6.9.1.12, and 3.12.2)
Ground Release Mixed-Mode Release Distance Sector X/Q D/Q X/Q D/Q (Miles)
N 1.39E-6 1.08E-8 2.38E-7 3.35E-9 1.52 NNE 1.50E-6 1.31E-8 3.21E-7 4.85E-9 1.40 NE 1.79E-6 1.50E-8 4.17E-7 5.81E-9 1.29 ENE 1.80E-7 1.50E-9 7.32E-8 9.95E-10 3.4t E 3.26E-7 2.02E-9 8.99E-8 1.28E-9 ESE 8.41E-8 7.84E-10 4.15E-8 6.01E-10 :
SE 1.00E-7 1.05E-9 5.01E-8 8.31E-10 3.96 SSE 1.51E-7 1.75E-9 8.18E-8 1.24E-9 2.50 S 3.96E-7 5.10E-9 1.52E-7 2.49E-9 1.25
-SSW 3.79E-7 4.76E-9 1.42E-7 2.50E-9 1.29 SW 7.86E-7 9.70E-9 2.43E-7 4.55E-9 1.02 i WSW 2.52E-6 2.61E-8 5.65E-7 9.81E-9 0.80 l
W 1.83E-6 1.59E-8 2.38E-7 4.97E-9 0.87 WNW 8.10E-7 5.36E-9 1.48E-7 1.82E-9 1.40 NW 4.76E-7 3.33E-9 8.26E-8 1.07E-9 2.10 NNW 7.00E-7 5.22E-9 1.09E-7 1.52E-9 1.86
!
- Reference 5 l
ODCM, Midland, Consumers Power Company .
miO283-1828c131-09 2.0-63 !
7 I' ~
, a
)
2.3 DEFINITIONS OF GASEOUS EFFLUENTS PARAMETERS Section of Term Definition Initial Use BR = breathing rate for child age group (3700 m 3/ year) 2.2.1.b from Table 2.2-10.
(BR), = breathing rate for a particular age group a (m 3/ year) 2.2.2.b from Table 2.2-10.
C = monitor reading of a noble gas monitor corresponding 2.1.1 to associated sample radionuclide concentrations (pCi/cc).
Cg = monitor reading of the noble gas monitor at the alarm 2.1.1 setpoint for the release pathway under consideration (pCi/cc).
D. = dose to an organ of an individual from radioiodines, 2.2.2.b J
tritium, and radionuclides in particulate form with half-lives greater than eight days (mrem).
D, = organ dose rate at time of release (mrem / year). 2.2.1.b D = skin dose rate at time of release (mrem / year). 2.2.1.a s
i ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-64
. o 2.3 DEFINITIONS OF GASEOUS EFFLUENTS PARAMETERS (Continued)
Section of Term Definition Initial Use Dg = total body dose rate at time of release (mrem / year). 2.2.1.a D = air dose due to beta emissions from noble gases 2.2.2.a p
(mrad).
D = air dose due to gamma emissions from noble gases 2.2.2.a (mrad).
D TB
= limiting dose rate to the total body of an individual 2.1.1 in an unrestricted area (500 mrem / year).
D ss
= limiting dose rate to the skin of an individual in 2.1.1 an unrestricted area (3000 mrem / year).
DFg , = inhalation pathway dose factor for child age group 2.2.1.b for organ o and radionuclide i (mrem /pCi inhaled) from Table 2.2-2.
D/Q = relative deposition concurrent with actual release 2.2.2.c (m-2),
D/Q' = annual average relative deposition for location of 2.2.2.b controlling (critical) receptor for pathways other
~
than inhalation or tritium (m ).
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-65
2.3 DEFINITIONS OF GASEOUS EFFLUENTS PARAMETERS (Continued)
Section of Term Definition Initial Use (D/Q')g = annual average relative deposition for location of 2.2.2.b controlling (critical) receptor for pathways other than inhalation of tritium for a mixed mode release type (m-2)
(D/Q')g = annual average relative depositiors for location 2.2.2.b of controlling (critical) receptor for pathways other than inhalation or tritium for a ground-level release type (m-2),
(DFA..)a lj = the inhalation dose factor for the ith 2.2.2.b radionuc1 die for the receptor in age group a
-(mrem /pCi) from Tables 2.2-1 through 2.2-4.
DFG.. = ground plane. dose conversion factor for 2.2.2.b IJ radionuclide i (same for all age groups) 2 (mrem /hr per pCi/m ) f rom 'Iable 2.2-9.
(DFL ), = the organ ingestion dose factor for the 2.2.2.b ith radionuclide for the receptor in age group a (mrem /pci) from Tables 2.2-5 through 2.2-8.
F = administrative allocation factor for gaseous effluent 2.1.1 B
pathways (dimensionless).
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-66 l
2.3 DEFINITIONS OF GASEOUS EFFLUENTS PARAMETERS (Continued)
Section of Term Definition Initial Use F
f
= the stable element transfer coefficient (days /kg) 2.2.2.d from Table 2.2-11.
F, = the stable element transfer coefficient (days / liter) 2.2.2.d from Table 2.2-11.
F s
= safety factor; a conservative factor applied to each 2.1.1 noble gas monitor to compensate for statistical fluctuations and errors of measurement (dimensionless).
'f = fraction of annual intake of stored vegetation grown 2.2.2.d locally (dimensionless).
f p
= fraction of the year that the cow is on pasture 2.2.2.b (dimensionless).
f, = fraction of the cow feed that is on pasture while the 2.2.2.b cow is on pasture (dimensionless).
I f = fraction of the annual intake of fresh leafy 2.2.2.d vegetation grown locally (dimensionless).
H = absolute humidity of the atmopshere (gm/m3 ). 2.2.2.b ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-67 J
_. ... . -- - _ - . _ - . . = _ - - _ - . _ - . .
l
. l l
l 2.3 DEFINITIONS OF GASEOUS EFFLUENTS PARAMETERS (Continued)
Section of Term Definition Initial Use i
0 K' = constant of unit conversion, 10 pCi/pCi. 2.2.1.b
- . K" = constant of unit conversion, 8760 hr/ year. 2.2.2.b K'" = constant of unit conversion, 10 3 g,j,3 . 2.2.2.b i
i Kg = total body dose factor due to gamma emissions from 2.1.1 radionuclide i (mrem / year per pCi/m3 ) from Table 2.1-1.
l Lg = skin dose. factor due to beta emissions from radio- 2.1.1 nuclide i (mrem / year per pCi/m3 ) from Table 2.1-1.
Mg = air dose factor due to gamma emissions from radio- 2.1.1 4
nuclide i (mrad / year per pCi/m3 ) from Table 2.1-1, 1
Ng = air dose factor due to beta emissions from noble gas 2.2.2.a radionuclide i (mrad / year per pCi/m3 ) from Table 2.1-1.
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-68
2.3 DEFINITIONS OF GASEOUS EFFLUENTS PARAMETERS (Continued)
Section of Term Definition Initial Use P,
g = organ dose parameter for organ o and radionuclide 2.2.1.b 3
i (mrem / year per pCi/m for inhalation 2
and all tritium pathways); (m -mrem / year per pCi/sec for other pathways).
QF = c w's or goat's consumption rate (kg/ day) (net 2.2.2.b weight).
Qg = rate of release of noble gas radionuclide i 2.1, (pCi/sec).
(Qg)G = rate f release of noble gas radionuclide i 2.1.1 for a ground-level release type (pCi/sec).
(Qg )g = rate of release of noble gas radionuclide i 2.1.1 for a mixed-mode release type (pCi/sec).
(Q{} = release rate of non-noble gas radionuclide i 2.2.1.b (pCi/sec).
(Q{)g = release rate of non-noble gas radionuclide 2.2.1.b i for a ground-level release type (pCi/sec).
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-69
2.3 DEFINITIONS OF GASEOUS EFFLUENTS PARAMETERS (Continued)
Section of Term Definition Initial Use-(Q{)g = release rate of non-noble gas radionuclide 2.2.1.b i for a mixed mode release type (pCi/sec).
Q.g
= cumulative release of noble gas radionuclide 2.2.2.a i over the period of interest (pCi).
(Qg )g = cumulative release of noble gas radionuclide i 2.2.2.a over the period of interest for a ground-level release type (pCi).
(Qg )g = cumulative release of noble gas radionuclide i over the period of interest for a mixed-mode release type (pCi).
Q .= cumulative release of radiciodines, tritium, or 2.2.2.b material in particulate form for radionuclide i over the period of interest (pCi).
= cumulative release of radioiodines, tritium, or 2.2.2.b (Q )G material in particulate form radionuclide for over the period of interest for a mixed-mode release type (pCi).
i l
I l
l l
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-70 l
. =
2.3 DEFINITIONS OF GASEOUS EFFLUENTS PARAMETERS (Continued)
Section of Term Definition Initial Use
( )g = cumulative release of radioiodines, tritium, 2.2.2.b or material in particulate form for radionuclide i over the period of interest for a ground-level release type (pCi).
(Qg )AG
= release rate of radionuclide i for the combined 2.1.3.1 source terms of routine Auxiliary Building Vent Stack No. I plus the Gaseous Radwaste Tank (pCi/sec).
(Qg)CP
= release rate of radionuclide i for the combined 2.1.3.2 source terms of routine Reactor Containment Ventilation System plus Containment Purge (pCi/sec).
= release rate of radionuclide i for the combined 2.1.3.3 (Qg)CR source terms of routine Containment Building Ventilation System plus Air Room Volume and/or Operational Containment Purge (pCi/sec).
qi = rate of release of noble gas radionuclide i from 2.1.3.1 the particular Containment Purge, Air Room Purge, or Gaseous Radwaste System (pCi/sec).
R, = monitor reading per mrem / year to the skin. 2.1.1 ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-71
. =
2.3 DEFINITIONS OF GASEOUS EFFLUENTS PARAMETERS (Continued)
Section of Term Definition Initial Use R = monitor reading per mrem / year to the total body. 2.1.1 R.
alpj
= dose factor for age group a, radionuclide i, 2.2.2.b pathway p, and organ j (mrem / year per pCi/m 3 or m2 -mrem / year per pCi/sec).
r = fraction of deposited activity retained on feed 2.2.2.b grass (dimensionless) (1.0 for radioiodines; 0.2'for particulates).
r, = monitor reading per mrem / year to the skin for the 2.1.3.1 Gaseous Radwaste System, Containment Purge, or Air Room Purge.
r = monitor reading per mrem / year to the total body 2.1.3.1 for the Gaseous Radwaste System, Containment Purge, or Air Room Purge.
SF = shielding factor, 0.7 (dimensionless). 2.2.2.b t = exposure time, 4.73 x 108sec (15 years). 2.2.2.b t = transport time from pasture to goat, to milk, to 2.2.2.b f
receptor (sec).
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-72
c: ,
2.3 DEFINITIONS OF GASEOUS EFFLUENTS PARAMETERS (Continued)
Section of Term Definition Initial Use t
h = transport time from pasture to harvest, to goat, to 2.2.2.b milk, to receptor (sec).
tg = average time between harvest of leafy vegetation and 2.2.2.c its consumption (sec).
U,p = receptor's milk ~or meat consumption rate for age 2.2.2.b group a (liters / year) from Table 2.2-10.
U as = c nsumption rate of stored vegetation by the receptor 2.2.2.c in age group a (kg/ year) from Table 2.2-10.
U af = consumption rate of fresh leafy vegetation by-the 2.2.2.c receptor in age group a (kg/ year) from Table 2.2-10.
W = pathway-dependent relative concentration or 2.2.2.b P
relative deposition for unrestricted areas of the
~
controlling receptor (sec/m3 or m ).
X/Q = relative concentration concurrent with actual release 2.2.2.c-(sec/m3 ).
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-73
. =
2.3 DEFINITIONS OF GASEOUS EFFLUENTS PARAMETERS (Continued)
Section of Term Definition Initial Use X/Q = highest annual average relative concentration at or 2.1.1 beyond the site boundary-(sec/m3 ).
(X/Q)g = highest annual average relative concentration for a 2.1.1 ground-level release type (sec/m3 ).
(X/Q)g = highest annual average concentration for a mixed-mode 2.1.1 release type (sec/m3 ).
(X/Q') = annual average relative concentration for location of 2.2.2.b controlling (critical) receptor for inhalation and all tritium pathways (sec/m3 ).
~
(X/Q')g = annual average relative concentration for location 2.2.2.b of controlling (critical) receptor for inhalation and all tritium pathways for a ground-level release type (sec/m3 ).
(X/Q')g = annual average relative concentration for location 2.2.2.b of controlling (critical) receptor for inhalation and all tritium pathways for a mixed-mode release type (sec/m3 ).
Y = agricultural productivity by unit area of pasture 2.2.2.b p
feed grass (kg/m2 ),
4
- ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-74
~ _ _ _ _ _ . __. __
I l
2.3 DEFINITIONS OF GASEOUS EFFLUENTS PARAMETERS (Continued)
Section of Term Definition Initial Use Y, = agricultural productivity by unit area of stored 2.2.2.b feed (kg/m2 ),
Yy = vegetation area density (kg/m2 ). 2.2.2.d Ag = decay constant for the ith radionuclide (sec~I). 2.2.2.b' Ay = decay constant for removal of activity on leaf 2.2.2.b
~7 and plant surfaces by weathering (5.73 x 10 sec -I)
(corresponding to a 14 day half-life). -
ODCM, Midland, Consumers Power Company
-miO283-1828c131-09 2.0-75
- = ' '-- y-- -. .-,e3. , , ~ _y, , , _ , _ . _ _ . , . . , . _ , , ,, _ . . _ . __ , , _. , _ __
2.4 GASEOUS RADWASTE TREATMENT SYSTEM Figures 2.4-1, 2.4-2 and 2.4-3 present minimum OPERABLE Gaseous Radwaste Treatment System and Ventilation System.
ODCM, Midland, Consumers Power Company miO283-1828c131-09 2.0-76
e
- FIGURE 2.C.1 ~
~
GASEOUS RADWASTE TREATMENT AND VENTILATION SY3fEMS s
s5 ,
-- Ii a
,M O
! 0.si.:
~
4 -
gl.l _i g
=r : a
~
IE j j 5,.f. :: -- O - f -
n.
3,-O- '.
- t. .! .! .
I ii,r p
si
.e
.t - .
.7 .. ...e , 3 *:
- e* : i (i88 L z:
r*
ze s r 4 r. 7.L: ir j.1 si g! : . . .
- L:Js g: a f h. !!
l .e .t :: .
- .... d, n e ,: o a n
u.n .
61 e-1g.:
- .2.. !.2t g a s..
u .3 .3 dl di 4
5i . :: .
- E: :53
+- j3i! -- +. jii: + 5!! z!*
e n
.*: . .. g
- 3 a m.
8- g::
- . jet - g .r .
.I '
1 !
di ii i _l ii::s
>+
1 g :. I.*: i .3 .!. 3 y .
- w a :
- ?.::
4 +-_ 475 '
s
- s s. ;
e
. I. a.a
- Ie .
g I_____y ,
r a i . I a c - . . - l a f t- -
3]
. 37Y 3 ~"I :. l r I e r. :.
9 *- a 8 z I T l -
n.i. i .n I :: l = f;:
' . ,. . .. a . a . . . *z -
l
=
ay 3 ,,
!: l ! i l
3 e, l g- l
' :=
5:
i a. > ;
.i !.!! ,
j ;:
-: 8: - 8 5;
4i I
l
~+-
i r8 i 1.;1-l ;
. s I :
. . I l s ..
z o l -
32 -
! (*a-; l l L_____J _
,L i - ::
==
_ r-e; s
g
- e ;
a ,
I*
3 i 1
. .... . . a a s {0 A 1
i.......u. ;.I g-g
. n. . . .u ..,.s.... .., .o n.. .a -
t.; se's . 2.a ....:-.,,.o
. . a.e s. .. .:
..... . ussa. :, .n 1.,n.e, ,l 8; 2.0- 77 ODCM MIDLAND CONSUMERS POWER CO.
c, '
, . g >-
~
.+
i s
-f- -s FIGURE 2.4 2
. n
. .. . e
, w GASCOUS RADWASTE TREATMENT AND VENTILATION SYSTEMS
\
' g.
+ ,
.. s o *2 sa I
~ __
2
.. .m g r _= :
c- .Es! g
.'s s -
.. 3 s .
- ~
~
f s N.
~ ,
~ __
~ '
v i
- 4 .. :
~ ~
e a T 'r 4
~ ->
.. g f ,
.v t
- a
,.'. a s : :
-- g* ~
,3 , . _
1 . , -
4 . . .
as .s
,m .
.. .,2
.s .-
b T
l e
.+ .
s i . N .tsi s
- 51 -
. v_ -
i s n i
s
.n
- ) n:f:-
g
~=
I
- !! - ;yi :i ri 4:1:: ::
Jl:i s: -; :: .-: 5:
._ jib t:.:.*J I
- - iis -
- 3: x p- . . . . , i. :
00 =- 3: l S i:=r
$=i 25 ii
?.:
'i at
- W t':.:*j 5:
g- i a
.'* 32 i
l s* _
~ - . ..t . -
a .
w
/
ODCM, MIDLAND, CONSUMERS POWER CO.
- l l
e e FIGURE 2.n.3 GASE0US RA0 WASTE TRE ATMENT AND VENTIL ATION SY STEM S n ll s
,5 E.
c.
... :: *~
j' &~ig
- l e
. 6 2 J w -v .
> s .
e, :
I:n : =
e a g *! j - - +
t . . .. .
'z _
> a 8 2
- I oo .
3 3 ;I w > r E = gE
, J :
E o
- s c
.j
- 2 M
- .; 8 E 4..
- w9 e a x>
. .l w
- 2 e i.6 ..i..w .
o- L 4
, u 3 C* ,
o -
5 n 3 : E
- 8 .
g =.
~
w.eee . .. j
- r. .
j %
gg !
.. e f .
S$2 3.
- 3. O
,5 w
O=gEik, 15:
- =
IIE! .
- 3). ; 3 8;,;2 :* .
- O og $#3pggo__
- o_ *: ..;.
3 2 z* ;;!. :*
3 3
3 3 303: a 3.:
- g 2-7 0' ~ .g j; - . -8 .
- I 3 3; IE I l
- :: o
- O
. . ! :' s .j
=
. I g := = ; :s o
t u ..
2: :::
- = '~
z e ij a t ~:
2*E [:,; :'
- :; a O 55 T .E 75 282 :
' a i :: ~
- a5
- 3:-
F-
- 1
-j son = i.i.;
.!! 3 3 ::= $: . ;
I. -
z a .
-2.
~
s L
g
. . .f g.
.o
- a a s 8.. .-
-.e. :
O o f !! a: : . :.
. ;3 u ::. _.
, ,a-* '
3 s -
oa -
f a
g.3 53
~ a uz 5se* ' 't l
<=
w > 4 g , ' _z u
~
E 6 e- -- - - - . _ _
O W O--vr if
- E
- t
.: .t a-n.
I 00D
- MIDL AND. CON SUMERS POWER Co.
2.0-79
3.0 RADIOLOGICAL ENVIRONMENTAL MONITORING Sampling locations as required in TS 3/4.12.1 are described in Table 3.0-1 and shown on the maps in Figures _3.0-1 and 3.0-2. ;
NOTE: For the purpose of implementing TS 3.12.2, sampling locations will be modified as required to' reflect the findings of the Land Use Census.
l f
i 1
l l.
ODCM, Midland Consumers Power Company
', miO283-1828d131' 3.0-1 l
e TARIS. 3.0-1 RADIOLOGICAI, ENVIRONMENTAL NONITORING PROGRAM Expo 1ure Pathway Number of Samples &
rnd/ar Sample Sample 1. orations Sampling & Collect ion Freepfency Type & Frequency of Analysis A_irborne Ridicindine and 5 - N, NE, E Sectors Continuous sampling at approximately I cfm Radiciodine cartridge: weekly for 1-131.
Particulate within 1000 meters with weekly collection. Sample size Particulate filter: Gross beta veck!y, gamma N Sector 2-3 miles approximately 2P5 m 3 isotopic quarterly on romposites by location.
S Sector 10-20 miles Direct Radiation 40 Stations Continuous dose accumulation by two far Gamma dose quarterly.
more) thermo-lumineu rnt dosimeters per location.
Wterhorne Surface 2 - Tittabawassee River Composite of weekly grab samples over a Gamma isotopic analysis monthly, tritium upstream and downstream one-month period. analysis quarterly.
of the discharge.
Drinking 2 - Midland and Bay City Composite sample over a one-month period. Cross beta and gamma isotopic monthly, tritium water supplies. analysis quarterly.
Aquetic Sediment 2 - Vicinity of Intake and Semiannual collection on the distharge Gamma isotopic analysis semiannually.
distharge. side of the river.
lngcation Milk 3 - 5 3 Miles At least once per 31 days during the Gamma Isotopic including 1-131 analysis of months May-October inclusive. cach sample.
Food Products 3 - Nr Quadrant < 3 miles Collection of broadleaf vegetation monthly Gaiana isotopic and 1-131 on edible portion 1 - S Sector 10-20 miles during the third quarter, as available. only.
Fish 2 - Tittahawassee River up- Semiannual collection as available. Gamma frotopic on edible portion only.
stream and downstream of discharge.
If 3 samples are not available within 3 miles, will use nearest available 3 sampics within 5 miles.
Milk monitoring is not required if the dose due to the broadleaf vegetation pathway is more limiting or the dose from the milk ingestion pathway is 51.0 r:ren/ yea r.
ODCM, Midland, Consumers Power Company ciO283-182Hel31 3.0-2
r r _.. _ _ _ _ . _- - - - - - - -
e 9 A l
') - [
4
, i i
P NS Os
+
sg WS 04 l
NS 06 AY NS 03 Y + I 33 o s.2:
+ +v=, so~,
i YN forested Selleck Creek .
7 /[
- ~
Ns5s+ ,,,,,e,,,
,/
"5-[ 'Yp
'[ N NS Og ,
_ _ 4 B
NS ll t
' I M
1., gW' U Top f Safft El astf 2e i
L Coettes pens NS 09 Y I
l
' K I'
J )
' T I
/ op er ofn,z gig,
./
u %-1U
,/: 6ersonville geog
"! [
g Ul
\.
P O
C D
us 02
IA+ 1 p 1 es. us.si i 1A J T J -- 1Jr e5 + en \ J \ __
- . 5, g x E CARJ hus.12 4
ft l $
%,s tallroes
> ncs '**
us.
' 3' us.sg 4 AIRBORNE F + DIRECT (TLD'S)
O SURFACE WATER sik*
e SEDIMENT D FOOD E FISH PRODUCTS l
- 5 MILK oYE.'t Tt7.cs.r. k hak On e DRINK No us. ,
M e Card 8
I CONSUMERS POWER COMPANY N MIDLAND PLANT H ODCM ENVIRONMENTAL SAMPLING LOCATION
\i : .
WS 60 \
MAP ON THE SITE PERIPHERY k \ FIGURE 3.0-1
, 8307130222-Ol 3.0-3
r- L ._ . . _ _ . . . - - - . _ _ . ~ _ , . _.. . . . . .__ ,m-_. _ . . _ . . _ _ _ . . _ . . . .
e ' T: m '. il-
- 2~r si T q
A ! ,,
s ,
f T '.
i **
^g . .
t
, -3,
- dl-l '
scmaar
. - I . . 1 , p 4 %
) - -A ' . . j- A.qi. 2. . .. _, e
--' _ % , E ....... .. g%
a
- q I.
y . . ,
, . e t r p_y.
a a,,
f 3
j .
- r. . ,M A ....m- ,
r r -
i 1
l ,,
.* - : 4 ! , 1 :
, co ~.- 'dT. y g.......i...........qt .,....
- , -r
- W 1"' "'
L x , ,L . ., '. -
9.~ - . ; . - - - . . .
i
% 3 , 4 Lap W %s- %
eastidM i,.w.
. 5 k1 -
, '(% ?, s ,
h* '1*
e h w d -
- '3'-
~
e e f* **A 4
. Dutt
"
- A '
, s us';--*- i
- ./ g 9.G. c \ *; ..
p
' M.' * .;
g . ..
..t
- I
- q. . 4 % e ..
- ..a+- p%-
- J d R.,r. : E- ... . R- % A".A'~ *-.7. , .
- !%.i .
4
. s . .
s' *.r > .< ; ow.; n t ,2 ."*'
! -w; g~%
4 1. s o s. - ,
J .
.f., cp s m j ; *'s .. .
,apc , m 4
. 6 4 si .. *..M p .* .. .. .
- s. [ 5 ,i .
j A f
. " . ..-- N K i
.r.'JA[-. .D iR*
r
- " ,Y A e .v.S-66 "a ,
4
, NS-31 (Nful . _ .
s -
A.'
a' y~, , -n . .
- D I
=-
. . < =
, y ..
j'ff,,n ,
. .- . . . n. , . .
[ - .
.. . :1 .. % _ _5 .~ . ve -
3 g,,.....
{ v.w _. -. : . _ .
g- " ' ._
'Q- "
l MS-67 A NNSf7 NS486
......' ; .. m" .........n2
. . . . .... .. * =**'
\
.=
L -
- &NS-8 '"1 -"
.. ~"-
3
. t .-r : a H3-85 -
./ ~ ;
f ' '
i . I p. -" MS-68 w3 p
, s u. , _ _ _ _m.
, . om
..m
,_. . . . c. ,.. ,. +
p.
g MS-80 a.
11 O gg kg . . MS-3 2 NS.31 -
__ __ l. _ . ~ i ~ a _ _-a_m .
f.y,,,=- 4 A =85 s ..
NS-8
,8 a.3 2 1 -
. - s MS 27
. r
-- k
.i * " -' MS-33 . . W
~1..L ; - ,' .=.. +,_ y ..- ' ' ".i . -
t
, p,i .7 1. .' t F -* - i '~d MS-70 . '
i -
r . ,
+
g,
- y
- r 47 l
. . ; MS-M (Mil.K) ,, l,Y ' -
J - .' -- ;; .
{*"*:.).!?1_-
.,,... e E ,. .
, . ;ze .y_
7, us-71 ,
- ,' tv 2 ..
.. .
- 31 MS-39 % 3-20 y- '. - _-
(p .
.A. . . -(;.. ... .. KK) - ;
Mi-by
. s, gg j I 5 r
m.q n-~.. .
. v. .. .! f. --
.v ., - ., si
~
- e. ~
, n. y w, 5,
- ~
- ?,
- v g .
t MS-72+ vgu , .. WSJ76 .m 4.r ) , ,i i
- i .
.. MS '
. s . . .
- ' ~-
"S "IMILK
'~,-
- M ,
MS-73 4 -
+ +
s' #'
ec.ene xc. .
I ,3 1 S m.NS-74 . ..-
,, ,"' y . ....
' .p-(.
W=
t ,
I it O l. , I* j hm"l s R' i *>, ' - -
1 A 1. F' ) . '
,., j
.',-x, v
+ .Q f ~
p .. .
6 ~q. - ,
r O T
* ~
M
' 1gl.:
P F.
u s a, " . '
. R. R. ; ; ; - . , - .
E -
s.
, ea,stw ,- . . . - . . - . _ . .. - - . - -
- t. i r . .,- .
. O I 7 : -
I
~.
.c .
- U I , a
,, i.s
! s i .
_s; 4 e r e . .
8
, , ". ' ,,,,f .U
-a
- - ru m., 2 -- 9mi I e 1 8 . .,. '
- I *
., g a RI L la ...s u o,j
._.c - - , a
- .e. s*
- n. g
,,... . - . - . . .a Q J s .
~ lf .
r,. T E15 ,)
'%' 11_'i , . .L I J O N E S'F I E 15%
- y *- ,
' . L - . ,
~E 4.L. R e ,-- - p .-~~ 4 y ?
- 1. .-I; R. .*** . - r m. - ,J.
k."-4g !
^
s ___. . A _ y
\ , .
2 -
. 5
} g l 4
-3a i .e g q ;.
!
- I - -
= a statu ',
- MS-IS ~(NILK) "
34 H3 l $ >9' e < A, i .
. * -* g,w , - - , ' , . . , * ' Oy. e a--~
- %Q *.'. --- , --
c 5
,2
- MS 1( , s .
(f((s . I I I ' ,, f* m ." -.
inct . i f 8
! ' ' - - 8 -J
._ _ __L M m ^J id'E -- - -
1 .
. - . m. , ,
)
,. , I . , f ,) l I .' i C * *.i ;
a f .
- . J
~
. _ _ . _ _ _ _ _ . . _ .__ ._ 7 _ _ _ _ _ _ _L ]
t
h. gp,- H =
p WL'g,;-l ! % '.="-
{
r
.4-1. . . m1 ';-
y u.g '-
rp.n,4 !-
a, l. ,
,e r - !. .
.g;. _ .
sann
[, ; I f 6 f . nL.iL4\ ,
m ,- 4 J . u[ )z.~.... L. . . n.-n --
f : '
_ z ,_., .q t! 84 i ENViRONWENTAL
. . ,N ,p a!a 7.~...,,+* ._ :w.-.\ ._ w,.,,\ e.
SAMPLE SYMBOLS Lm_g i mg! y...)7h %+- w.;; A Aw y.
7 m .%,.( s<g
- a AIRBORNE f
.w.s ' .
s y ' y. e p::- . i.\ + TLD p ~u. ; I.* _. d ,,:: "p % L . _.'.. $ _4 o SURFACE WATER
~s l
I ~
~ .e -
p .{g . %-; gg, . ... e SEDlWENT e DRINKING WATER
,;p "9 -_A 7 9 _ q' s
( ..
y%. .
~
4 -
l, . . a..
.e.b., 0 FOOD PRODUCTS
!. l' , t
- -- ' g . . .?
.r . :
e FISH J
. aunc . 7. , e . 4, %s g..' a.%._
y _.
it
,, .a
- . ",...\ g g;gg i -
! , ,. W .m ,
sW, , w %_; ,,,)rv. 4t g f,h
'_l 4
__lj:.
5 n ,.j,, ,
naasaagsp[3
-c j 4-Ae, ; A. g., * -.
, ,s
. AC_a . j .h _..e , c ,'m .
g,, J!^ ,
,N, _ g o R t; l
..,, . : r% * ! . s . .
e !s
~ .: .J . B .m.. .\. ,
H- +- -.- s= w ,A_ %f, g \.g', .1. _ . . . _. NS-25 s
? *~
y .
o ,y. e l .i l ,, o e
,rf'
.R ,
, t'70 .s Nini& W-.-
- t Ol j I
L su s ; ....c..- --
a-J[j,eA )O.h",'
q ES-79
". * *g --'+ ! . )a::- 7t : - W H ,f 4
eds- '
~,
-' +-a w . :. w_.
eg .
l .
J' I
. y. f . .f ,.
. as . r-.-
-i
- 4.4. . ,:
p.4,3,yo!=.,g 4.Q.;,- ..
3 g
l g ,. .. 4,. sa _,m.p ,.:. f: e., , 3
,q..,,,.
l . . ,
7, , .m. . -g. - ,
[ v,. EmJ
'e - - --
=.
. , ' ~ r.i s.i.o.4. . W "u %_ L D i d
-Aw.a. ca
~~
MS.8g . .- .
, . . , , g 1 -
,c y
Q y 4 - t, 4rigj . ,. \
G
. ,j. 4, t _l L &' . s 'J f r; ., r.,;, ( j
~~
= ' i
/ _
?- v y
, e i
- 2, .
1 .. t .
r ! l <
4' .
?
l
%n .sexar [ ,.,,.P<Mg ....
,_ -u., i yr M
. 6 f. .5.
- .s's % ,. ( ? . s .! l,. *. mLJ
,. '%.t.J _4 , ,. ,
k-
>... . . . , -- . .*>_f.. e* .s
- 4. .-
- t. ,,-
j t'
.g gj . gJf,k.r..5s
- r ' . g , ,,, r g I H_w n -
.t- s I RIA'N
._y..~-
A E 2 .s . 1 f-i 1
- a. ,.s, Q. . y s . I
'. -:::,'q* O-. A,, i f ~ *',If,_t,'_:
6
.. . g i- .
AB : A g% A. L NW
_ Q t
.i s
.'p.
, '. '"'" . ; Y..gT' ", DI" i
F*
- V / %Na 1 1 { ; { .
- g. .a 'N-.
. m m . __ _ _.;4( '. , y , , ,, q ' y
- K iO CI H fVf I { L LS E j' I . "4 . *!, I ,
'
- i
.-- .s. ,.
-m_.. 's w_\_., . _
f
- k,..,2., l s : -
- g. . ,,
i f~ a.[,.
- e i .,
w .n, f-
-i N. .;/
- ,f.,
6
.5 8 C* , , . .
.w
] ,, _I . a v' g f_. x . ... ,
i 4 .
- l. ! 8 t 1 7;37,y_,- fjgg g g
leti l ,,,,,,,,,
p .. , ,j 6 r4 , iqsasag,;
.g., p ,c ? .<
, 6 , , ri A r t e ~ et #
3 st d-
, . ... ), g]
3 0
. ..j=s-._d _ EAR _ ,4-;3 , ,
l
+
J-t sn .. .... t.
,s.
-l t .
n R O L L.
. *j t sca'"1 cists.,A w. .s 'oN 1 ,. - !_ ,+aml i
- a. .t i
- .... CONSUMERS POWER COMPANY y.4 7
.(gpJ.,. .. k ..'
- j tq L 4 w ,[ i e
, 1
- MIDLAND PLANT g Lu~~Ans(,., ,imT"- LO-ft,...? '; ~ ... ODCM
.,...- y
_ _m.7. 7 j wp 7.i pqs.4 .y
,.y .N Wr.%.
ENVIRONMENTAL SAMPLING LOCATION i,
J; 3. g .
. m} -
'. s., g .,. l .
y - _
.-.- MAP BEYOND THE SITE VICINITY s . . - - - -
p ,
.6 . _.
. . . -- - g 52 2 .n '
er.
,f: -. y A , . A G I .- ,. N . A.; ,
. . u . . . .',.- _ .. . . R ,1,. ., - .
g x,
- . FIGURE 3.0-2
- s. . t. m..,. . t......,.
88 0 713 0 2 2 2 - oh 3 0-4
, l a ;*
l TABLE 3.0-2 ,
1 Midland 1 Radiological Environmental '
Monitoring Program Sample Locations ;
Number Approximate Location Samples MS-01 ~2400 ft ENE, power pole near TLDs SE corner of Dow perimeter fence MS-02 ~1750 ft NE, 4th power pole E TLDs, Airborne of corner in Dow perimeter fence MS-03 ~1350 ft NNE, instrument bracket on TLDs Dow tertiary feed pipe MS-04 ~1350 ft N, power pole near TLDs, Airborne N end of steam pipe bridge to Dow MS-05 ~2250 ft NNW, power pole near TLDs fork in road, S of Dow Bldg 1005 MS-05b ~900 ft NNW of Mech Shop- TLDs MS-06 ~2500 ft NW, guard post on N TLDs Dow tertiary pond dike MS-07 ~1200 ft W, base of site TLDs Meteorological tower MS-08 ~2900 ft WSW, corner fence post TLDs near NW corner of pond dike MS-09 ~5900 ft SW, corner fence post TLDs near where pond fence drops off dike, Wells #14 and #15 on SW pond dike MS-10 ~6250 ft S, near Well #12 on TLDs S pond dike, Wells 11, 12 & 13 on S pond dike-MS-11 ~5400 ft SE, on rail of pond TLDs outlet structure on E pond dike MS-12 ~1150 ft E, on SE leg of TLDs, Airborne 138 kV transmission tower, Wells 1, 2 &.3 on the N pond Dike and the site dewatering discharge ODCM, Midland, Consumers Power Company miO283-1828f131 3.0-5
t TABLE 3.0-2 (Contd)
Number Approximate Location Sartples MS-13 ~2.5 mi N, Ashman Circle TLDs, Arborne Substation MS-14 ~18 mi SW, Breckenridge Substation TLDs, Vegetation (Vegetation G-15, G-14, G-13)*
MS-15 ~12 mi S, Hemlock Substation (Vegetation G-1, G-12)* Vegetation-(Milk-cow herd) Milk MS-16 TLD - QC Sample TLDs (Dummy floating location)
MS-17 SSE, Cooling Fond - Unit 1 & 2 Surface water, Sediment, Discharge Side Fish MS-18 ESE, Cooling pond - Service Surface water, Sediment, Water Intake Fish MS-19 S, Cooling pond - Circulating Surface water, Sediment, Water Intake Fish MS-20 ESE, River - Railroad bridge Surface water, Sediment, Fish MS-21 NNE, River - Makeup Screenhouse Surface water, Sediment, Intake Fish MS-22 SE, River - Freeland Road Bridge Surface water, Sediment, Fish MS-23 Presently not in use MS-24 Presently not in use MS-25 E, Bay City Drinking Water Supply, Drinking Water at Wilder Ed Service Center MS-26 Drinking Water Supply, QC Sample Drinking Water MS-27 N, Midland City Drinking Water Drinking Water, Suppy at Washington St Service (TLDs Storage Area)
Center MS-28 E Sector (May sample several Milk locations, specify type of sample and exact location under Remarks)
- Garden sample numbers ODCM, Midland, Consumers Power Company miO283-1828f131 3.0-6
n e
- TABLE 3.0-2 (Contd)
Number- Approximate Location Samples MS-29 SE Sector (Milk - 2 goats) Milk
-MS-30 ESE Sector (Milk - I cow) Milk MS-31 NNE Sector (Vegetation G-4, G-7, Milk, Vegetaton and G-11)*
(Milk - cow herd)
MS-32 NE Sector (Vegetation G-2, G-3)* Vegetation MS-33 ENE Sector (Vegetation G-5, G-6)* Milk, Vegetation (milk - 3 goats)
MS-34 N Sector (Vegetation G-8, G-9, Milk, Vegetation and G-10)*
MS-35 NE, River - Plant Discharge Surface water, Sediment, Fish MS-36 Presently not in use MS-37 Presently not in use MS-38 Presently not in use MS-39 Presently not in use MS-40 W Sector (Milk - I cow) Milk MS-41 Presently not in use MS-42 Presently not in use MS-43 Presently not in use MS-44 Presently not in use MS-45 Presently not in use MS-46 Surface water QC sample MS-47 QC sample MS-48 Vegetation QC sample MS-50 Fish or sediment QC sample MS-51 1000' WNW/ rear of equipment parking lot TLD
- Garden sample numbers ODCM, Midland, Consumers Power Company miO283-1828f131 3.0-7 L
o TABLE 3.0-2 (Contd)
Number Approximate Location Samples
-MS-52 1000' NW/ steam bridge fence near Bullock TLD Creek and Tittabawassee Rivers MS-53 1000' NNW/just west of screenhouse TLD MS-54 800' N/near screenhouse TLD MS-55 900' NNE/near screenhouse TLD
'MS 1000' ENE/near screenhouse TLD, Airborne MS-57 1000' ENE/ west of dump TLD MS-58 4200' WSW/ guard house fence TLD Main gate MS-59 4000' ESE/ railroad spur just off TLD pond dike road MS-60 6200' SSE/ pond dike south of blowdow TLD area MS-61 1000' SSW/ pond dike southwest corner TLD of pond MS-62 2000' WSW/ guard parking lot fence near TLD propane truck filling area MS-63 600' SE/ north end of baffle dike TLD MS-64 15-20 mi/ Bay City Service Center TLD parking lot, southwest corner MS-65 Tri-City airport, roof of FAA Building TLD MS-66 Sanford DNR Station TLD MS-67 4 mi NNW/Larkin Substation, Eastman TLD Road past Wheeler Road MS-68 4 mi NW/4 mi north of Northwood TLD Institute on W Main MS-69 4 mi WNW/at Metro TV & Appliance on TLD M-20 between Homer and Sandow MS-70 4 mi W/ corner of Pine River Road and TLD Parrie ODCM, Midland, Consumers Power Company miO283-1828f131 3.0-8
% 'o TABLE 3.0-2 (Contd)
Number Approximate Location Samples MS-71 4.5 mi WSW/ corner of Gordonville and TLD Homwer Road MS-72 4.5 mi SW/on Brooks in front of house TLD
- 2242 MS-73 4.8 mi SSW/Freeland x Poseyville Road TLD MS-74 4.5 mi S/ corner of Freeland x Sasse TLD MS-75 4.8 mi SSE/ corner of Freeland Road TLD and Smith MS-76 4.5 mi SE/ corner of Brooks and Orr TLD MS-77 4.8 mi ESE/ corner of Hotchkiss and M-47 TLD MS-78 4.2 mi E/ corner of Carter and Salzburg TLD MS-79 4.2 mi ENE/ corner of Carter and Midland TLD Road MS-80 4.3 mi NE/ corner Wilder and Flajole TLD MS-81 4 mi NNE/ corner of Waldo and Wheeler TLD MS-82 5 mi N/ corner of Jefferson and Wackerly TLD MS-83 4.5 mi ENE/ north on Carter next to TLD railroad tracks MS-84 4.6 mi E/one-half mi east past Carter TLD on Salzburg MS-85 4.1 mi NE/ west of Flajole on Wilder TLD MS-86 4.5 mi NNE/Waldo 1/2 mi north of US-10 TLD MS-87 4.7 mi N/ corner of Swede and US-10 TLD l
ODCM, Midland, Consumers Power Company miO283-1828f131 3.0-9 i
cr. .(
- ,. . e s } ~,
Consumers Power James W Cook Vice President - Projects, Engineering and Construction Generet offices: 1945 West Parnell Road, Jackson, MI 49201 * (517) 78i.1-0453 June 23, 1983 Harold R Denton, Director Office of Nuclear Reactor Regulation Division of Licensing US Nuclear Regulatory Commission Washington, DC 20555 MIDLAND ENERGY CENTER PROJECT MIDLAND DOCKET NOS 50-329, 50-3'30 0FFSITE DOSE CALCULATION MODEL FILE 0973/0505.20 SERIAL 22018 ENCLOSURES Sixty Copies of the Midland Plant Offsite Dose Calculation Manual Enclosed are sixty (60) copies of Consumers Power Company's Midland Plant Offsite Dose Calculation Manual for NRC Staff review and approval. The Midland Plant Offsite Dose Calculation Manual is submitted pursuant to Section 3.6 of "The Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants," NUREG-0133.
~
JWC/JMT/fms CC RJCook, Midland Resident Inspector DSHood, US NRC DBMiller, Midland Construction (w/o)
DRHoffman, US NRC Od I
\
oc0483-1732a131
jn- .. .
CONSUMERS POWER COMPANY Midland Units 1 and 2 Docket No 50-329, 50-330 Letter Serial 22018 Dated June 23, 1983 At the request of the Commission and pursuant to the Atomic Energy Act of 1954, and the Energy Reorganization Act of 1974, as amended and the Commission's Rules and Regulations thereunder, Consumers Power Company submits the Midland Plant Offsite Dose Calculation Manual. This information is also submitted pursuant to Section 3.6 of NUREG-0133.
CONSUMERS POWER COMPANY By JW ook, Vice President Projec , Engineering and Construction Sworn and subscribed before me this 27 day of June 1983 .
~ an.ad_D _ Notary Public /
Jackson County, Michigan i
My Commission Expires September 8, 1984 l
l l
l t
l l
oc0483-1732a131